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Abstract 
 
Aim:  
To estimate: 
1. The incidence, prevalence and disability adjusted life years (DALY) for traumatic brain injury 
(TBI) in New Zealand (NZ) in 2010 projected to 2020. 
2. From a societal perspective the direct and indirect cost of traumatic brain injuries (TBIs) in New 
Zealand (NZ) in 2010 projected to 2020. 
Methods: 
A multi-state life table model was constructed using inputs for first-ever in a lifetime TBI incidence and 
severity distribution from the Brain Injury Outcomes New Zealand in the Community (BIONIC) study, TBI 
mortality data from the NZ Ministry of Health’s Mortality Collection, and population data from Statistics 
New Zealand. The modelled estimate of prevalence was combined with the disability weights for TBI (by 
stage, and severity level) from the Global Burden of Disease 2010 study to obtain estimates of health 
loss (DALYs) for TBI. TBI incidence and prevalence were then projected to 2020. 
An incidence-based, cost-of-illness model was developed using data from the BIONIC study. Details of 
TBI-related resource use during the first 12 months after injury were obtained for 725 cases using 
resource utilisation information from participant surveys and medical records. Total costs are presented 
in NZ dollars (NZ$) year 2010 value. Multivariate probabilistic uncertainty analyses were undertaken to 
provide information on the strength of the results. 
Findings: 
Approximately 11,300 first-ever incident traumatic brain injuries occurred in NZ in 2010, with 527,000 
New Zealanders estimated to have ever experienced a TBI (prevalent cases). The estimated 20,300 
DALYs attributable to TBI accounted for 27% of total injury-related health loss and 2.4% of DALYs from 
all causes. Of the total TBI attributable DALYs 71% resulted from fatal injuries. However, nonfatal 
outcomes still accounted for a substantial share of the burden (29%) with mild TBI making the greater 
contribution of non-fatal outcomes (56%).  
Total first-year cost of all new TBI cases were estimated to be NZ$71 million with total prevalence costs 
of NZ$151 million. The average cost per new TBI case over a lifetime was NZ$8,824 (95% Cl NZ$7,118-
NZ$11,709), varying from NZ$6,908 (95% CI NZ$5,597-NZ$8,286) for mild cases to NZ$54,605 (95% CI 
NZ$24,359-NZ$97,371) for moderate/severe cases. Due to the unexpectedly large number of mild TBI 
(95% of all TBI cases) the total cost of treating these cases was nearly three times that of 
moderate/severe. The total lifetime cost of all TBI survivors in 2010 was NZ$218 million and is expected 
to increase to NZ$263.9 million in 2020. 
xvii 
 
Conclusion: 
The burden of TBI in NZ is substantial and mild TBI contribute to major part of nonfatal outcomes. The 
results suggest that while the cost of treating TBI varies greatly with most severe TBI attracting maximal 
costs; the cost of all mild TBI cases accounts for a large proportion of the overall impact due to the 
increased incidence. There is an urgent need to develop effective interventions to reduce the incidence 
of lower cost mild injuries.   
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CHAPTER ONE: Introduction 
 
Overview  
Traumatic brain injury (TBI) is a leading cause of disability and death in New Zealand (NZ) (Feigin et al., 
2013) and persons of all ages, ethnicity and incomes are affected. Brain injury has a significant impact 
not only on the individual (Aitken et al., 2009), but also on their immediate and extended family or 
whanau (Aitken et al., 2009), friends, and society (Mock, Quansah, Krishnan, Arrelo-Risa, & Rivara, 
2004). This study will estimate the number of incident and prevalent cases of TBI identified within the 
Hamilton and Waikato region extrapolated to the NZ general population in 2010. This study will also 
estimate from a societal perspective the one-year and life-time direct (medical) and indirect (loss of 
productivity) costs of TBI in NZ in 2010 projected to 2020. Quantifying the economic impact of TBI in NZ 
may inform the magnitude of costs relative to other conditions, however it does not inform whether 
spending on healthcare for this group should increase or decrease on the basis of the likely benefit for 
more or less investment made. No reliable information on the economic burden of TBI exists in NZ or 
internationally. This study will provide essential information for health care services provided for TBI in 
NZ.  
Traumatic brain injury is an important public health issue 
Internationally injuries are responsible for approximately five million deaths worldwide (Krug, Mercy, 
Dahlberg, & Zwi, 2002), over half of these due to TBI alone (Kraus, 1993). The incidence of TBI is high in 
developed countries. For instance, in the United Kingdom and North America 200-300 people per 
100,000 are admitted to hospital with a TBI each year (Torner & Schootman, 1996). In-hospital incidence 
in NZ is higher, estimated at 600/100,000 (Barker-Colllo, Wilde, & Feigin, 2009). Despite the reported 
incidence in NZ being higher than for overseas populations, these rates are still likely to be a significant 
underestimate; excluding cases of mild TBI which account for approximately 70-90% of all TBIs (Von 
Holst & Kleiven, 2007), non-hospitalised TBIs or those TBIs that do not seek immediate medical 
attention (Maejima, 2001; McGarry et al., 2002; Tate, McDonald, & Lulham, 1998), and TBIs 
undiagnosed due to their being overshadowed by other conditions (e.g., internal injury, spinal cord 
injury, facial/hip fractures). Much research focus to date has been on the outcomes experienced by 
those having a moderate and severe TBI (Access Economics, 2009; Davis, Joshi, Tortella, & Candrilli, 
2007). It is commonly accepted that these survivors experience significant disability and the highest 
usage of health resources. Less is known about the magnitude of mild TBI and its complications  (Cassidy 
et al., 2004) despite a growing literature suggesting 70% to 90% of TBIs are mild (Maejima, 2001; Tate et 
al., 1998; Von Holst & Kleiven, 2007). A recent World Health Organization (WHO) systematic review 
reported the annual incidence of mild TBI is estimated to be over 600/100,000. Current evidence 
suggests mild TBI is of great interest and can lead to a significant and persistent difficulty (New Zealand 
Guidelines Group, 2006; Wrightson & Gronwall, 1998) such as post-concussion (Sotir, 2001; Yang, Tu, 
Hua, & Huang, 2007) and intracranial haematoma (Stein, Burnett, & Glick, 2006; Stein, Fabbri, & 
Servadei, 2008).  
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The risk of TBI is known to increase between 15 and 30 years of age, and TBI-related mortality peaks 
from 15 to 24 years of age (Torner & Schootman, 1996). Due to the high incidence of TBI at an early age 
and the long-term impact on employment, TBI-related disability has enormous personal, economic and 
social consequences across the lifespan (Donders & Warschausky, 2007; New Zealand Guidelines Group, 
2005).  
Previous studies have described differences in TBI incidence and outcomes by ethnicity or race (Hart, 
Whyte, Polansky, Kersey-Matusiak, & Fidler-Sheppard, 2005; Langlois, Rutland-Brown, & Thomas, 2005; 
Rutland-Brown, Wallace, Faul, & Langlois, 2005; Sherer et al., 2003).  In particular, previous authors 
found greater risk of TBI and higher mortality after having a TBI among ethnic minority groups compared 
to European ethnicity (Frankowski & Whitman, 1985; Thurman, Dunn, Guerrero, & Sniezek, 1999; 
Whitman & Desai, 1984). The results from a study on functional outcomes and social integration a year 
after having a TBI suggests that while all experienced some impairment, minorities reported feeling 
isolated, less engaged in social integration, and less involved with friends and family (Rosenthal & 
Harrison-Felix, 1996). Another unfortunate consequence from having a TBI among minorities was low 
return to work and employment rates at one-year post injury. The result was also found for those who 
were employed prior to injury (Hodgkinson, Veerabangsa, Drane, & McCluskey, 2000; Livingston et al., 
2005). Bazarian, McClung, Cheng, Flesher, and Schneider (2005) assessed ethnic disparities in 
emergency departments among those with mild TBI in the US. Their findings concluded that while 
incidence among ethnic minorities was higher than among white Americans, ethnic minorities often 
experienced longer waiting times to see a doctor and were less likely to be referred to other physicians 
upon discharge. 
Significant ethnic disparity in TBI incidence has also been reported in NZ. For instance, Barker-Colllo et 
al. (2009) noted that in-hospital incidence for Maori and Pacific men were much higher than the non-
Maori and non-Pacific population, suggesting that Maori and Pacific people share a disproportionate 
burden of TBI in NZ. The NZ TBI Guideline Development Group (New Zealand Guidelines Group, 2006) 
identified an urgent need to quantify the incidence and burden of TBI in NZ. This study will address one 
of the eight future research objectives identified by the Group (New Zealand Guidelines Group, 2006) by 
contributing to the knowledge of ‘burden’ by quantifying the incidence and prevalence of TBI for NZ and 
by estimating the direct and indirect cost of TBI. 
What is traumatic brain injury? 
TBI is defined by the WHO and the NZ TBI guidelines (New Zealand Guidelines Group, 2006), as an acute 
brain injury resulting from mechanical energy to the head from external physical forces (Carroll & Holm, 
2004). Operationally, TBI has been defined as including the presence of ≥1 of the following: (1) 
confusion or disorientation; (2) loss of consciousness; (3) post-traumatic amnesia; (4) other neurological 
abnormalities (e.g. focal signs, seizure) (Carroll & Holm, 2004). These indices of TBI are not due to drugs, 
alcohol or medications, caused by other injuries or treatment for other injuries (e.g. systemic injuries, 
facial injuries or intubation), or caused by other problems (e.g. psychological trauma or  co-existing 
medical conditions) (Carroll & Holm, 2004).  
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Figure 1: Illustration of brain impact  
 
TBI severity has been defined using the standard definitions outlined in Table 1 (Ponsford et al., 2004; 
Shores, Marosszeky, & Sandanam, 1986; Teasdale & Jennett, 1974). Mild TBI is defined as Glasgow 
Coma Scale (GCS) (13-15) and/or post-traumatic amnesia (PTA) (Ponsford et al., 2004) <24 hours; 
moderate TBI  as GCS 9-12 and/or PTA one-six days; and severe TBI  as GCS 8 or less and/or PTA seven or 
more days. If GCS and PTA severities differed, the more severe category is assigned. If no information on 
PTA is available, severity is based on the GCS score alone. All confirmed cases of TBI where a GCS score 
is not recorded are classified as mild. 
Table 1: Classification for severity of traumatic brain injury 
Severity of injury Glasgow Coma Scale 
Score 
Duration of Post 
Traumatic Amnesia 
Mild 13-15 <24 hours 
Moderate  9-12 1-6 days 
Severe  <8 7 days or more 
 
Economic burden 
Previous studies have suggested that the economic burden of TBI is substantial, with known 
approximations in Europe for annual direct healthcare cost of €2.9 billion (Gustavsson, Svensson, & 
Jocobi, 2011). Similarly in the United States, the Centre for Disease Control and Prevention estimated 
direct and indirect costs of TBI totalling between US$56-60 billion (measured in 1995 dollar value). 
Given the long-term economic impact and burden of disability to family, work and society, average 
lifetime cost per person for TBI in the US is estimated to be US$396,000 (Faul, Wald, Rutland-Brown, 
Sullivent, & Sattin, 2007). The cost of TBI in Australia was estimated to be AU$8.6 billion, costs 
attributable to moderate and severe TBI was AU$3.7 billion and AU$4.8 billion respectively with the 
greatest portions borne by the individual (64.9%). Lifetime costs per case varied from AU$2.5 million for 
moderate and AU$4.8 million for severe TBI across Australia (Access Economics, 2009). One limitation of 
previous studies is that these focused on: i) more severe injuries and ii) hospital admissions only; this 
means that the cost of non-hospitalised cases and mild TBI has not been considered. 
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In NZ, the Accident Compensation Corporation (ACC) reported an annual payout over NZ$100 million 
(measured in 2005 dollar value) for post-acute TBI claimants (New Zealand Guidelines Group, 2005). 
Reported cost was inclusive of all new and on-going TBI cases. Cost figures described here may be an 
underestimate as it is widely accepted that many TBI cases are mild and sufferers either do not seek 
immediate medical attention or are misdiagnosed. As a consequence, these cases are unlikely to make 
an ACC claim and will not be identified by ACC statistics. Accurate total cost information for TBI is lacking 
both here in NZ and internationally. Previous studies have used national hospital data to identify the 
associated costs with TBI (Access Economics, 2009; Davis et al., 2007; Faul et al., 2007; McGarry et al., 
2002). Despite current studies on the outcomes and costs of TBI, information on direct (including third-
party payments) and indirect costs is limited.  
Why look at the costs associated with TBI? 
There are a number of advantages linked with understanding the contribution of costs associated with 
TBI. Firstly, estimating the cost of TBI provides additional information in quantifying the magnitude and 
scope of the problem and potential savings from interventions aimed at reducing the incidence, or 
improving treatment for TBIs. Secondly, identifying the predictors of high costs, including differences by 
age, gender, ethnicity and severity of injury and/or other measures of socio-economic status, can help 
health care providers identify the sufferers who are most likely to be in need of extensive treatments. 
From an equity standpoint, evidence of differential access to services by subgroups within the 
population (i.e. that have greater access to services than others) provides information on the extent to 
which NZ is meeting the health needs of its disadvantaged populations. Here costs reflect the amount of 
resources used per individual, so therefore act as a “proxy” measure of health care utilisation. Good 
treatment requires people to have good access to care, so if TBI survivors do not have good access, as a 
consequence allows researchers to identify key leverage points indicating areas where public health 
could intervene.  Lastly, by analysing the cost of TBI services, we then are able to evaluate potential 
interventions to inform policy. 
Cost-of-illness estimates have value for public health decision makers interested in incorporating the 
economic impact of TBI along with morbidity, mortality, incidence and prevalence statistics when 
developing public policy. Cost-of-illness studies attempt to quantify the value of a disease to society. 
Cost components typically include the value of medical care resources used to treat a disease and the 
losses in productivity to society as a result of illness. A full economic evaluation of TBI is essential to 
advocate for more preventive resources, as well as for policy makers to inform changing allocation of 
scarce public resources (Bennett, Jacobs, & Schwartz, 1989; Spearman et al., 2001). The current study 
seeks to quantify the expected numbers of people likely to have TBI and to estimate direct and indirect 
costs at a population level. Although a full economic evaluation (i.e. cost effectiveness of TBI prevention 
strategies) will add great value to the debate; it is outside the current scope of the present study and 
will be the subject of a recommendation for further studies.   
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Context and aims of the thesis 
The Brain Injury Outcomes New Zealand in the Community (BIONIC) study was a population-based, 
(follow-up) TBI-incidence study which used known surveillance methods previously used for strokes in 
Auckland (Anderson, Carter, & Hackett, 2005; Bonita, Broad, & Beaglehole, 1993; Feigin, Lawes, & 
Bennett, 2003; Krishnamurthi et al., 2014). This thesis builds on the recent completion of the BIONIC 
study by exploring the economic burden of TBI in NZ. Three key areas were expanded on what has been 
previously reported: 1) to estimate the burden of disease attributable to TBI; and 2) assess healthcare 
and community resource use - data collected at one, six and twelve months post injury to estimate 
direct and indirect costs associated with TBI; and 3) investigate the success of known injury prevention 
measures to inform design and implementation for future interventions for people with TBI.  
Research aims and objectives 
Using incidence data from the BIONIC study, in combination with self-reported health care use, 
electronic hospital records and official death records, this thesis will address the following questions: 
1. What is the first-ever incidence and estimated prevalence of traumatic brain injury among all 
age groups in NZ in 2010? 
2. What is the projected future first-ever incidence and prevalence of TBI in NZ in 2020? 
3. What is the burden of disease for TBI in NZ measured in disability adjusted life years (DALYs) in 
2010 projected to 2020? 
4. What are the first-year and lifetime direct (medical) and indirect (productivity loss) costs of all 
TBI by severity in NZ in 2010? 
5. What are the projected direct and indirect costs of all TBI in NZ in 2020? 
It is hypothesised that the cost of mild TBI cases will account for a large proportion of the overall impact 
of TBI in NZ. 
Study design 
Economic evaluations are increasingly used to inform health care decisions and health policy making. 
Economic analysis of health care services is a way to assess whether the efficiency of the health care 
service represents good value for money (Barton, Bryan, & Robinson, 2004; Briggs, Nixon, Dixon, & 
Thompson, 2005).  Current research utilised prospective and population level data to develop a cost of 
illness model for TBI in NZ. Data for this study will primarily be sourced from the incidence data from the 
study titled Traumatic brain injury in NZ: a population-based incidence and outcomes (09/063A Feigin et 
al BIONIC study). Health services costs post TBI will be obtained from the costing department Waikato 
District Health Board and the National Minimum Dataset including all hospital admissions.  
The study will confirm TBI hospitalisation using ICD-10 codes (e.g. S06.0-S06.9). The methodology 
involves linking electronic medical records with self-reported health care service use, using statistical 
risk analysis modelling and Monte Carlo simulations. Detailed information on costs, mortality and 
morbidity will be examined as a function of severity of TBI. Per-patient costs will be estimated for 
resource utilisation during 12 months after injury. Multi-level analysis will be employed to identify 
predictors of high cost TBIs as a function of age, gender and severity of injury.  
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Study rationale 
This study is unique in NZ, being one of only a few economic evaluations ever to be completed.  The 
economic cost of TBI in NZ study will collate accurate and nationally representative estimates of the cost 
burden of TBI (Tilford, Aitken, Goodman, & Adelson, 2007). The proposed research is most relevant to 
evidence-based planning, health-service utilisation, and improving outcomes following TBI. The 
approach taken in the current thesis is from a health services research perspective. Which draws from 
areas relating to public health and health economics, by examining utilisation and cost of healthcare as 
well as looking at ways to improve the organisation of services or prevention strategies.  
The contribution of applying health economic tools helps us to understand how people make decisions 
about their health and health care. Topics such as whether or not to engage in protective health 
behaviours, when to visit a doctor, and how health care should be financed and organised to get the 
best results are all within the realm of health economics. But health economics is also concerned with 
understanding and identifying efficiency in the delivery and organisation of health services, including 
whether procedures or interventions are cost effective. This is information that health funders and 
consumers of health care (both nationally and internationally) require, to demonstrate that public 
health services represent good value for money. When deciding whether to introduce new 
interventions, or to identify the best alternative between interventions, it is important to consider the 
cost and resources that will be required and the outcomes that can be expected. Applying health 
economic concepts to a research inquiry provides a rigorous and evidence-based platform to explore 
options to improve health care delivery. The options are then weighed up in terms of effectiveness, cost 
effectiveness and the impact on patient flow through the health system.  
Point of difference for the current study  
While the current study uses data from the BIONIC study, the methodology underlying this thesis is 
independent of the BIONIC study.  That is, this PhD reports on the economic analysis of the BIONIC 
study. The current PhD fellowship addresses a novel aspect of examining trends in economic burden for 
TBI by severity for the reference year 2010 and estimating economic burden of TBI in NZ projected to 
2020. The work reported here, including the intellectual content, study design, data collection, data 
analysis and interpretation of results have been conducted under the direction of Professors Valery 
Feigin, the Principal Investigator of the BIONIC study and Paul Brown, a Health Economist with primary 
responsibility for overseeing and supervising the health services research aspects of the BIONIC study.  
Structure and organisation of the thesis 
The structure of the thesis is as follows: The first chapter provides an overview of the significance of TBI 
among people of all ages and severity as a public health issue. This provides the reader with an 
understanding of the importance of the thesis. Chapter two is presented in two parts: the first provides 
a review of published literature examining key concepts of cost-of-illness studies, and the second 
provides a summary of previous cost-of-TBI studies. The goal is to highlight the methods used in 
previous studies to quantify the economic cost of TBI. Chapter three reports the estimates of TBI 
incidence and prevalence, controlling for mortality in NZ using multi-life table methods. In Chapter four 
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the direct (medical) and indirect (productivity lost) cost of TBI is outlined. Chapter five presents the 
results of the health disparities analyses, identifying key areas for public health to intervene.  In the final 
chapter (six), the main findings of the research are summarised, the strengths and limitations of the 
current investigation are discussed and implications for future health services research are presented.  
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CHAPTER TWO: Methodological issues for guiding cost-of-illness studies for 
traumatic brain injury: a literature review 
 
Introduction 
New Zealand is similar to other middle and high income countries, where traumatic brain injury (TBI) is 
the leading cause of disability and death in young adults (Feigin et al., 2013; Mock et al., 2004). Although 
the cost of treating TBI is significant, few studies have summarised the cost to society of treating TBI and 
the burden TBI places on the health care system and families. This is partly due to the lack of accurate 
population level data about resource use and health impact of TBI (Theadom et al., 2012). As a result, 
many decisions allocating resources to injury prevention may not be underpinned by evidence that the 
intervention works or represents ‘value-for-money’ (Barton et al., 2004).  
Assessing the economic burden (economic and health outcomes) of TBI on society provides information 
on the scope of the problem and potential cost savings from interventions aimed at reducing the 
incidence or severity, or improving treatment for TBIs (Kreutzer, 2001; Vitaz, McIlvoy, Raque, Spain, & 
Shields, 2001). A review of cost-of-illness literature of TBI is one of many important factors that is 
needed to aid best informed decision making. Cost of illness studies provides essential information 
required to enable an evaluate the effectiveness of interventions, to advocate for more preventative 
resources, as well as for policy makers to inform changing allocation of scarce public resources. If the 
economic impact of TBI can be quantified and compared relative to other diseases, it can provide 
another evidence-based argument for allocating resources (Kolakowsky-Hayner, Miner, & Kreutzer, 
2001; Thurman et al., 1999).   
This chapter aims to review relevant published literature to analyse the methods used. First a general 
description of the cost-of-Illness (COI) methods used from different studies is provided to inform 
appropriate COI methodology. Secondly, the direct and indirect cost estimates reported from previous 
COI studies for TBI are presented as a baseline comparison for the present study. 
Methods 
Cost-of-illness study 
The main aim of COI studies is to provide a snapshot of the costs associated with treating a disease 
condition (in this case brain injuries) (Hodgson & Meiners, 1982). One important methodological aspect 
is to collect accurate disease identification, resource consumption, as well as detailed information on TBI 
survivorship and the pathways of care post TBI. These aspects are needed in order to understand equity 
and efficiency issues for TBI sufferers. Tracking the cost-of-care post TBI requires both an accurate 
identification of TBI and ideally longitudinal data on health service utilisation post TBI. COI studies 
provide estimates that describe resource consumption characterised by the disease condition being 
assessed. The economic impact of TBI refers to the value (measured in dollars) of medical care resources 
used to treat the condition, indirect costs are also included, such as losses in productivity to society as a 
result of illness (Koopmanschap & Rutten, 1993; Rice, 2000). Cost categories include: hospital treatment, 
outpatient and other medical expenses, long-term cost of care (i.e. caregiver and support services) and 
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loss of wages and income as a result of having a TBI. The goal is to identify the “additional” (including 
lifetime costs) or “marginal” costs associated with the condition (i.e. not total costs, only costs due to 
TBI) (Rice, 1967). Cost of illness data is an essential tool that will aid decision makers on (1) advocating 
for more specialised resources or health prevention programmes; and (2) their use as an evidence-
based, priority-setting measure when determining budget or resource allocation within societies 
managing economic constraints.  
Defining the disease condition and population 
This is widely dependant on how a disease condition is defined; conditions could be defined by clinical 
guideline criteria or be diagnosis-based using the international classification of disease manual. For the 
purpose of the current thesis, TBI will be defined using the WHO definition (Holder, Krug, Lund, Gururaj, 
& Kobusingye, 2001) (see chapter one). 
Epidemiological approach 
There are two main epidemiological approaches used in most COI studies. The first approach is to 
estimate the total cost of a disease in a given year (prevalence approach). The second approach 
commonly used is to estimate the lifetime costs of cases first diagnosed in a given year (incidence 
approach).  The prevalence-based approach seeks to sum together all costs (direct and indirect) for all 
who suffered a given disease condition (including first-ever and recurrent events) measured at one point 
in time, regardless of when the disease first occurred. It provides a cross-sectional view of the costs 
associated with a given condition.  A prevalence-based approach COI study would be useful for 
answering research questions like “how much do we spend each year to treat individuals with TBI in 
Auckland, New Zealand?” On the other hand an incidence-based costing approach measures the 
number of new cases of TBI and the costs associated with treatment, as well as other financial and non-
financial costs (such as, productivity losses, loss of quality of life) over the person’s lifetime, due to TBI. 
An incidence-approach method for estimating the cost of illness for TBI will be best suited to link into 
further cost-effectiveness analyses (CEA) of current TBI interventions, due to the availability of data. 
Perspective of the analysis and costs assessed 
The perspective of the study is the viewpoint used to examine the costs associated with a disease 
condition. For instance, if the study reports the results from the perspective of the health system or 
funder (Gold, Siegel, Russell, & Weinstein, 1996), then it would include the direct health care costs 
associated with the condition (e.g. hospitalisations, doctor visits, medications, and auxiliary treatments). 
A societal perspective (Byford & Raftery, 1998) includes the direct costs, but also includes indirect costs 
such as lost wages, out-of-pocket expenses, and other caregiver costs. Thus the societal perspective 
includes a wider range of costs (both direct medical and indirect costs such as productivity loss) and 
outcomes (in some cases measured as either life expectancy, clinical outcome or some sort of health 
preference measure (quality adjusted life years or disability adjusted life years). 
Estimating resource use consumption 
Methods estimating resource use consumption often vary depending on the design of the study and the 
availability of data. For instance, a prospective cohort study is a longitudinal study following a 
population of interest forward in time, with the goal of assessing exposure in the present tense. With 
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appropriate ethical approvals, individual information can be linked (using a health tracker) and matched 
between datasets. While a retrospective cohort study is of similar nature, it often follows a cohort using 
historical data (i.e. back in time). One clear difference involves a limitation of the data. Because 
individual consent is often required to link data from different healthcare providers, reported health 
service usage is often limited to a single organisation (i.e. hospital admissions). In order to accurately 
analyse individual level health service information, prospective cohort databases are able to be linked 
and matched to national (i.e. Ministry of Health) or regional databases (i.e. District Health Boards) for 
each individual by personal identification number. Another source often used in previous literature is 
case report forms or patient and caregiver surveys. Collected information via prospective questionnaires 
includes the type of service used, frequency of use, duration of time and who paid for the service. 
However, survey responses are often susceptible to recall and memory bias (Thorn et al., 2013). 
Valuation of unit costs 
Generally there are two universal approaches to examine costs. First is a top-down approach which uses 
aggregate estimates for specific diseases (Drummond, Sculpher, Torrance, OBrien, & Stoddart, 2005). 
With a top-down approach costs are typically calculated by health expenditure by the proportion of 
health services use as observed by a given disease condition. For instance, this approach involves 
estimating per-person costs by averaging total expenditure divided by the number of people with a 
specific disease. The second is to use a bottom-up approach and unlike the previous approach it 
estimates costs based on individual units consumed by the individual (Drummond et al., 2005). An 
example of a bottom-up cost approach involves recording resource use for each individual and 
calculating costs per resources used; this does not include a valuation of resources unused.  The aim of 
valuing unit costs is to ascertain the value (measured in dollars) which reflects the true opportunity cost 
of those resources being consumed. There is some uncertainty for unit costs due to varying unit costs 
between hospitals or health care providers since cost estimates are determined by the manufacturer. 
Methods for dealing with uncertainty will be further described (see sensitivity analysis).  
Direct costs include both costs to the health system (service usage), and out-of-pocket expenses. The 
source of cost information will vary from study to study; but in most cases, these costs are sourced from 
health care providers (medical records) or health insurance organisations. One way to estimate costs is 
using a resource-based costing approach. This approach multiplies health services usage by a market 
price for those services. Unit prices for resources utilised by an intervention (i.e. TBI rehabilitation) 
should be sourced from the most accurate and up-to-date sources for each provision of service. The 
costs of health services are measured in real prices for the reference year. 
Indirect costs are often assessed using three methodological approaches: human-capital approach 
(Koopmanschap & Martin Van Ineveld, 1992; Koopmanschap & Rutten, 1993), friction approach 
(Koopmanschap & Rutten, 1996), or the willingness-to-pay approach (Gafni, 1991). Estimating 
productivity loss will include loss of employment due to lower re-employment after the disease 
condition and/or premature death. The human-capital approach (HCA) can be justified here as it 
provides a measure of the cost of a disease. HCA reflects earning and productivity. Cost of productivity 
will be approximated using estimates of annual living wages sourced from governmental departments 
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combined with a probability of loss of earnings. HCA takes an individual’s perspective where loss of 
productivity is calculated by summing any hours not worked (up to retirement age) as hours lost. The 
frictional approach, on the other hand, assumes a short absence from employment (i.e., sick leave, 
entitled leave with or without pay).  Friction cost method takes the employer perspective and only 
considers hours not worked until the individual is replaced with another employee.  There is on-going 
debate around which methods to use for valuing indirect costs. For instance some authors favour 
friction cost method as an alternative to human capital approach, as it takes “worker replacement” into 
account (Birnbaum, 2005; Koopmanschap & Martin Van Ineveld, 1992). While other authors argue that 
friction cost approach based on implausible assumptions and not supported by neoclassical economic 
theory (Johannesson & Karlsson, 1997). The willingness-to-pay approach is often used to determine the 
value of people’s (consumers) willingness and ability to pay (for health services or treatment) in order to 
avoid health risks (Gafni, 1991). Such techniques involves assessing personal preferences and 
understanding their protective health behaviours about reducing risk of having a TBI or avoiding early 
mortality. A critique of this costing method is that it may tend to overstate estimates (Johannesson, 
1996). 
Historic costs obtained from literature, will be inflated using the consumer price index (CPI) of the 
source country.  This enables all costs to be standardised to a common year. When cost source year is 
not presented, the year prior to the publication will be used to adjust cost. International cost estimates 
will be exchanged to NZ value in 2010 dollars using purchasing power parities (see OECD website 
http://www.oecd.org/std/prices-ppp/).  
Discounting costs 
To ensure the cost results occurring beyond one year reflect the present value of costs and or benefits 
accruing over the time horizon of the analysis, future costs should be discounted to account for the time 
preference. In practice the discount rate reflects the long-term bond rate set by the economy. While 
there are a number of discount rates quoted in previous studies, authors should justify their rates. For 
example, a common discount rate of 3% is recommended by a consensus panel of health economists in 
the USA for cost-effectiveness analysis (Phillips & Chen, 2002). 
Sensitivity analysis 
Sensitivity analyses are recommended to address uncertainties in the present data and/or methodology. 
To account for uncertainty, sensitivity analysis will explore the robustness of the results by varying key 
variables. The different forms of sensitivity analysis often include one-way or multi-sensitivity and 
probabilistic (Barton et al., 2004; Briggs, Sculpher, & Claxton, 2006). As stated by Briggs and Gray (1999) 
one-way sensitivity analysis examines the impact of each variable in the study. Single variables are 
tested by varying across plausible ranges of values, for example a high cost unit for neuroimaging vs low 
cost unit. Likewise a multi-sensitivity analysis involves varying a number of variables simultaneously and 
is usually used to generate best- and worst-case scenarios of the study being evaluated (Briggs & Gray, 
1999). Similarly probabilistic sensitivity analysis examines a series of variables simultaneously but is 
based on a large number of Monte Carlo simulations according to a statistical distribution for 
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parameters. For example, gamma distribution is the predefined distribution for cost variables as it re-
samples plausible values from 1 to infinity (Briggs, 2004). 
Presentation of results 
Like many other studies, the results should be consistent with documented data collection and methods 
reported in the study. For COI studies, it is important that cost data be disaggregated by subgroup and 
health care category (see Table 4 and appendix two for a quality checklist of reviewed articles). In 
addition COI should also test for uncertainty of cost and or health benefits. 
Literature review 
Data sources and search terms  
A review of previous literature was intended to assess available information on economic analysis for 
TBI. Synonyms relating to TBIs (e.g. head injury, head trauma, brain injury, traumatic brain injury, brain 
trauma and brain concussion) were combined with selected search terms from the Scottish 
Intercollegiate Guideline Network (SIGN) search filter for economic evaluations aimed at restricting 
results to economic and cost-related studies (see appendix one for the search strategy).  Computerised 
searches used a general health search engine of the EBSCO Health database; this collection of databases 
included: Biomedical Reference Collection: Basic, CINAHL Plus with Full Text (1937-present), Health 
Business Elite (1922-present), Health Source-Consumer Edition, Health Source: Nursing/Academic 
Edition, MEDLINE, Psychology and Behavioural Sciences Collection, SPORTDiscuss with Full Text and 
Dentistry and Oral Science Source. Further keyword searches were conducted using the centre for 
review and dissemination NHS Economic Evaluation Database (NHS EED).   
 
All resources were searched for recent studies published between 2000 to May 2014 and restricted to 
English language articles. Reference sections of publications found were scanned to find further relevant 
literature. Hand-searching was also conducted of the table of contents of the following journals: Injury; 
Injury Prevention, Journal of Neurotrauma, Journal of Trauma, Journal of Trauma, Injury, Infection and 
Critical Care, and Brain Injury. In addition in an attempt to obtain unpublished reports or documents, 
database searches were conducted. Each report was independently reviewed by screening titles and 
abstracts using a pre-defined inclusion and exclusion criteria (see appendix three and four). A full text 
review was then conducted and a decision made regarding study eligibility. A thorough analysis of each 
article was performed to extract data from included studies.  Primary studies that reported acute and 
post-acute costs relating to TBI were included. 
All COI studies that performed an analysis of cost and outcome were incorporated.  These included 
whether the study provided the measure of effect as either quality adjusted life years (QALYs) or life 
expectancy as the effect measures or no outcomes. Studies that reported acute, rehabilitation, 
community support and on-going costs associated with head injuries/brain injuries (TBI) were also 
included. Other economic evaluation studies, for example those that performed a comparative analysis 
of both costs and effects of at least two competing strategies, were excluded. Where possible, all 
studies which included adults and/or children of any age diagnosed with TBI with mild (i.e. GCS 13-15), 
moderate (i.e. GCS 9-12) and severe (i.e. GCS 8) injuries were included. 
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Data collection and analysis 
The methodological assessment of the selected studies was assessed using the quality checklist for 
health economic studies adopted from Drummond (Drummond et al., 2005) and used in previous cost-
of-illness reviews (Costa et al., 2012; Molinier et al., 2008). The criteria derived from Drummond used to 
assess the quality of included studies were: definition of illness, epidemiological sources, unit costs, 
sources of cost, costing, adjustments for timing of cost, allowance for uncertainty and presentation of 
results (see appendix two). All articles meeting the inclusion criteria were reviewed and summary 
information was extracted. The review and extraction of summary information was independently 
completed. From each study the following variables were extracted: author(s), country setting of the 
study, type of health care system, year of costs, type of currency, perspective of the analysis, study 
design, sample size, follow up and baseline results.  
All reported costs from the literature were reported in US dollar currency and adjusted to NZ dollars 
using the purchasing power parity (PPP).  This enables all costs to be standardised to a common 
currency. When cost source year was not presented, the year prior to the publication was used to adjust 
cost to US value in 2010 dollars. Meta-analysis was not carried out due to the heterogeneity of the 
eligible studies. 
Results 
Overview of eligible studies identified 
Twelve articles met the criteria and were identified using the search strategy (see figure 2). Of these, ten 
studies were conducted in the United States (Ettaro, Berger, & Songer, 2004; Farhad et al., 2013; Faul et 
al., 2007; Leibson et al., 2012; McGarry et al., 2002; Rockhill, Fann, Fan, Hollingworth, & Katon, 2010; 
Rockhill et al., 2012; Schootman, Buchman, & Lewsi, 2003; Stroupe et al., 2013; Vangel, Rapport, Hanks, 
& Black, 2005); one was carried out in Canada (Chen et al., 2012) and one study in China (Yang et al., 
2007).  All studies varied in sample size ranging from 63 (Vangel et al., 2005) to 254,500 participants 
(Schootman et al., 2003). Methodological assessments of selected studies are shown in Table 2; five 
studies scored “yes” in points assessed (Chen et al., 2012; Faul et al., 2007; Leibson et al., 2012; Rockhill 
et al., 2012; Schootman et al., 2003). 
Defining the disease condition  
TBI was defined using clinical diagnosis codes in eleven studies (Chen et al., 2012; Ettaro et al., 2004; 
Farhad et al., 2013; Leibson et al., 2012; McGarry et al., 2002; Rockhill et al., 2012; Vangel et al., 2005; 
Yuan et al., 2012). Of these, three studies gave a detailed definition using the Centres for Disease 
Control and Prevention case definition (Faul et al., 2007; Rockhill et al., 2010; Schootman et al., 2003). 
However one study did not define TBI at all (Stroupe et al., 2013). 
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Figure 2: Literature search and selection process 
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Perspective of the analysis and costs assessed 
Characteristics of the COI studies in TBI are presented in table 3. Eleven studies were conducted from a 
health system/health funder perspective (Chen et al., 2012; Ettaro et al., 2004; Farhad et al., 2013; 
Leibson et al., 2012; McGarry et al., 2002; Rockhill et al., 2010; Rockhill et al., 2012; Schootman et al., 
2003; Stroupe et al., 2013; Vangel et al., 2005; Yuan et al., 2012). Most of these were carried out in the 
US. Acute hospitalisation costs was mostly considered among the included studies; direct costs also 
included rehabilitation, outpatient, medication, physician or specialist, home care or out of pocket. 
Many of these studies examined costs over a short timeframe; four studies had follow up post 12-
months (Chen et al., 2012; Faul et al., 2007; Rockhill et al., 2010; Rockhill et al., 2012). Only one study 
conducted their analysis from a societal viewpoint (Faul et al., 2007) thus quantifying both direct 
medical and indirect costs. Interestingly, no studies quantified informal care costs associated with TBI 
survivors. 
Estimating resource consumption 
All studies calculated prevalence-based health care costs.  No study conducted an incidence-based 
analysis. Prevalence results were estimated primarily from hospital databases or medical billing records; 
while three studies combined national data with patient surveys at follow up (Rockhill et al., 2010; 
Rockhill et al., 2012). Eight studies utilised a retrospective cohort study design (Chen et al., 2012; Ettaro 
et al., 2004; Farhad et al., 2013; Leibson et al., 2012; McGarry et al., 2002; Schootman et al., 2003; 
Stroupe et al., 2013; Vangel et al., 2005). Three studies used a prospective cohort design (Rockhill et al., 
2010; Rockhill et al., 2012; Yuan et al., 2012) and one study conducted a decision analysis (Faul et al., 
2007). Of the included studies most undertook a bottom-up approach to gather activity data and to 
measure resource use consumption. One study however used a top-down approach and used 
aggregated cost figures and assumptions sourced from literature by severity of disability (Faul et al., 
2007). 
Valuation of unit costs 
Total annual costs of TBI are shown in table 4. Direct costs were estimated from published literature 
(Faul et al., 2007) and hospital billing charges (Chen et al., 2012; Leibson et al., 2012; Rockhill et al., 
2010; Rockhill et al., 2012). Only one study gave micro-level cost units per health resource consumption. 
The majority of direct costs occurred during the acute hospitalisation phase; estimates ranged from 
US$1,054 (Rockhill et al., 2010) to US$62,804 (Vangel et al., 2005) (see table 4). Over half of the studies 
reviewed estimated annual costs per person. For instance, Rockhill et al. (2012) estimated the one year 
cost of TBI in the US to be over US$7,377 per person, while Leibson et al. (2012) estimated the cost to 
be US$27,187 per patient (US$2007). Similarly in Canada, Chen et al. (2012) reported annual cost per 
person at CAN$32,132 (CAN$2007) while a study in China estimated acute costs to be US$1,715. One 
study estimated indirect costs using the human-capital approach methodology. Faul et al. (2007) 
reported that the associated indirect cost of TBI in the US was estimated to be US$330,827 (US$2002).   
Discounting costs 
Only two studies reported a discount rate of 3% for occurring costs beyond one year post TBI (Rockhill et 
al., 2010; Rockhill et al., 2012). One study in the US conducted their research using decision modelling 
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techniques and projected costs over the lifetime of the cohort; but the authors did not account for 
present net value of costs occurring in the future (Faul et al., 2007). 
Sensitivity analysis 
Although three studies declared their main assumption and limitation of their data (Chen et al., 2012; 
Faul et al., 2007; Vangel et al., 2005); surprisingly none of these studies conducted a sensitivity analysis 
(i.e. using either one way, multi or probabilistic) to test the robustness of the estimates.  
Presentation of results 
Six studies presented aggregated hospitalisation cost (Ettaro et al., 2004; Farhad et al., 2013; Leibson et 
al., 2012; McGarry et al., 2002; Schootman et al., 2003; Yuan et al., 2012). From their results it was hard 
to differentiate the rehabilitation proportion of costs. Other studies (six) presented disaggregated direct 
and indirect costs (Chen et al., 2012; Faul et al., 2007; Rockhill et al., 2010; Rockhill et al., 2012; Stroupe 
et al., 2013; Vangel et al., 2005); with four articles describing their dissemination (Chen et al., 2012; 
Rockhill et al., 2010; Rockhill et al., 2012; Vangel et al., 2005). All studies reported per-patient cost 
estimates.  
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Discussion 
The purpose of this chapter was to review current literature on the cost of TBI, including the methods 
used to analyse the costs. The review of literature identified twelve COI studies on TBI, according to the 
methodological assessment tool (see Table 2) with five studies scoring “Yes” on the majority of the 
points assessed (Chen et al., 2012; Faul et al., 2007; Leibson et al., 2012; Rockhill et al., 2012; Schootman 
et al., 2003). This review found that COI studies on TBI were scarce and few were conducted of high 
quality health economic methodology. The review confirms that TBI is associated with significant direct 
medical costs and the indirect cost component accounts for the largest proportion (Faul et al., 2007). 
The main finding from the review indicated that the annual per-person cost associated with TBI ranged 
between NZ$2,951 to NZ$1,323,098 (see table 3). These results indicate that although the cost of TBI is 
substantial there was also considerable variability (in methods used and sample size). However, it is 
difficult to make a clear definitive statement about these costs as each study adopted different 
methodological approaches and were taken over different time periods. Many previous studies were 
conducted over short timeframes (i.e. less than 12 months of observation) and only assessed acute 
hospitalisation costs. Very few studies assessed health care utilisation and cost up to 12 months post 
injury (Chen et al., 2012; Leibson et al., 2012; Rockhill et al., 2010; Rockhill et al., 2012). One important 
aspect that is lacking in previous studies is data on the resource utilisation for TBI over the past 12 
months. Lifetime direct and indirect economic impact with TBI is hugely unknown; this is partly due to 
the lack of accurate longitudinal data.  
Secondly, the type of health care system of each country may possibly explain the influence of higher 
treatment costs. For instance, ten of the studies were conducted in a country that is predominately a 
market-driven economy. The US as opposed to Canada and China has a private health system, where the 
environment is shaped by competitive “fee for service” type arrangements. By contrast, in a public 
health system treatment costs are contained and often regulated by government, which in turn may 
drive costs down (less market competition). Moreover countries differ significantly in health care costs, 
and this is reflected in the costs of TBIs. 
Thirdly, previous COI reviews (Costa et al., 2012; Molinier et al., 2008) stated that comparing 
international cost estimates is problematic due to differences in the dollar value of each currency. The 
reported costs were inflated to the US dollar 2010 value using consumer price indices and then 
converted to NZ dollar 2010 value using purchasing power parity which attempts to make dollar values 
equivalent.  
Fourthly, it was noted that among the majority of the studies reviewed, included TBI who were admitted 
into hospital and identified using medical diagnosis codes. One study did not state how TBI was defined 
at all (Stroupe et al., 2013). This is problematic as TBIs are often missed and overshadowed by other 
injuries (Ribbers, 2007; Stephenson, Henley, Harrison, & Langley, 2004; Stephenson, Langley, & Cryer, 
2005) This review also found that previous literature often excluded those with TBI who were not 
hospitalised or did not seek immediate attention (Feigin et al., 2013) for their injury. The reason for the 
exclusion is unclear, but may be due to the limitation of sources of available information (e.g. admission 
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registries and hospital admission data) for identifying cases. It is clear that any further population-based 
TBI incidence studies must reflect appropriate methodology for instance utilising hot-pursuit methods 
(Theadom et al., 2012). Identifying additional cases of  TBI through cross checks of general practitioner 
databases and hospital admissions are more like to find cases who did not seek immediate medical 
attention but saw a medical professional later due to the consequences associated with TBI (Cassidy et 
al., 2004; Feigin et al., 2013). The omission of the mild TBI cases and those who do not seek immediate 
medical attention may lead to a overestimation of the cost per person. 
In conclusion, internationally the cost of treating TBI varies greatly. This review has demonstrated the 
high cost TBI sufferers can incur and there are differences between treatments received. The economic 
burden for TBI is high, but substantial cost savings and improvements in outcomes may be achieved by 
targeting high cost individuals. Given that New Zealand has a unique healthcare system and social 
insurance scheme for those who have sustained TBI. It is important for New Zealand health planners and 
policy makers to understand what the cost of TBI is to New Zealand society
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CHAPTER THREE: Estimating the incidence, prevalence and disability-
adjusted life years for TBI in New Zealand 2010: A burden of injury study 
 
The main findings of the results reported in this chapter have been published. The details of the 
publication are: 
1. Te Ao B, Tobias M, Ameratunga S, McPherson K, Theadom A, Dowell A, Starkey N Jones K, 
Barker-Collo S,  Brown P,  Feigin V, on behalf of the BIONIC Study Group. (2015). Burden of 
traumatic brain injury in New Zealand: incidence, prevalence and disability-adjusted life years. 
Neuroepidemiology 44:255-261 (see appendix five) 
 
Introduction 
Traumatic brain injury (TBI) is a major cause of disability and death in New Zealand (NZ) (Feigin et al., 
2013). In addition to these long term impacts on personal and whanau/family wellbeing, TBI has major 
economic consequences for society (Te Ao et al., 2014).  Robust information on the population-based 
epidemiology and health impact of TBI should guide health policy, including the allocation of resources 
to prevention, treatment and rehabilitation (Arciniegas, 2011; Tobias, Cheung, Carter, Anderson, & 
Feigin, 2007). However, previous attempts to measure the impact of TBI suffer from major 
methodological limitations. For instance, many studies have focused solely on injuries admitted to 
hospital (Corrigan, Selassie, & Orman, 2010). Case ascertainment often relies on clinical diagnosis codes 
(McGarry et al., 2002; Ribbers, 2007) yet TBI is often overshadowed by other injuries (e.g. internal 
injury, spinal cord injury, facial/hip fractures) (McGregor & Pentland, 1997). Estimates based on 
routinely collected data may fail to identify a substantial proportion of TBI, especially mild cases. 
Approximately, 70-95% of injuries are classified as mild severity (Cassidy et al., 2004; Feigin et al., 2013) 
managed in the community by primary care providers and are not hospitalised (Leibson et al., 2012; 
Tate et al., 1998).  
The recently completed Brain Injury Outcomes New Zealand in the Community (BIONIC) study was the 
first to assess the incidence of TBI across all age groups and in rural and urban populations in New 
Zealand (NZ) (Feigin et al., 2013). The authors found that when community cases were included, the 
incidence of TBI especially  mild TBI, was far greater in NZ than previously estimated (Feigin et al., 2013). 
This chapter presents an assessment of the epidemiology of TBI in NZ to provide important information 
for assessing demands on our health system.  
The current study combines regional brain injury incidence rates from the BIONIC study with current 
mortality statistics and NZ population data to construct a multi state life tables model to estimate 
national incidence, prevalence and disability adjusted life years (DALY) for TBI in NZ in 2010.  The DALY is 
an integrated measure of health loss that combines both fatal and non-fatal outcomes into a single 
metric (Murray, Vos, & Lozano, 2012). The constructed model outputs estimates of TBI incidence and 
prevalence for the study community (Hamilton Waikato), which was extrapolated to the NZ national 
population.  
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Public health surveillance 
According to the Centre of Disease Control and Prevention, public health surveillance is defined as the 
on-going, systematic collection, analysis, interpretation and dissemination of data regarding a health-
related event for use in public health action to reduce morbidity and mortality and to improve health 
(Centre for disease control and prevention, 2002). For the purpose of this analysis, health-related events 
were interpreted to include both disease and injury. The two main aims of surveillance are to provide 
information to support firstly, control measures and secondly, prevention strategies (Baker, 2010). Both 
options depend on the input quality of identifying an accurate description of events to support 
evidence-based policy. Epidemiology is the study of disease within a community. Currently in NZ there 
are a number of examples of data sources useful for monitoring the health of populations.  
Within the BIONIC study, brain injury identification utilised a methodology that captures the TBI cases 
that may currently be missed by existing databases (i.e. hospital records) including: (1) people who die 
as a result of TBI prior to being admitted for medical attention (e.g. autopsy records); (2) people who 
obtain medical attention following an accident, but where TBI is not recorded and/or is overshadowed 
by other injuries (e.g., orthopaedic injuries); (3) people who do not seek immediate medical attention 
post TBI (about 5% of cases) (Annegers, Grabow, Kurland, & Laws, 1980) but access services at a later 
time for TBI-related sequelae; and (4) people who do not wish to make an Accident Compensation 
Corporation (ACC) claim (e.g. those with very minor TBI or who access private insurance instead). Finally, 
existing databases tend to restrict case definitions to particular diagnoses based on the ICD-10 coding 
systems. ICD-10 codes include injuries to the head which do not reflect a brain injury (e.g. superficial 
injury of the head, open wound of the head, injury of the eye/orbit). Thus, the data reflects head injury 
and not necessarily brain injury.   
Rationale for the study 
The incidence and prevalence of TBI injury across all ages in New Zealand has not been well described. 
Therefore a multi-state life table model using data from a population-based TBI incidence study and 
national mortality was conducted. The aim of the study was to provide health funders and planners with 
internally consistent estimates of TBI incidence and prevalence in 2010 based on BIONIC. Projections of 
TBI incidence and prevalence to 2020, based on the estimates for 2010 and population (age structure) 
projections to 2020 produced by Statistics New Zealand were also generated. The research questions 
this study addresses are: 
1. What is the first-ever incidence and estimated prevalence of traumatic brain injury among all 
age groups in New Zealand in 2010? 
2. What is the projected first-ever future incidence and prevalence of traumatic brain injury in 
New Zealand in 2020? 
3. What is the burden of injury for TBI measured in disability adjusted life years? 
Methods 
Definitions 
TBI was defined according to the World Health Organisation (WHO) (New Zealand Guidelines Group, 
2005, 2006; Ribbers, 2007) recommendations as an acute brain injury resulting from mechanical energy 
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to the head from external physical forces which resulted in the presence of one or more of the 
following(Carroll & Holm, 2004): 
1.  confusion or disorientation;  
2.  loss of consciousness;  
3.  post-traumatic amnesia;  
4.  other neurological abnormalities (e.g. focal signs, seizure) (Carroll & Holm, 2004).  
These indices of TBI were not due to drugs, alcohol or medications, caused by other injuries or 
treatment for other injuries (e.g. systemic injuries, facial injuries or intubation), or caused by other 
problems (e.g. psychological trauma or co-existing medical conditions) (Carroll & Holm, 2004).  
Figure 3: The conceptual disease model (adopted and modified from Barendregt, Oortmarssen, Vos, and 
Murray (2003)) 
 
Healthy Population: number of healthy people (i.e. without the disease/injury under consideration); TBI: the number of 
diseased/injured people; Death (TBI): number of people dead from the disease/injury; and Death (Other causes): number of 
people dead from all other causes, with (a) an age subscript. There are four transition hazards: i: incidence, r: remission, f: case 
fatality, and d: other-cause mortality. 
 
Brain Injury Outcomes New Zealand in the Community (BIONIC) Study 
The methodology of the BIONIC study has been described elsewhere (Barker-Collo & Feigin, 2009; 
Theadom et al., 2012). Incidence estimates were obtained from the BIONIC study. This is a large 
prospective population-based TBI register covering the total population of the Hamilton and Waikato 
districts of New Zealand (approximately 170,000 rural and urban residents). Hamilton and Waikato 
population has demographic and social characteristics that are reflective of the NZ population according 
to the 2006 NZ census data. All cases (n=1369) of TBI were ascertained over a 12-month period between 
1 March 2010 to 28 February 2011, using prospective and retrospective surveillance. Complete case 
ascertainment was assured by using multiple overlapping sources of information for all new hospitalised 
and non-hospitalised TBI cases (fatal and non-fatal). Hot pursuit methods were used to identify 
additional cases of TBI through cross-checks of general practitioner databases and hospital admissions.   
Regional TBI incidence estimates and the definition of TBI severity utilised are reported elsewhere 
(Feigin et al., 2013). Our focus is on estimates of first-ever in a lifetime TBI incidence (N = 521), (as a 
measure of true incidence), this is different from the injury rates (incidence and recurrent TBI) 
d
i r d
f
Healthy 
Populationₐ
Death
(Other causes)ₐ
Death
(TBI)ₐ
TBIₐ
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previously reported. TBI mortality was defined as deaths registered in the NZ Ministry of Health’s 
Mortality Collection (2010-2011) as resulting from a TBI (ICD10 S06.0-S06.9). Deaths from causes other 
than TBI are described as “other cause” mortality (see Figure 3). All-cause deaths and population 
denominator data were obtained from Statistics NZ. 
The BIONIC study utilised a methodology that was built upon WHO’s Injury Surveillance Guidelines 
(Holder et al., 2001) and has since recommended a number of conditions be considered (Barker-Collo & 
Feigin, 2009). This study addresses two points of their recommendation that is to: (i) present first-ever 
TBI events for both sexes separately; and (ii) present data by five-year age groups available for 
comparison with other studies.  
Current 2010 and projected 2020 estimates 
The BIONIC study is the first worldwide to meet the criteria for an ‘ideal’ TBI incidence study (Feigin et 
al., 2013).  First-ever TBI incidence rates were derived from the BIONIC study. Age and sex structures of 
the NZ population census data for 2006 for Hamilton city (urban residents) and Waikato district (rural 
residents) were used as denominators to calculate age and sex-specific TBI incidence. Age and sex-
specific TBI incidences from Hamilton, Waikato region (BIONIC) were then applied to the general NZ 
population.  Due to the low deaths recorded from BIONIC, TBI-related mortality rates obtained from the 
national mortality collection were used instead. TBI mortality was identified using ICD10 S06.0-S06.9, 
the codes which correlate strictly to brain injuries (Access Economics, 2009).   
Given these estimates of first-ever TBI incidence and mortality, the multi-state life tables could be 
constructed using DISMOD II software (Barendregt et al., 2003; Barendregt & Ott, 2005; Chung, Cheong, 
Park, & Kim, 2008) (see appendix six for input variables in DISMOD II). DISMOD II was recently developed 
by the WHO (Barendregt et al., 2003) and has been previously used in the Global Burden of Disease 
(GBD) studies for estimating the epidemiology of a disease. It is based on a series of algorithms to 
quantify age-specific incidence, prevalence and mortality (Barendregt & Ott, 2005; Mathers, Vos, Lopez, 
& Ezzati, 2001). In DISMOD II, remission rate refers to a proportion of individuals with TBI recovering to 
a normal state, and “0” (zero) was applied as suggested in the GBD in consideration of the irreversible 
nature of TBI (World Health Organization, 2006) whether or not residual clinically apparent  sequelae 
occur. Prevalence was computed based on incidence from the BIONIC study, and mortality from the 
New Zealand Health Information Service. The theoretical background and the application of multi-state 
life tables for epidemiology are discussed elsewhere (Barendregt et al., 2003). The incidence, 
prevalence, and mortality rates output of the model were then used to estimate the level of TBI burden 
in the population for 2010. In turn, the expected number of future TBIs can be estimated by combining 
BIONIC incidence data with NZ population projection estimates by age and gender for 2020. A cohort-
based approach was used to project the TBI burden to 2020, using NZ population (census year 2006) 
under the strong assumptions that age/sex-specific incidence and excess mortality rates remained 
stable. 
The model was built by first smoothing the input data using a “moving average” interpolation whereby 
to smooth shape continuities between adjacent 5 year age groups to prevent difficulties in modelling 
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prevalence. The incidence estimates were considered more reliable than the cause-specific mortality 
estimates, which were derived from routine cause of death coding (Ribbers, 2007). Accordingly, the 
DISMOD modelling was carried out anchoring on incidence, so giving less ‘weight’ to the excess 
mortality estimates. Remission was zero by definition (since at this stage we are modelling the 
prevalence of survivors of first ever in lifetime TBI, irrespective of disability level). DISMOD software was 
used to produce internally consistent estimates of incidence, prevalence, duration and related mortality. 
Annual crude incidence (all first-ever events) of TBI rates are presented as rates per 100,000 per person 
per year.  Direct standardisation was employed to age standardise the rate to the world population, 
using the WHO’s standard population (World Health Organization, 2000). 95% uncertainty intervals 
were computed using the 2.5th and 97.5th percentile of the distribution. 
Quality adjusted life years vs. disability adjusted life years 
Both quality adjusted life years (QALY) and disability adjusted life years (DALY) are measures of burden 
of disease by aggregating mortality and morbidity into a single metric. One difference in these two 
measures is the way health states are weighted and collected. QALYs are derived from “ individual 
preference based” health related quality of life instruments (such as the EQ-5D or SF-6D), where quality 
of life weighting are directly collected by the individuals (Polinder et al., 2011). Unlike DALYs, weights 
are elicited from clinical experts. Even though QALYs are collected directly from the individual, DALYs 
were used in this current study (Gabbe et al., 2013). The rationale for using DALYs, is so it can be 
compared against international literature such as the Global Burden of Disease studies (Murray et al., 
2012). 
Quantifying disability-adjusted life years (DALYs) 
Population burden of TBI was measured in disability-adjusted life years (DALYs) (Murray et al., 2012; 
Salomon, Vos, & Hogan, 2012). DALYs can be expressed as the sum of the “years of life lost” (YLL) and 
“years lived with disability” (YLD). As TBI is often associated with high levels of physical impairment 
DALYs might be more suited as an important component of DALYs is the concept of “social weighting”, 
which has a heavy reliance on life expectancy (Moodie et al., 2004). When quantifying a disease burden 
the DALY would incorporate a years of life lost component, which would be acquired from life tables 
often with weights for dying at each age based on the "social value" of dying at that age. In addition to 
this, one would also quantify a years lived with disability component acquired by weighting years lived 
with a particular disease, elicited through some kind of preference-based method (such as “time trade 
off”(Attema, Edelaar-Peeters, Versteegh, & Stolk, 2013), “standard gamble” (Gafni, 1994)). At present 
there is no known reported standard assessment tool to measure DALYs (i.e. survey instrument). Years 
of life lost was calculated by multiplying the number of deaths from TBI by the remaining life expectancy 
at age of occurrence in five-year age bands. Remaining life expectancy at each age was taken from the 
GBD 2010 standard life table YLDs were calculated by multiplying the prevalence of the condition by 
severity level in each five-year age band by the relevant disability weight, taken from the GBD 2010. At 
12 months post-TBI, the proportion of participants identified as having no, mild, or moderate/severe 
disability (defined by the Glasgow Outcome Score (Jennett & Bond, 1975)) was sourced from the BIONIC 
dataset and used to determine the probability of residual disability (i.e., after 12 months). If an 
43 
 
individual had residual disability (including mild or moderate/severe TBI) at 12 months, this was 
assumed to persist for a lifetime. Disability weights are based on health state valuations on a scale from 
0 (no health loss) to 1 (complete health loss, equivalent to being dead), estimated from a set of global 
health surveys (Cassidy 2004 Salmond 2012). Disability weights were specific for stage (i.e., year post 
occurrence) and level of severity A short-term (Year 1) disability weight of 0.235 was assigned to all 
cases A longer-term (Year 2+) disability weight for mild and moderate / severe residual disability of 
0.106 and 0.425 respectively were applied A disability weight of zero was attributed to those with no 
neurological deficit after the first year post TBI(Ministry of Health, 2012)(see Table 5). 
 
Table 5: Health states and disability weights adopted from the New Zealand Burden of Disease Ministry 
of Health (2012))  
Constituent Health State Health State Disability Weight 
Short term 0.235 
Long-term effects ( i.e. neurological deficit, 
psychological effects) for mild TBI 
0.106 
Long-term effects (i.e. neurological deficit, 
psychological effects) for moderate to severe 
TBI 
0.425 
 
Results 
Descriptive epidemiology of TBI, 2010 incidence 
Table 6 summarises the estimated national incidence of first-ever in lifetime TBI in NZ in 2010. Incidence 
rates of first ever TBI by five year age bands are shown in figure4. Higher incidence rates of first-ever TBI 
are observed among younger age groups and among males. Translating rates into counts, the model 
estimates that almost 11,300 first-ever TBIs occurred in NZ in 2010, 57% of them in males. Almost 43% 
of first-ever TBIs occurred in people aged between 0 to 14 years. The crude incidence rate of first-ever 
TBI was 281 cases per 100,000 person years (males 330 cases per 100,000, females 233 cases per 
100,000). Mild TBI cases are estimated to be 268 per 100,000 per year (age standardised rate of 297 
cases) (see Table 7). The estimated mean age at diagnosis of first TBI was 23.0 years, (males 22.9 years, 
females 23.9 years).   
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Figure 4: Modelled age and sex-specific incidence of first TBI in 2010 
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Prevalence 
Modelled prevalence rates of TBI (this includes total number of cases including first and recurrent TBI) 
are plotted by five-year age groups in figure 5 and summarised in Table 8.  The results indicate that in 
2010 approximately 527,400 New Zealanders (13% of the NZ population) had experienced at least one 
TBI event at some time in their lives. Crude prevalence estimates were 14.8% for males and 11.4 % for 
females. The prevalence of TBI was 23% higher in males than in females, adjusting for differences in age 
distributions. The highest prevalence occurred in the 40-49 years age group in both males and females.  
The age distribution of TBI survivors is skewed to the right with two-thirds (68%) of prevalent cases aged 
35 years and older. Of these numbers of cases, an estimated 12,847 (or 2.4%) would have residual 
disability one year after having a brain injury (see table 9). 
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Table 9: Modelled age and sex-specific prevalence of people who have had one or more TBI in 2010 with 
residual disability 
Age 
group 
(years) 
With residual disability 
Rates per 100,000 Counts (Number of cases) 
Male  Female Persons Male  Female Persons 
0-4 29 20 25 40 27 68 
5-9 119 83 101 174 116 290 
10-14 197 134 166 309 200 509 
15-19 273 181 228 417 267 684 
20-24 345 218 281 465 296 762 
25-29 401 243 319 470 305 775 
30-34 441 262 347 577 382 959 
35-39 468 277 368 669 440 1109 
40-44 489 290 385 738 472 1209 
45-49 511 300 403 731 451 1182 
50-54 537 310 422 667 398 1066 
55-59 561 322 440 647 381 1027 
60-64 582 338 458 514 309 822 
65-69 600 359 476 433 274 707 
70-74 611 373 486 341 228 569 
75-79 617 380 489 286 209 494 
80-84 625 385 482 182 166 348 
85+ 643 396 473 114 154 268 
Figure 5: Modelled age and sex-specific prevalence of people who have had one or more TBI in 2010 
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Duration of survival 
Table 10 presents the estimated duration of survival after first-ever TBI (i.e. the time from onset of first 
TBI to death from any cause). Males were slightly younger at onset than females, and also had a higher 
mortality.  On average, females survive nearly five years longer after first TBI than males (58.9 years vs 
54.3 years). 
Table 10: Modelled survival times (years) of TBI survivors, 2010 
Duration of survival after first TBI (years) 
Point estimate, 95% UI 
Age at first 
TBI (years) 
Male Female 
0-4 
73.8 79.7 
73.6 74 79.6 79.8 
5-9 
69.2 75 
27.7 69.3 75 75.1 
10-14 
64.2 70.1 
48.2 64.4 70 70.2 
15-19 
59.5 65.4 
55.9 59.7 65.4 65.5 
20-24 
55.2 60.8 
53.5 55.3 60.7 60.8 
25-29 
50.8 56 
49.7 50.9 56 56 
30-34 
46.3 51.2 
45.5 46.4 51.1 51.2 
35-39 
41.6 46.3 
41 41.7 46.3 46.4 
40-44 
36.9 41.6 
36.4 37 41.6 41.6 
45-49 
32.3 36.9 
32 32.4 36.9 36.9 
50-54 
28 32.3 
27.7 28.1 32.3 32.4 
55-59 
23.7 27.7 
23.5 23.8 27.7 27.8 
60-64 
19.7 23.6 
19.5 19.7 23.6 23.6 
65-69 
16.1 19.8 
16 16.2 19.8 19.9 
70-74 
12.6 16.2 
12.4 12.6 16.2 16.3 
75-79 
9.3 12.7 
9.2 9.3 12.7 12.8 
80-84 
6.9 9.8 
6.8 6.9 9.8 9.9 
85+ 
4.3 7 
4.2 4.3 7 7 
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TBI-related mortality 
Modelled TBI-related mortality rates are plotted in figure 6.  TBI-related deaths among males were 1.98 
times higher than females, with an annual death rate of 15 deaths per 100,000 for males compared to 
eight deaths per 100,000 for females.  Translating rates into counts, 448 deaths in 2010 were estimated 
to be attributable to TBI, of which 293 (66%) were male. Modelled TBI-related deaths numbered 16% 
fewer than those registered as being caused by TBI in routine mortality statistics (448 modelled deaths 
vs 519 registered). 
 
Figure 6: Modelled TBI-related mortality rates (per 100,000) 2010 
 
 
Projection of TBI epidemiology in 2020 
Projected TBI incidence and prevalence of TBI survivors are presented in Table 11. The number of 
incidences is expected to increase to 13,591 (2% per year increase) and the number of prevalent cases is 
expected to increase to 641,104. The incidence and prevalence counts generated by DISMOD II assume 
similar rates of TBI incidence and prevalence to those estimated for 2010. Information on the number of 
incidences and prevalence in the future provides information to health planners and funders on the 
likely demand for health services.  
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Table 11: Projected number of first-ever TBI 2010-2020 
Age group 
(years) 
Incidence (counts) Prevalence (counts) 
Male  Female Persons Male  Female Persons 
0-4 1356 1135 2491 3445 2891 6336 
5-9 1151 919 2070 9737 8058 17795 
10-14 1054 784 1838 15000 12121 27121 
15-19 893 598 1491 17790 14064 31854 
20-24 740 411 1151 22034 16601 38635 
25-29 548 300 848 25649 19026 44675 
30-34 348 236 584 26416 20234 46650 
35-39 233 181 414 25328 20122 45450 
40-44 197 138 335 23523 19284 42807 
45-49 242 143 385 26048 21630 47678 
50-54 251 151 402 27238 22086 49324 
55-59 207 191 398 28780 23068 51848 
60-64 184 253 437 26678 21496 48174 
65-69 106 177 283 23221 19183 42404 
70-74 56 87 143 20467 17390 37857 
75-79 47 42 89 14288 12625 26913 
80-84 49 41 90 9339 8975 18314 
85+ 72 70 142 7720 9549 17269 
Total 7734 5857 13591 352701 288403 641104 
 
Total DALYs due to TBI in NZ 
As shown in Table 12, TBI accounted for approximately 20,300 DALYs. This is 27% of all injury-related 
health loss and 2.4.% of DALYs from all causes in 2010 (Ministry of Health, 2012). The TBI DALYs were 
made up of 14,386 years of life lost (YLLs) (71%) and only 5891 years lived with disability (YLDs 29%). 
Thus the majority of health loss from TBI reflects fatal outcomes. Of the nonfatal health loss from TBI, 
56% (approximately 3300 YLDs) resulted from mild cases and 44% (approximately 2,600 YLDs) from 
moderate to severe cases. DALY rates were approximately twice as high in males than females (adjusting 
for differences in their age distributions). DALY rates were higher in younger than older age groups, 
peaking in the 20-24 age group (Figure 7). After adjusting for age and sex distributions, population 
burden for TBI is expected to increase to 29,485 DALYs in 2020 (Table 14). 
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Table 12: Disability-adjusted life years due to TBI, 2010 
  YLL YLD 
(mild) 
YLD 
(moderate 
severe) 
% YLD due to 
short term 
consequence 
% YLD due to 
long term 
consequence 
DALYs DALYs per 
100,000 
population 
Current 2010        
Boys and Men 9,823 1,745 2,153 39% 61% 13,721 698 
Girls and Women 4,564 1,532 461 57% 43% 6,556 318 
Total 14,386 3,277 2,614 45% 55% 20,277 503 
 
 
Figure 7: TBI DALYs by sex and total population, 2010 
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Table 13: Disability-adjusted life years due to TBI, 2010 
 
YLL YLD Mild YLD Moderate/Severe 
DALY 
 
Age Female Male Female Male Female Male Female Male Total 
0-4 82 78 188 215 7 24 278 317 594 
5-9 78 74 168 199 14 58 260 331 591 
10-14 220 208 165 208 21 94 406 510 916 
15-19 546 899 151 204 26 122 724 1225 1949 
20-24 634 1605 107 158 27 132 769 1896 2664 
25-29 351 1259 80 107 27 130 458 1496 1954 
30-34 161 949 82 90 34 157 277 1196 1473 
35-39 195 904 82 81 39 181 315 1166 1481 
40-44 351 809 78 84 41 199 470 1092 1563 
45-49 391 607 72 90 39 198 502 895 1397 
50-54 206 498 64 82 35 181 305 760 1066 
55-59 149 479 68 68 33 174 250 721 972 
60-64 152 357 68 53 27 138 247 548 795 
65-69 210 292 52 35 24 116 287 443 730 
70-74 187 218 32 22 20 91 239 331 570 
75-79 132 178 26 20 18 76 176 274 450 
80-84 156 164 23 16 14 49 193 228 422 
85+ 361 245 26 14 13 31 401 290 691 
 
Table 14: Disability-adjusted life years due to TBI projected to 2020 
  YLL YLD Mild YLD Moderate/Severe DALY 
Age Female Male Female Male Female Male Female Male Total 
0-4 82 78 263 302 10 34 356 414 770 
5-9 156 148 224 264 19 78 399 490 889 
10-14 293 277 200 248 26 116 519 641 1160 
15-19 615 1092 162 216 29 135 805 1443 2248 
20-24 824 2141 124 187 33 165 981 2492 3473 
25-29 468 1970 103 149 37 190 608 2308 2916 
30-34 214 1249 91 105 39 194 344 1548 1892 
35-39 195 1039 78 79 38 185 312 1303 1615 
40-44 351 768 67 69 37 172 455 1009 1464 
45-49 430 643 73 82 41 190 544 915 1459 
50-54 275 622 75 85 42 199 392 906 1299 
55-59 209 639 86 77 44 210 339 926 1265 
60-64 228 558 97 69 41 195 367 822 1189 
65-69 358 475 76 49 37 169 470 692 1162 
70-74 323 406 52 35 33 149 408 590 997 
75-79 198 267 33 26 24 104 255 397 651 
80-84 195 253 26 21 17 68 238 342 581 
85+ 4323 0 34 24 18 56 4374 81 4455 
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Discussion 
The aim of this study was to estimate first ever in lifetime TBI incidence, prevalence of TBI survivors in 
the population, TBI attributable deaths and TBI-attributable health loss (denominated in DALYs) for NZ 
in 2010. Combining information from the BIONIC study with NZ national health data, the modelled 
results suggest that there were approximately 11,300 first-ever TBI events in 2010 with a total 
prevalence of approximately 527,000.  Males experienced higher rates of TBI than females. A high 
proportion of TBIs occurred among children (aged <16 years) and young adults (aged <34 years), 
accounting for about 75% of all first-ever TBI cases.   
 Health loss attributable to TBI in NZ was estimated to be approximately 20,300 DALYs in 2010.  This is 
over one quarter (27%) of all health loss attributable to intentional and unintentional injuries in that 
year, and almost 2.4% of all health loss from all causes (i.e., all diseases and injuries) (Ministry of Health 
and Accident Compensation Corporation, 2013). Importantly, we found that most of the health loss 
attributable to TBI (71%) resulted from fatal injuries. However, nonfatal outcomes (i.e., disability) still 
accounted for a substantial share of the total TBI burden. While both moderate/severe and mild TBI 
contributed to this nonfatal burden, mild TBI made the greater contribution (56% of total TBI YLDs).  
Our findings are consistent with previously reported studies. Tagliaferri and colleagues (Tagliaferri, 
Compagnone, Korsic, Sevadei, & Kraus, 2006)  reviewed 23 studies conducted in Europe and reported an 
aggregate hospitalised TBI incidence rate of 235 per 100,000 person-years. However, these estimates 
reflect episode rates of TBI (incident and recurrent) sourced from hospitalisation data. In the BIONIC 
study approximately 30% of incident TBI cases were never seen in hospital. Similarly Corrigan et al. 
(2010) reviewed TBI incidence and prevalence studies conducted in the US and abroad. The authors 
concluded that approximately 235,000 Americans are hospitalised for non-fatal TBI each year,  but were 
unable to estimate the incidence of non-hospitalised events (Corrigan et al., 2010). In contrast, a 
prospective birth cohort study found the incidence of TBI to be much higher (McKinlay et al., 2008). The 
authors reported an incidence rate of 1,750 per 100,000 per year. The result was based on a population 
capture methodology which included non-hospitalised TBI (McKinlay et al., 2008). However McKinlay et 
al.’s (2008) findings were limited to a 0-25 year age group.  It is of note that high quality epidemiological 
design and case ascertainment is lacking in most previous studies.  TBI DALYs have previously been 
reported for  New Zealand in the New Zealand Burden of Disease Study (Ministry of Health, 2012) these 
estimates are consistent with those reported here, despite differences in time period, methodology and 
data sources.  
Strengths of this study include the use of data from a population-based TBI incidence study (Barker-
Collo & Feigin, 2009; Feigin et al., 2013; Theadom et al., 2012). Unlike previous studies (Cassidy et al., 
2004; Ribbers, 2007; Tate et al., 1998), the estimates reported here are based on investigating TBI in 
both hospital and community settings across all ages and severities of injury.  
The main limitation of our study is the use of routinely collected mortality data to estimate TBI 
mortality. However, the multi-state life table model corrects for inaccuracy in routine cause of death 
coding. Thus we estimated 448 deaths from TBI in NZ in 2010, whereas 519 deaths were coded to this 
cause in the official mortality statistics. This correction is itself a useful output of our study and helps to 
inform policy makers of the true impact of TBI on our society; reasons why TBI appears to be over-
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reported as the underlying cause of death require further investigation to understand how underlying 
causes of death are coded, especially where multiple trauma is involved. Secondly, the data used on 
levels of disability (from the BIONIC Study) is subject to self-report bias, however it is the best available 
data.  
Finally, the model as currently constructed does not disaggregate by ethnicity or by socio-economic 
status due to insufficient data. This clearly reduces the policy relevance and value of our findings.  
Despite these limitations the model still provides an internally consistent description of TBI 
epidemiology (including incidence, prevalence and survival) and current burden (including both YLL and 
YLD). 
In conclusion, the current study quantifies the substantial population health impact of TBI in NZ. Further 
studies are needed to extend the findings to ethnic and socioeconomic subpopulations, and study 
trends in TBI epidemiology and impacts over time, including recurrent TBI. Such data is essential for 
planning and evaluating public health interventions and clinical TBI services.  
 
Summary 
The current study used DISMOD II and multi-state life table modelling to estimate the incidence and 
prevalence of TBI for NZ. The results suggest that the number of TBI sufferers in NZ is substantial and is 
expected to increase further by 2020. Further similar studies are needed to confirm the findings in other 
populations; to establish reliable estimates for monitoring TBI as more population-based longitudinal 
data becomes available. Taking further steps towards improving models will allow predicting the burden 
of TBI to be extended to a fuller and effective description. Good information on disability outcomes are 
lacking and current research make the best possible estimates as to the true disability burden.  
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CHAPTER FOUR: The direct and indirect cost of traumatic brain injury in New 
Zealand: A cost-of-illness study 
 
The main findings of the results from this research have been published; the key findings of this paper 
are reported in this chapter. It was presented as an oral communication at the 3rd International Congress 
on Neurology and Epidemiology in 2013. The details of the publication are: 
1. Te Ao B, Brown P, Tobias M, Ameratunga S, Barker-Collo S,  Theadom A, McPherson K, Starkey 
N Dowell A, Jones K, Feigin V, on behalf of the BIONIC Study Group. (2014). The cost of 
traumatic brain injury in New Zealand: Evidence from a population based study. Neurology; 83; 
18:1645-1652. (see appendix seven) 
 
Introduction  
Previous authors have concluded that hospitalisation costs accounts for a large portion of the overall 
direct medical costs associated with TBI. The direct and indirect cost increases with TBI severity (Access 
Economics, 2009; Brener, Harman, Kelleher, & Yeates, 2004; Davis et al., 2007; Grabow, Offord, & 
Rieder, 1984; Tilford et al., 2005), with estimates including CAN$32,132 (per person) for patients 
hospitalised with a brain injury in Canada (Chen et al., 2012). The investigators also provided evidence of 
an overall annual medical cost for all patients hospitalised with TBI of approximately CAN$120·7 million. 
Other international estimates of average hospitalisation charges for TBI include US$21,160, US$25,271 
for mild and moderate TBI and US$57,637 for severe TBI (Farhad et al., 2013) in the US, and £15,462 per 
person per hospitalised patient in the UK (Morris, Ridley, Lecky, Munro, & Christensen, 2008).   
A limitation of previous studies is that these have been focused primarily on individuals who were 
hospitalised for their TBI (McGregor & Pentland, 1997). These patients tend to have the most severe 
injuries and as a result, the costs of non-hospitalised TBI were not considered. Given that mild TBI (as 
measured by Glasgow Coma Scale ≥ 13) constitutes 95% of all cases, this omission might tend to 
overstate the average cost per individual but understate the total societal cost of TBI. A further 
limitation of previous studies is the lack of focus on the other, non-hospitalisation costs TBI places. This 
is in part because accurate population level data about resource use and the health impact of TBI is 
scarce. The aim of this chapter is to utilise brain injury data from the population-based BIONIC study in 
combination with electronic hospital records, official death records, and self-reported health service 
usage to estimate the societal cost of TBI in one year and the lifetime direct and indirect costs of TBI for 
NZ in 2010 projected to 2020.   
Chapter objectives  
1. From a societal perspective, what are the one-year and lifetime direct and indirect costs of 
all TBI by severity in NZ in 2010? 
2. What are the projected societal costs of all TBI in NZ in 2020? 
3. What are the predictors of high immediate (hospitalisation) and long-term (one-year 
community health service utilisation) costs for persons with TBI? 
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4. What are the first-year direct costs of all TBI by age, gender and ethnicity, area of 
residence and cause of injury in NZ in 2010? 
Methods 
The primary outcome was the cost of health care services and loss of productivity associated with 
having a TBI.  
Estimating TBI incidence and prevalence in New Zealand 
NZ has a public health system that is available to all, accounting for over 95% of all expenditure on 
inpatient and outpatient care. In addition, home support services post-TBI (including home help and 
personal care) are funded by the public health system (including an accident compensation scheme). 
These publicly funded expenditures can be linked to the TBI survivor via a unique identifier (the National 
Health Index, (NHI)) that accompanies each reimbursement to health providers. The NHI is also used to 
record other medical events and treatments and death following TBI.  Identifying the burden of TBI 
requires consideration of factors such as the age and sex structure of the general population, and the 
treatment and health care services used by the general public. Incidence or first-ever events from the 
BIONIC study were combined with NZ national population estimates to provide the number of first-ever 
cases of TBI for NZ in 2010.  
The BIONIC study used multiple overlapping sources of information to capture all new TBI cases (fatal 
and non-fatal, hospitalised and non-hospitalised) across all age groups and the TBI severity spectrum 
(mild, moderate, severe) in urban and rural residents of Hamilton and Waikato districts (population 
approximately 170,000) from 1 March 2010 to 28 February 2011. During the course of the study a total 
TBI incidence of 790 cases (95% CI 749-832) per 100,000 person-years was identified; incidence per 
100,000 person-years of mild TBI was 749 cases (95% CI 709–790) and of moderate to severe TBI was 41 
cases (95% CI 31–51). All TBI cases consenting to participate in the study (n=725; 53%) were followed-up 
over 12 months following injury. Further details of the methodology, diagnostic criteria and main 
incidence results of the study have been reported elsewhere (Feigin et al., 2013; Theadom et al., 2012). 
Where possible all surviving participants were interviewed at baseline, one, six and twelve months post 
injury. TBI severity was defined using standard definitions (Ponsford et al., 2004; Shores et al., 1986; 
Teasdale & Jennett, 1974). Mild TBI was defined as Glasgow Coma Scale (GCS) 13-15 and/or post-
traumatic amnesia (PTA) (Ponsford et al., 2004; Servadei, Teasale, & Merry, 2001) <24 hours; moderate 
TBI  as GCS 9-12 and/or PTA one-six days; and severe TBI as GCS 8 or less and/or PTA seven or more 
days. If GCS and PTA severities differed, the more severe category was assigned. If no information on 
PTA was available, severity was based on the GCS score alone. All confirmed cases of TBI where a GCS 
score was not recorded were classified as mild. 
The information collected at baseline included demographics, medical history and place of residence 
prior to TBI. Information at one month documented initial acute treatment. At six and twelve months 
participants’ use of outpatient, rehabilitation and home care services, and health status were recorded.  
For those recruited to BIONIC, information on emergency department presentations and hospital 
admissions was obtained from the National Minimum Dataset (NMDS), NZ Ministry of Health (data 
received on 29/10/2012). The NMDS includes all presentations and admissions to public or private 
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hospitals in NZ and are linked to the individual via their NHI number (Ministry of Health, 2010a). Only 
information for services funded in whole or part by district health boards and the Accident 
Compensation Corporation (ACC), a no-fault personal accident insurance cover (health funders in NZ), 
was available. Unit cost and prices for outpatient services used were obtained from ACC.    
Prevalence was modelled (Dismod II, 2013) from data on incidence, remission and mortality using multi-
state life table methods (Barendregt et al., 2003; Barendregt & Ott, 2005).  Compared to the total NZ 
population census (base 2006) information, the Hamilton and Waikato populations have demographic 
and social characteristics that are reflective of NZ with the exception of having a slightly lower 
representation of Pacific peoples. TBI incidence and prevalence were estimated for NZ in the reference 
year and then projected to 2020, assuming similar trends in TBI prevalence to that estimated for 2010. 
Data management 
A quality check on completed health resource use data forms was undertaken by the candidate (N=725; 
53% of completed cases), post-data lock. Every tenth case report form (BIONIC questionnaire) was 
audited by comparing the data forms with the original database for keying errors. As with many studies 
it is hoped that the level of missing data is kept to a minimum; in some cases it will not be possible to 
avoid. The main analysis was conducted on non-missing data (i.e. complete case analysis). 
Data preparation involved the following steps: 
 Identification of relevant clinical measures and health service use variables for estimating the 
cost of TBI from the BIONIC database. 
 Resource use data collected at baseline, one, six and twelve months were extracted into a 
separate file. Costs were calculated using unit costs from Waikato District Health Board’s 
costing system. Costs per unit service were interpolated between follow-up points using a 
moving average.   
 Extraction of data for index hospitalisation and hospital readmission from the NMDS (Ministry 
of Health, 2010a), removal of duplicates and selection only of the inpatient information relating 
primarily to having a TBI.  
 Matching participant occupation information identified from the BIONIC database to average 
income by occupation (ANZCO) from Statistics New Zealand (Statistics New Zealand, 2010a, 
2013) 
 Merging of all data onto a single line by participant ID. 
Health care resource usage questionnaire 
The questionnaire was designed to capture and measure health care use, out of pocket costs related to 
TBI as well as home aids and equipment over the 12 month follow up period. The questionnaire covers 
relevant aspects of health and productivity, including TBI related absence from work.  Questions were 
developed based on existing design and recommendations from large incidence studies undertaken over 
three decades within the wider Auckland region for stroke (Anderson et al., 2005; Bonita et al., 1993; 
Feigin et al., 2003; Krishnamurthi et al., 2014) with inputs from a multidisciplinary and multi-instutional 
team including health economists, health services researchers, psychologists rehabilitation consultants 
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and neurologists.  Resource use and TBI related absence from work were assessed at one, six and twelve 
months follow up points. Each consented participant were asked to recall their frequency of visits to 
health care professionals (i.e., general practioners, medical specialists, allied health professionals) and 
any community services (i.e., home help) within the last month of being assessed. The participants were 
also asked to identify who paid for each service they visited (i.e., out of pocket, health insurance, DHB or 
ACC).  Resources were valued according to funding source. Participants were asked to state the quantity 
of hours work performed compared to regular work hours in order to asses productivity loss.  
Cost-of-Illness model 
An incidence-based, COI model (bottom-up approach) was developed to estimate the economic cost of 
TBI in NZ. Average costs per case for the first year following TBI and the lifetime direct and indirect costs 
were calculated. 
Costs 
The types and unit costs of each health service are shown in appendix eight.  The cost analysis included 
direct health care costs (e.g. hospitalisations and outpatient rehabilitation services), indirect costs (e.g. 
productivity loss for persons with TBI) and out-of-pocket expenses (e.g. aids and home modification). 
Costs are presented in New Zealand dollars, 2010 value. 
Hospital inpatient and outpatient costs – There were two steps involved with identifying the cost of 
hospitalisation. First we identified those admissions primarily due to a TBI, second the average cost of 
hospitalisations relating to TBI (costs relating to other conditions were not included) was estimated by 
multiplying the percentage of individuals hospitalised for TBI times the average cost per person 
hospitalised. TBI hospitalisations were confirmed by ICD-10 codes (i.e. S02.1, S02.7, S02.9, S06.0-S06.9 
and S07.1). For the purpose of data extraction from the National Minimum Dataset and ACC’s claims 
data, the Classification of Disease 10th revision codes (ICD 10) is used. Specific ICD 10 codes are listed in 
Table 15. 
 
 
 
 
 
 
 
 
 
 
 
Table 15: Specific International Classification of Disease codes relating to brain injuries 
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Description  ICD-10 
Open wound of the head  S01.0-S01.9 
Fracture of the skull and facial bones  S02.0, S02.1, S02.3, 
S02.7, S02.8, S02.9 
Injury to optic nerve and pathways  S04.0 
Intracranial injury  S06.0-S06.9 
Crushing injury of head  S07.0, S07.1, S07.8, 
S07.9 
Other unspecified injuries of head  S09.7-S09.9 
Open wounds involving head with neck  T01.0 
Fractures involving head with neck  T02.0 
Crushing injuries involving head with neck  T04.0 
Injuries of brain and cranial nerves with injuries of nerves and spinal cord at neck 
level 
T06.0 
Sequelae of injuries of head  T90.1, T90.2, T90.4, 
T90.5, T90.8, T90.9 
 *Note: Codes in bold are most relevant in the context of strictly brain injuries 
 
The cost was taken from assessed hospital charges. Hospitalisation costs were determined using 
weighted discharge value known as the Weighted Inlier Equivalent Separations (WIES) for all National 
Minimum Dataset events by the Ministry of Health (Ministry of Health, 2010a).  The national price for 
financial year 2010/2011 per WIES was NZ$4,410.38 (Ministry of Health, 2010b). The public-hospital-
based inpatient (including medical and surgical) units of NZ$4,410.38 will be multiplied by inpatient 
service case weight to obtain the cost of inpatient services. As the hospital services are provided by the 
publicly owned district health boards (DHBs) (not patient charges) the costs are internal weighted 
estimates (based on Disease-Related Groups and length of stay) of the cost of each type of care. WIES 
cost weight includes medical costs, ward stay, medication, laboratory tests, diagnostic imaging, and 
nursing and other ward staff. 
Community and home support – Although most formal care for home support services is funded by the 
state, most providers contract with the government to provide the bulk of services. As a result, no 
accurate information exists regarding the individual charges for TBI-related community and home 
support. To estimate the cost of these services, a resource-based costing approach was used where a 
common price was applied to each resource (e.g. cost per hour per therapist). 
Number of visits to therapists (i.e. visiting nurses, physiotherapists, medical specialists, occupational 
therapists, speech therapists, general practitioners, counsellors, psychologists and social workers) over 
the month prior to each of the BIONIC assessments (i.e. one, six and twelve months post TBI) were 
assessed via patient and significant other questionnaires. The cost of therapy visits were estimated by 
multiplying visit numbers by the resource unit cost. Similarly, the hours of home support (home help 
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and personal care) were estimated using BIONIC follow-up questionnaire data with the cost estimated 
by multiplying the number of reported hours provided by the current cost of care for the service (in NZ$, 
2010). Thirdly, the cost of basic maintenance and home modification support resulting from TBI was 
estimated by combining the information provided from the patient, family or caregiver survey responses 
with current market prices.  
Direct costs included hospitalisation and emergency department visits, regardless of whether or not 
they resulted in an admission, and the number of therapy visits provided to individuals living at home 
included home help and personal care services. All categories were summed together to estimate 
average cost per case. National incidence costs were estimated by multiplying the average cost per case 
by the national TBI incidence (based on the incidence of TBI calculated from the BIONIC study).  The 
proportion of prevalent (including those who were still symptomatic at 12 months post TBI) TBI cases 
having a disability at 12 months follow up were estimated and combined with total NZ incidence cases 
to estimate national prevalence costs. TBI cases with no disability (at 12 months follow up) were 
assumed to have no on-going costs.  
Lifetime direct costs associated with TBI 
At each follow up BIONIC participants were questioned about direct medical resources used relating to 
their TBI. At 12 months post TBI, the proportion of participants identified as having a moderate to 
severe disability (as measured by the Glasgow Outcome Score (GOS) (Jennett & Bond, 1975)) was 
sourced from the BIONIC dataset and used to determine the probability of needing on-going health 
resources (i.e. post 12 months). GOS describes the degree of recovery and prediction of long-term 
disability (Jennett & Bond, 1975). If an individual with either mild or moderate severe TBI had residual 
disability (moderate or severe) at 12 months, this was assumed to persist for a lifetime. A weighted 
average cost for adults and children identified as having a moderate to severe TBI was then calculated 
(i.e. average direct cost per case x probability of having a moderate/severe disability). The discounted 
lifetime health care costs (see statistical analysis section) occurring in each year were then summed 
together with the first year costs.  
Productivity loss  
First, production losses within 12 months of injury were estimated only for a friction period after the 
loss of paid work (Koopmanschap & Martin Van Ineveld, 1992; Koopmanschap & Rutten, 1993). A 
friction-cost approach assumes individuals who die or leave the workforce due to disability (for instance 
from TBI) will be replaced after a specific time period, resulting in short-term productivity loss 
(Koopmanschap & Martin Van Ineveld, 1992). Following similar methods in (Cadilhac et al., 2011) three 
months was used as the friction period. Secondly, in an attempt to estimate long-term productivity loss, 
at 12 months follow up the proportion of participants reporting a decrease in their income was 
identified.  The value of time lost from employment or productive activity (indirect costs) up to the age 
of 65 years was estimated both for adults in the paid workforce and for adults in unpaid productive 
activity before injury. Costs of productivity were estimated using reported loss of income from BIONIC 
case record forms combined with Statistics NZ data on average weekly earnings linked to occupation for 
those who were in the paid workforce (Statistics New Zealand, 2010a). Long-term loss of production 
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cost methods are presented in appendix nine.  Due to lack of accurate information, cost of informal care 
(including care for childhood TBI) or compensation was not included in the analysis. 
Statistical analysis 
SPSS statistics version 20 (IBM SPSS Statistics) and Microsoft Excel 2010 (Microsoft Corporation 2010) 
were used to analyse data for this study. The results are presented from the perspective of the society in 
terms of direct and indirect costs for incident and prevalent TBI cases (per person and total for NZ) for a 
given year and overall (lifetime cost). Descriptive analyses, including means and 95% confidence 
intervals [CI] using bootstrapping methods, were used to determine the economic profile of TBI in NZ 
(by levels of severity). We calculated average per person costs for TBI overall and by TBI severity (mild 
and moderate to severe). Ethnicity was self-identified and was extracted from the BIONIC dataset. 
Prioritised ethnic origin in accordance with the New Zealand 2006 census was used to obtain a single 
ethnicity. Participants were groups as European, Maori, Pacific, Asian or Other. We combined the 
moderate and severe categories because of the small number of cases in these groups. Significance of 
differences between the costs of mild TBI and moderate/severe TBI were tested using t-tests and 
Wilcoxon rank sum tests. The level of significance was set at P<0.05 (2-sided).  
Sensitivity analysis 
Multivariate probabilistic uncertainty analyses including a 5000 replications Monte Carlo simulation 
were undertaken using @Risk software version 6 (Palisade Corporation 2013) to estimate a mean and 
95% uncertainty interval for the outcome parameters. Calculation of sensitivity analysis used gamma 
distributions for costs estimates. A discount rate of 3.5% was used for lifetime cost projections as 
recommended by the NZ Treasury (New Zealand Treasury, 2005; Wren & Barrell, 2010) and PHARMAC 
(an organisation that manages all hospital medicines and vaccines funded by NZ Government) 
(PHARMAC, 2007). Further, one-way sensitivity analysis was conducted to test net present value for 
lifetime cost projections by varying the discount rate between 0% and 6% for projected costs. 
Results 
Demographic information 
A summary of the participants’ characteristics is shown in Table 16.  Of the 725 TBI participants, the 
average age at time of injury is 25.9 years (25.7 years for mild and 32.2 years for moderate severe), 
mostly male (60.6%) and residing in the urban centre (74.6%). The majority of the participants are of 
European descent (70.3%) compared to other ethnic groups while 47% are classified with an area 
deprivation of decile 8 or higher. While most TBI were identified through hospital sources 29.6% were 
identified in the community. 
 
 
 
 
 
Table 16: Overview of incidence and prevalence of TBI in the BIONIC study 
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Mild TBI                        
n=691 
Moderate/severe 
TBI n=34 
Total                               
n=725 
  n  (%) n  (%) n  (%) 
Mean age in years (SD) 25.7 20.3 32.2 23.2 25.9 20.5 
Median age in years (IQR) 20 10-39 26.5 17-55 20 11-39 
Male 412 59.6% 27 79.4% 439 60.6% 
Urban residency 519 75.1% 22 64.7% 541 74.6% 
ACC claim 615 89.0% 31 91.2% 646 89.1% 
NZDep ≥ 8 324 46.9% 17 50.0% 341 47.0% 
Ethnic origin             
European 418 60.5% 20 58.8% 438 60.4% 
Maori 230 33.3% 11 32.4% 241 33.2% 
Pacific 23 3.3% 2 5.9% 25 3.4% 
Asian 18 2.6% 1 2.9% 19 2.6% 
Other 2 0.3%     2 0.3% 
Site of case detection             
Hospital* 479 69.3% 31 91.2% 510 70.3% 
Family doctor 125 18.1%     125 17.2% 
Other 87 12.6% 3 8.8% 90 12.4% 
History of TBI 284 41.1% 13 38.2% 297 41.0% 
Cause of TBI             
Transport accident 126 18.2% 12 35.3% 138 19.0% 
Fall 282 40.8% 11 32.4% 293 40.4% 
Exposure to mechanical force 144 20.8% 2 5.9% 146 20.1% 
Assault 119 17.2% 7 20.6% 126 17.4% 
Other 7 1.0% 2 5.9% 9 1.2% 
Unknown (not specified) 13 1.9%     13 1.8% 
* through emergency department, does not indicate hospital admission 
    
In 2010, 11,301 first-ever TBI cases are estimated to have occurred in NZ, 57% of which are among 
males. The majority (75%) are aged less than 35 years. Taken together the total number of TBI patients 
in NZ (including prevalent cases) is estimated to be 527,388. In the year 2020, the number of first-ever 
cases is estimated to increase to 13,591 and the number of prevalent cases (period prevalence) is also 
expected to increase to 641,104 cases (see Table 17) (refer to chapter three). The increase in incidence 
and prevalence are due to increases in population. 
 
 
 
 
Table 17: Incidence and prevalence of traumatic brain injury in New Zealand in 2010 projected to 2020 
(modelled estimates from the BIONIC study) 
. 
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  Current Burden (2010) Projected Burden (2020) 
  Incidence Prevalence Incidence Prevalence 
Male 6,488 291,146 7,734 352,701 
Female 4,813 236,242 5,857 288,403 
Total 11,301 527,388 13,591 641,104 
 
What are the first-year and lifetime direct and indirect costs of all TBI by severity in NZ in 2010? 
Average first-year per person cost of TBI in New Zealand 
A detailed breakdown of 12-month follow-up resources used and average per-person costs are 
presented in Table 18. Of the 725 cases, about 64% were not initially hospitalised for their TBI. Of those 
who were hospitalised, survivors spent on average 2·6 days (min 0 days, max 61 days) in hospital. After 
discharge most of the patients used general practitioner services (36% [263]), allied health services (18% 
[133]) and specialised medical care (14% [105]) at follow up. Total direct health care costs over 12 
months per-patient amount to NZ$5,637 (min NZ$38, max NZ$167,052). On average 17% [124] reported 
having a loss in income due to their injury. Costs attributable to production losses were estimated at 
NZ$2,980 (min NZ$243, max NZ$19,745), resulting in an average total first year cost of NZ$6,144 per 
person (95% CI NZ$5,104-NZ$7,413). This amount is reflective of the high proportion of mild TBI (95%) 
identified in the study cohort and high proportion of cases not needing acute hospitalisation. 
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Table 18: Proportion and cost per case for the categories of resource use during the first year – Cost of all 
traumatic brain injury in New Zealand (modelled estimates from the BIONIC study 
 
  Users 
Resources per 
patient (N. of 
days or N. 
visits) 
Cost per category (NZD) 
  % Mean Mean 95% CIᵅ 
Total (N) 725        
Health care         
Emergency Department 42%   $270   
Initial hospitalisation 36% 2.6 $4,374 $3,157-$5,800 
Hospital readmission 4% 6.5 $7,009 $3,591-$11,461 
Outpatient care 6% 6.1 $2,669 $1,441-$5,923 
Specialised medical care 14% 9.6 $3,476 $2,579-$4,423 
Allied health care 18% 21.4 $6,289 $5,081-$7,690 
General practice 36% 9 $1,421 $1,244-$1,610 
Nursing 4% 19.1 $3,366 $1,625-$5,907 
Radiology 1% 3.8 $3,544 $795-$7,328 
Community services 3%   $31,735 $15,952-$51,866 
Out-of-pocket expenses 4%   $1,033 $352-$1,919 
Other expenses 100%   $215 $211-$218 
Total direct medical 
costs per person 
100%   $5,637 $4,605-$6,959 
Non-health care 
(indirect) 
        
Loss in productivity 17%   $2,980 $2,470-$3,553 
Total 1-year costs per 
person 
100%   $6,144 $5,128-$7,446 
On-going direct medical 
costsᵇ 
5%   $25,929 $9,351-$49,770 
Long-term productivityᵇ  3%   $46,130 $25,215-$71,185 
Total lifetime cost per 
personᵇ 
100%   $8,824 $7,118-$11,709 
ᵅBootstrap results are based on 1000 bootstrap samples 
ᵇ 3.5% discounting 
Average first-year cost by TBI severity 
Table 19 summarises the resources used and average per person cost in survivors who had a mild or a 
moderate/severe TBI. Six hundred and ninety one cases (95% [691 of 725]) are found to be mild (GCS ≥ 
13) and 34 cases are moderate/severe (GCS ≤ 12). A consistent pattern of resource usage is found in the 
mild cohort. The composition of costs varied over the 12-month follow-up period, with general practice 
(37% [253 of 691]) and allied health services (17% [119 of 691]) most commonly used. In contrast, a 
higher percentage of those with moderate/severe TBI (88% [30 of 34]) required initial hospitalisation 
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(min $869; max $109,317) with an average length of stay 13.3 days. Of those who were hospitalised, 
12% [4 of 34] were readmitted. Cost of hospital readmission is significantly greater than for those whose 
injuries were mild (Wilcoxon rank sum Z=-2·191, P=0.028). After discharge allied health services (41% 
[14 of 34]), general practitioner (32% [11 of 34]) and specialised medical care (29% [10 of 34]) are the 
most commonly utilised services, with 12% [4 of 34] having some community home care support. One 
year cost per case for mild (95% of all cases) and moderate/severe TBI are NZ$5,058 (95% CI NZ$4,142-
NZ$5,867) and NZ$31,854 (95% CI NZ$16,114-NZ$47,377), respectively. Due to the higher cost of 
hospitalisation, the one year cost of moderate/severe TBI is significantly higher than that for mild TBI 
(Wilcoxon rank sum Z=-5·914, p≤0.0001). The total cost of treating all mild TBI cases over a one year 
period is three times that of all moderate/severe TBI cases. 
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What are the projected societal costs of all TBI in NZ in 2020? 
Total first-year incidence and prevalence costs in 2010 projected to 2020 
Details for the main cost drivers during the first year for all TBI are provided in figure 8. The results 
suggest, that in the first year hospitalisation (29%) accounts for the largest costs in all patients (NZ$20·7 
million). Followed by (21%) outpatient rehabilitation (NZ$14.8 million), (17%) community services 
(NZ$12.3 million) and the value of indirect costs (loss of productivity), which are estimated to be NZ$5.7 
million. 
Figure 8: Annual cost according to cost category for traumatic brain injury NZ$  
 
 
When applied to all TBI survivors in NZ (Table 20) the total first-year costs of all new cases of TBI that 
occurred in NZ during 2010 are estimated to be NZ$71 million (95% CI NZ$53.2 million-NZ$88.3 million). 
Using a prevalence-based approach, the total cost for all TBI equates to NZ$151 million (95% CI 
NZ$112.9 million-NZ$186.5 million). While assuming similar trends in TBI incidence to those estimated 
for the reference year, the prevalence cost of TBI is expected to increase by 21% to over NZ$182.7 
million (95% CI NZ$136.6 million-NZ$225.5 million) in 2020. Source of healthcare funder distribution in 
the first year for TBI is illustrated in figure 9.  The majority of health care resources are funded by ACC 
(43%) followed by personal out-of-pocket payments (31%), and 23% are funded by the DHB. It is 
interesting to note, that a fairly large proportion of healthcare services is financially covered by the 
individual, most likely due to co-payments for service.  
 
 
 
 
 
$17,997,200 
$12,887,824 
$12,261,949 
$5,904,831 
$5,771,297 
$5,688,474 
$2,725,486 
$2,424,774 
$1,925,903 
$1,628,754 
$1,255,314 
$528,741 
$364,057 
Initial hospitalisation
Allied health care
Community services
General practice
Specialised medical care
Loss in productivity
Hospital readmission
Other expense
Outpatient care
Nursing
Emergency department
Out-of-pocket expenses
Radiology
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Figure 9: Healthcare funder distribution in the first year 
 
Table 20: Current and future burden of traumatic brain injury 
 
 Cost estimates for New Zealand 
Current Burden 
2010 
Projected Burden 
2020 
Incidence (First-ever TBI)     
One-year direct healthcare cost $65,676,129 $78,189,847 
One-year indirect cost $5,688,474 $6,819,650 
One-year total cost $71,364,604 $85,009,497 
Lifetime cost $103,342,853 $122,831,743 
      
Prevalence      
One-year direct healthcare cost $138,948,741 $168,045,754 
One-year indirect cost $12,118,102 $14,655,733 
One-year total cost $151,066,843 $182,701,487 
Lifetime cost $218,284,240 $263,994,762 
 
Estimated lifetime costs per person 
Estimated on-going direct health care and long-term loss of productivity costs of first TBI having 
occurred in 2010 are outlined in Tables 18 and 19. A total average lifetime cost per case is estimated to 
be NZ$8824 (95% CI NZ$6,861-NZ$11,374). Estimated lifetime costs for mild and moderate/severe TBI is 
NZ$6,908 (95% CI NZ$5,538-NZ$8,274) and NZ$54,605 (95% CI NZ$16,123-NZ$91,979) respectively. The 
results suggest that the average lifetime cost of a mild TBI is significantly lower (i.e. less than 15%) than 
that of the cost of moderate/severe cases. However, given the distribution of TBI by severity levels (95% 
ACC, 43%
Personal 
payment, 31%
DHB, 23%
Insurance, 2% Residential 
Home, 1%
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mild TBI, 5% moderate/severe TBI), the overall average lifetime cost of all mild TBI patients in NZ in 2010 
(10,771 x NZ$6,908) is nearly three times greater than the overall average lifetime cost of all 
moderate/severe TBI patients (530 x NZ$54,605). The total lifetime cost of all incident and prevalent TBI 
cases in NZ is NZ$218 million (95% CI NZ$145·2 million - NZ$290·1 million) in 2010 (see Table 19).  
Sensitivity and uncertainty analyses 
Following the sensitivity and uncertainty analyses, the total lifetime cost of TBI in NZ (of first TBI 
occurring in 2010) may range between NZ$86 million and NZ$119.9 million (Table 21). The average 
lifetime cost per person is NZ$8,018 (95% uncertainty interval NZ$7,914, NZ$8,173), ranging from 
NZ$7,312 (95% uncertainty interval NZ$7,195, NZ$7,490) for mild and moderate severe cases equating 
to NZ$59,276 (95% uncertainty interval NZ$58,087, NZ$60,832). When projected lifetime costs are not 
discounted, estimated future costs are up to 19% greater. The present value of future average costs per 
person with a 6% discount rate is NZ$6,283 for mild TBI and NZ$44,825 for moderate/severe (Table 22). 
Overall the probabilistic sensitivity analysis suggests that the results are robust to different sources of 
uncertainty. 
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Table 22: Sensitivity analysis varying discount rates for projected costs 
Scenario Cost/case in first 
years, NZ$ 
Cost/case over 
lifetime, NZ$ 
All TBI   
Base case (3.5%) $6,144 $8,824 
0% discount rate $6,144 $9,881 
6% discount rate $6,144 $,7831 
Mild TBI 
  Base case (3.5%) $5,058 $6,908 
0% discount rate $5,058 $7,585 
6% discount rate $5,058 $6,283 
Moderate Severe TBI 
  Base case (3.5%) $31,854 $54,605 
0% discount rate $31,854 $64,721 
6% discount rate $31,854 $44,825 
 
What are the predictors of high immediate (hospitalisation) and long-term (one-year 
community health service utilisation) direct costs for persons with TBI? 
Methods 
Multiple linear regression analyses were performed to determine predictors of costs incurred by TBI 
patients during the first-year follow up, for direct healthcare costs. The following predictors were used: 
socio-demographic conditions (age: young age (<34 years) vs older age), gender, ethnicity and living 
condition (living alone vs living with family), residency (urban or rural), socio-economic status (i.e. 
income and NZDEP), comorbidities, functional outcomes according to Glasgow Coma Scale (at baseline) 
and disability (GOS).  All possible predictors with significance (p<0.05) of the coefficients generated by 
stepwise procedure were reported. Due to non-normal distribution of cost data all costs were 
logarithmically transformed to run the regression models. 
  
79 
 
Results  
Table 23: Predictors of high direct costs 
Independent variable B SE Sig. 
Disability 0.913 0.169 0.00 
Young age -0.713 0.145 0.00 
Severity of injury 1.629 0.279 0.00 
comorbidity 0.28 0.129 0.03 
(Constant) 7.388 0.154 0.00 
        
R² 0.18     
n 725     
Dependent variable: log of direct costs 
Table 23 shows the results from the regression analysis. When the log of direct costs was predicted it is 
found that disability (beta=0.913, p<0.01), young age (beta=-0.713, p<0.01), TBI severity (beta=1.629, p< 
0.01) and comorbidity (beta=0.28. p<0.05) are significantly associated with direct medical costs. The 
overall model fit is R2=0.18. 
What are the first year direct costs of all TBI by age, gender, ethnicity, area of residence and 
cause of injury in NZ in 2010? 
 
The results do not record any statistically significant difference in the direct cost for TBI by sex, area of 
residence (rural vs urban) and ethnicity.   Table 24 shows direct cost per person for TBI by sex, age and 
severity of injury. Our results suggest that age-specific cost begins to increase at the age of 35 years and 
continues to increase with age. Although there are no significant differences by sex, males report having 
slightly higher costs than females (total direct cost for males NZ$6,201 vs total direct costs for females 
NZ$5,056).  There are high peaks in age-specific costs among the over 65 years age groups, which could 
reflect older peoples experience with trauma and better access and co-ordination to services provided 
by the DHB.  Similar trends are observed for per-person direct cost by residency (see Table 25).  The 
results suggest that rural populations require more health care resource for their injury while urban 
populations spend a lot less on direct costs. Figure 10 illustrates direct costs of TBI by ethnicity (Maori vs 
Non-Maori). While there is a NZ$1,216 (NZ$5,864-NZ$4,648) difference in cost between Maori females 
and Non-Maori females, direct costs by ethnicity are similar indicating no evidence of differential access 
to health care services.  Direct costs by cause of injury are shown in Table 26.  Traffic accidents 
(NZ$9,553) are associated with the highest per person costs followed by falls (NZ$6,320). Per-person 
costs related to traffic injuries peak in the 15-34 year age group and are highest among rural populations 
(NZ$17,077). 
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Figure 10: Direct cost per person by ethnic origin (Maori vs non-Maori), and injury severity 
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Discussion  
This study utilised data from a population-based TBI incidence study to report first-year and lifetime 
costs of TBI by severity levels across all age groups of the urban and rural population. Our cost estimates 
are based on patterns of resources used during the first year after having a TBI and provides important 
information for future health care planning.  New Zealand is among other high income countries that 
are faced with balancing expenditure versus benefit in tight fiscal environments. The results provide 
evidence that the cost of treating TBI varies greatly, with the most severe TBI sufferers attracting 
maximal costs. Our main findings estimate total first-year incidence costs for TBI in NZ during 2010 to be 
NZ$71 million (US$47.7 million) with total prevalence cost of NZ$151 million (US$101.3 million). This 
equates to an average cost per person of NZ$6,144 (US$4,123) with average costs per person for mild 
(95% of all cases) and moderate/severe TBI NZ$5058 (US$3,395) and NZ$31,854 (US$21,379) 
respectively. Although the cost per case of mild TBI is significantly lower than the cost of 
moderate/severe injuries, the unexpectedly large number of mild TBI (95% of all TBI cases) means that 
the total cost of treating these cases is three times that of moderate/severe. Lifetime costs per person 
for all first TBI occurring in 2010 are estimated to be NZ$8,824 (US$5922) for all severities pooled, 
NZ$6,908 (US$4,636) for mild and NZ$54,605 (US$36,648) for moderate/severe. The overall lifetime 
cost of all incident and prevalent TBI cases in NZ was NZ$218 million (US$146.3 million) in 2010 and is 
projected to increase to NZ$263.9 million (US$177.1 million) in 2020, if the current trend in TBI 
incidence continues. 
The per-person (first year) cost estimates reported in this study are much lower than those reported in 
previous TBI cost studies (Access Economics, 2009; Chen et al., 2012; Davis et al., 2007; McGarry et al., 
2002; Morris et al., 2008; Schootman et al., 2003). The explanation may be that previous studies focused 
primarily upon patients who were hospitalised for their TBI. These patients tend to have more severe 
injuries and, as a result, the highest direct and indirect health care costs. While we acknowledge that it 
is difficult to assess accurate hospital costs between countries, it is unclear the extent to which the 
conclusions relate to other hospital settings, due to different costing systems.  By contrast, the present 
results are based on the first large prospective population-based study investigating TBI incidence and 
outcomes in both hospital and community settings (non-hospitalised TBI patients) across the spectrum 
of severity in all age groups in a geographic region with urban and rural populations (Feigin et al., 2013; 
Theadom et al., 2012). A significant proportion of TBI patients (64%) were not hospitalised at the acute 
stage of TBI (the majority sustaining mild TBI) and a significant proportion (30%) were identified through 
non-hospital sources. Based on the estimated number of people who experience new mild (51.8-56.4 
million) and moderate/severe (2.2-3.6 million) TBI per year in the world (Feigin et al., 2013), 
extrapolation of our estimates to the world population suggest that the global economic burden for TBI 
may range between  NZ$331.7 billion (US$222.6 billion) and NZ$368.6 billion (US$247.4 billion). 
Information regarding the cost and pattern of health services usage is useful for identifying areas in 
which interventions might improve outcomes. This analysis does not account for factors that might 
determine access to TBI care, such as prospects for recovery, nor does it attempt to link outcomes (such 
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as life expectancy) with access to specialised TBI care. Such an endeavour would require controlling for 
health status and TBI severity and modelling the pathways that individuals follow after care.  
Caregiver time and expense is clearly a significant cost to those living at home, but estimating the cost 
requires a different methodology than used in the current study. Basing lifetime cost estimates on short-
term data may overstate calculated estimates; therefore, estimating lifetime cost of TBI requires 
identifying the outcomes and health service usage over a longer period (i.e. five years or more) and 
modelling the likely use of other health services after TBI. In addition, we are not able to estimate costs 
associated with possible long-term consequences of TBI, especially repeated, such as cognitive decline, 
dementia etc. Taken together, these limitations of the data suggest that the estimated health service 
use and cost of services presented in this study should not be taken as the total cost of TBI in NZ. 
In summary the economic burden for TBI in NZ is high, but significant cost savings and improvements in 
outcomes may be achieved by targeting high cost individuals, and by reducing the incidence of lower 
cost mild injuries.  Further studies are required to confirm the findings in other populations and to 
explore the impact of TBI on families and caregivers, and ways to prevent both moderate/severe and 
mild TBI. The findings from this study represent the first economic study estimating the cost of TBI on a 
population level.  Every effort has been made to include only those costs that are attributable to the 
condition. Given the considerable costs associated with TBI, further investigation of the cost 
effectiveness of a variety of prevention strategies and rehabilitation services aimed at improving TBI, 
should be a priority. 
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CHAPTER FIVE: Trends in mild TBI in New Zealand and the public health 
response 
 
Introduction 
Approximately half a million New Zealanders will experience a traumatic brain injury (TBI) each year and 
this is expected to increase by 21% in 2020 (see chapter three).  Of all identified cases, about 95% were 
estimated to be mild TBI.  The high prevalence of brain injuries warrants governments and health 
systems to invest in evidence-based polices and interventions for both mild and moderate/severe TBI. 
Although the first-year per-capita cost of mild TBI in NZ is comparatively minimal when compared to 
moderate and severe (NZ$5,058 per mild TBI vs NZ$31,854 per moderate/severe TBI), overall it is rather 
significant due to the increased incidence (see chapter four).  Of those who suffer from mild TBI, many 
do not seek medical attention (34%) (Feigin et al., 2013) and are not referred to accident emergency 
departments or admitted into hospital for observation (64%). In particular, the mild TBI cohort is of 
great interest as previous research has demonstrated that even mild TBI can lead to significant and 
persistent long-term difficulty (New Zealand Guidelines Group, 2006; Wrightson & Gronwall, 1998) such 
as post-concussion (Sotir, 2001; Yang et al., 2007), and intracranial haematoma (Stein et al., 2006; Stein 
et al., 2008).  A better understanding of mild TBI and people with TBI not seeking medical attention may 
bring about population health efforts to improve prevention strategies. If predictive factors of severity 
of injury hospitalisation and on-going care can be identified, they can be useful for informing public 
health interventions aimed at reducing the incidence and related costs.  
Chapter objectives 
Obtaining accurate population level data and health service use information among those who do not 
seek medical attention is challenging. A methodological limitation of previous studies has been a heavy 
reliance on clinical diagnostic codes (ICD codes) used in hospital medical records.  As a result the 
characteristics of patients included in these studies are those who seek medical care, as opposed to 
those who do not.   
This chapter combines data from a prospective population-based incidence study of brain injuries in 
Hamilton and Waikato region, NZ (population approximately 170,000), that identified TBI in the 
community, including people not presenting to hospitals for treatment or who died immediately 
following their TBI.  The purpose of this chapter is to identify what public health officials should do to 
prevent TBI in NZ.  
The chapter objectives are: 
1. To examine the characteristics of people with mild TBI who seek medical attention compared 
with those who do not. 
2. To identify predictors of hospitalisation among mild TBI. 
3. To identify predictors among mild TBI of needing on-going care.  
4. To identify the effectiveness of prevention strategies for mild TBI. 
5. To estimate potential cost savings from effective prevention strategies in the literature. 
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A review of current TBI prevention strategies 
The following section will present an overview of the recommendations for preventing TBI both 
nationally and internationally.  Published and grey literature on TBI prevention strategies were analysed 
to describe current policies and guideline recommendations.  
New Zealand Accident Compensation Co-operation (ACC) 
Consultation between ACC with clients, their families and caregivers was undertaken in the early 
development stages of the current strategy to gain insight and understanding of the patient experience 
(New Zealand Guidelines Group, 2005, 2006). Similarly close communication with service providers was 
also carried out to better understand the part “providers” play in the rehabilitation phase. The present 
strategy is focused on adults with moderate to severe injuries. This approach provides direction for 
treatment and rehabilitation and to ensure the right systems and services are in place. The strategy has 
four key objectives: 
1. Achieving optimal client outcomes: 
a. person-centred approach to rehabilitation 
b. rehabilitation that is meaningful for the client and their family 
c. Optimal outcomes.  
2. Providing quality services from initial care to on-going rehabilitation services and community 
support (i.e. compensation for lost wages etc.): 
a. high quality of care 
b. right services at the right time in the right place 
c. Continual drive for improvements. 
3. Ensuring providers are engaged and focused on achieving the right client outcomes across the 
continuum of care: 
a. skilled external capability 
b. engaged external capability 
c. Measureable results from service provided. 
4. To maintain ACC’s role and involvement in the provision and funding of TBI treatment and 
rehabilitation services: 
a. understanding of TBI 
b. strong internal capability 
c. Collaboration with other agencies. 
One positive output from ACC’s strategy was the introduction of a residential rehabilitation project 
(Accident Compensation Coorporation, 2014). A critique of the current strategy is that it does not 
include adults and children with mild TBI. Despite recent research indicating a large proportion of TBIs 
are in fact mild, it is equally important that polices reflect evidence from research. TBI is commonly 
known as the “silent epidemic” due to the growing number of mild TBI occurrences which often occur 
without notice for the individual and society as a whole (Feigin et al., 2013).  
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Australia 
No specific prevention strategy for TBI was found in Australia; however, most efforts are currently 
focused towards the general unintentional injuries (e.g. falls) with a strong focus on falls among the 
elderly (The Australian Commision on Safety and Quality in Health Care, 2009) and road traffic injuries 
(Newstead, Cameron, & Leggett, 2001).  
Europe 
Whereas in the United Kingdom (UK), both the National Health Services (NHS) (Millward, Morgan, & 
Kelly, 2003), and the National Institute for Health and Care Excellence (NICE)  support the use of 
protective head gear to reduce head injuries. There is evidence of a prevention strategy aimed at minor 
head injuries and severe head injuries. The overarching strategy emphasised the following key areas: 
 safety helmets 
 safety in the home 
o including home modifications to reduce the chances of falls or slips 
 childproofing the home environment 
 safety at work 
 Sport safety. 
United States 
TBI is at the forefront of injury prevention in the United States (US). Increased interest in TBI is driven 
namely through sports such as American football and returning soldiers with severe head injuries or 
disability. Similar to efforts found in Europe, the Centres for Disease Control and Prevention (CDC) 
developed the “Heads up: educational initiative” which helps protect people of all ages from 
concussions and other serious brain injuries in the US (see http://www.cdc.gov/concussion). The 
initiative is aimed at parents, clinicians, high school coaches, youth sport coaches and school staff, and is 
available in print or mobile app. The tool starts with describing the conditions of concussion and brain 
injuries, to signs and symptoms, responding to concussion, danger signs and severe brain injury. The 
prevention concludes with safety information around the use of helmets, and car restraints. 
Lastly, the CDC recommends seven ways to reduce TBI. 
1. Use a child safety seat or booster seat or seat belt (Turner, McClure, Nixon, & Spinks, 2005). 
2. Wear a seat belt every time while driving or riding in a motor vehicle (Rivara, Thompson, & 
Cummings, 1999). 
3. Never drive under the influence of alcohol or drugs (Elder et al., 2002). 
4. Wear a helmet and make sure children wear helmets when: 
a. riding a bike or motorcycle 
b. Playing contact sport, such as hockey, boxing or football. 
5. Make living areas safer for seniors (Campbell, Robertson, Garner, Norton, & Buchner, 1999) by: 
a. installing hand rails on stairways 
b. Using non-slip mats in bathrooms. 
6. Make living areas safer for children by: 
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a. installing window guards 
b. Using safety gates. 
7. Make sure children’s playground surfaces are made of shock absorbing material (Mack, Sacks, 
& Thompson, 2000). 
Methods 
BIONIC study data source 
In brief the BIONIC study is a large TBI-incidence and outcomes study undertaken in Hamilton Waikato 
district (population 170,000) NZ and encompassed the use of multiple overlapping sources to ascertain 
all new and recurrent cases of TBI among residents in Hamilton Waikato region, over a 12-month 
calendar period (2010 to 2011). In the study area, Europeans constituted 55% of the study population, 
Maori 20% (the indigenous population of NZ), Pasifika (Pacific Island people living in NZ) 2%, and people 
of other ethnic groups 15%. The details of the study have been described elsewhere (Feigin et al., 2013; 
Theadom et al., 2012). Case definition and TBI surveillance procedures are reported in chapter three.  
Each diagnosis of potential TBI patients was identified by health care providers (e.g. health centres, 
family doctors, and physiotherapists), hospital emergency departments, and ambulance services and 
was verified by the BIONIC study operations group at weekly meetings. For cases flagged as needing 
classification of inclusion criteria further review were followed up by the study diagnostic adjudication 
group. All surviving patients were interviewed at baseline, one, six and twelve months post TBI. Baseline 
information included demographics, medical history and place of residence prior to TBI. Information at 
one month documented initial acute treatment while at six and twelve months included use of 
outpatient, rehabilitation and home care services, and health status.   
Variables measured 
The following baseline and follow-up outcome variables from adult and child forms will be summarised. 
Glasgow Outcomes Score (GOS) describes the degree of recovery and prediction of long-term disability 
to return to work and activities of daily living (Jennett & Bond, 1975). The scale has the following 
categories: 
1. Dead 
2. Vegetative state – unresponsive and unable to interact with environment 
3. Severe disability – able to follow commands, but unable to live independently 
4. Moderate disability – able to live independently, but unable to return to work or school 
5. Good recovery – able to return to work or school. 
New Zealand Deprivation 
The New Zealand Deprivation 2006 score (NZDep2006) combines nine variables from the NZ census 
2006 to provide a deprivation score for each geographic area in NZ (Salmond, Crampton, & Atkinson, 
2007). Deprivation scores range from 1 to 10, where 10 represents the most deprived areas.  
Deprivation scores were assigned by automatically geocoding individual participants’ known street 
addresses to meshblock. NZDep2006 scores apply to geographical areas not individual people. The nine 
variables used to derive an NZDep2006 score are (see Table 27): 
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Table 27: Description of the nine dimensions of deprivation 
Dimension of deprivation Variable description 
Income 
People aged 18-64 receiving a means-tested benefit 
Income 
People living in households with incomes below an 
income threshold 
Owned home People not living in own home 
Support People aged <65 living in a single parent family 
Employment People aged 18-64 unemployed 
Qualifications People aged 18-64 without any qualifications 
Living space 
People living in households below a bedroom occupancy 
threshold 
Communication People with no access to a telephone 
Transport People with no access to a car 
 
Individual income 
In order to estimate individual annual income, occupational information for all adults who were in paid 
employment sourced at baseline was linked to average annual earnings (Statistics New Zealand, 2010a) 
using the Australian New Zealand Standard Classification of Occupation (Trewin & Pink, 2006). Median 
annual earnings in 2010 of NZ$39,998 were assigned to adults who were in paid employment but did 
not record occupation information at baseline (Statistics New Zealand, 2010a). Applicable, parent or 
significant other occupation information was used as proxy for those younger than 15 years. 
Outcomes 
The outcomes measures included findings of CT scan that lead to either complications or neurosurgical 
intervention. Abnormal CT findings are determined by CT findings attributable to brain trauma, which 
includes lesions, skull fracture, and intracranial bleeding. Secondary outcomes were identifying those 
that needed hospital admission for their mild TBI.  
Review of current injury prevention programmes 
A review of the literature was conducted to identify systematic reviews or intervention studies 
evaluating prevention strategies for TBI. Studies that compared the effect of the interventions of two or 
more alternative strategies were sought. Articles were selected by searching MEDLINE and Google from 
1990 to the present.  The list of keyword search terms used to conduct the search included, but was not 
limited to, the following: prevention (consisting of accident prevention and fall prevention), traffic 
accidents, motor vehicle and pedestrian. Selected articles were English language. A summary of the 
literature on interventions and effectiveness of reducing injuries relating to TBIs were presented.  
Costs analysis and estimation of potential cost savings 
The analysis is taken from a NZ health funder perspective. The cost per case of TBI can inform decisions 
regarding cost-effective interventions to reduce TBI by providing information on the costs that can be 
averted through prevention activities. Unit costs are presented in appendix seven in NZ dollars 2010 
value. The costs included the following: 
93 
 
 The cost of administrating a brain computerised tomography scan was NZ$133.37 (see 
appendix seven). 
 The cost of hospitalisation for mild TBI of NZ$2,813 (based on an average of 1.76 days) and 
health service usage were sourced from the BIONIC study (Te Ao et al., 2014). 
Direct costs (e.g., hospitalisation and out-patient) as well as out-of-pocket expenses (e.g. aids and home 
modification) were summed and averaged to estimate per person costs and multiplied by the national 
incidence to give a cost total for the country. Potential cost savings from prevention strategies were 
estimated by calculating costs saved from numbers of injuries averted. Total first year direct medical 
costs associated with TBI have been previously estimated (see chapter four). From a health policy 
standpoint it quantifies the amount of money that could be saved if effective interventions are 
introduced. The unknown parameters of interest in the current study are the efficacy rates of reducing 
the incidence of TBI. The purpose of the analysis is to identify interventions known to reduce injury and 
to estimate potential cost savings.  
Statistical analysis 
Descriptive analyses included calculation of means, median and standard deviations for continuous data 
and counts and percentages for categorical data.  Differences in characteristics and causes of brain 
injury were assessed by chi square or t-test. Significance level was set at p<0.05 (2 sided). Logistic 
regression analyses were used to identify factors associated with severity of injury. Regression analysis 
used a forward step wise calculation approach. Factors examined as possible predictors include: 
baseline demographics such as age at injury (<34 years vs 35 years and over), gender, ethnicity (Maori vs 
non Maori), residency (urban vs rural), intention of injury (accidental vs self-harm), moderate to severe 
disability and mechanism of injury. Using the same independent variables, two further logistic 
regression analyses were undertaken, first to examine predictors of in-hospital admission among mild 
TBI survivors (using “hospitalisation” as the dependant variable), and second to examine predictors of 
needing on-going care (post-acute phase). 
Results 
Characteristics of those seeking medical attention 
Over 85% of consenting TBI survivors sought immediate medical attention from either emergency 
departments (EDs) (including 24 hour accident and medical clinics) or from their family doctor. Brain CT 
scan was performed on admission for 14% of TBI survivors; however, for four patients the brain was 
explored on admission by MRI. The results of brain CT scan were as follows: 33% of those scanned had 
external lacerations, 43% had bruising, 1% was identified as having a subdural haematoma, 0.4% 
epidural haematoma, 1.7% subarachnoid haemorrhage and 2.5% had another identified structural 
lesion. Around 39.4% (244/618) of patients who attended the ED with a brain injury were admitted into 
hospital; in comparison with those that did not attend ED of which approximately 18.7% (20/107) were 
admitted. On admission, six (0.8%) patients needed neurosurgery.  The most observed surgical 
interventions were: craniotomy, evacuation of a subdural haematoma and elevation of depressed skull 
fracture; while 41 (5.7%) patients needed either orthopaedic or other surgery.  
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As seen in Table 28, moderate to severe TBI are more likely to seek medical attention (100%) and to be 
admitted into hospital (88%) for further observation. The most alarming descriptive is the low 
performance of brain CT scanning among TBI patients (14%), despite the efforts to increase screening 
through current NZ clinical guidelines. However for moderate to severe TBI, the uptake of neuroimaging 
was high (12% for mild, 71% for moderate/severe). A large proportion of TBI (64%) is managed in the 
community (i.e. not in a hospital setting), which is inclusive of approximately 458 mild TBI survivors. 
Table 28: Percentage TBIs seeking immediate medical attention 
 
All TBI (n=725) Mild TBI (n=691) 
Moderate Severe TBI 
(n=34) 
n % n % n % 
Seek medical 
attention 
Yes 618 85% 584 85% 34 100% 
No 107 15% 107 15% 0 0% 
CT Scanning 
Yes 104 14% 80 12% 24 71% 
No 621 86% 611 88% 10 29% 
Hospital 
admission 
Yes 263 36% 233 34% 30 88% 
No 462 64% 458 66% 4 12% 
 
Predictors of severity of injury and in-hospital observation 
Logistic regression analysis was undertaken to examine for any systematic differences to predict severity 
of injury. As can be seen in Table 29, urban residency, and TBI caused by either road traffic accident or 
exposure to mechanical force was significantly related to increased injury severity at baseline post TBI. 
As shown in Table 30, another logistic regression analysis identified significant differences between the 
characteristics of mild TBI patients admitted into hospital compared with those who did not. In-hospital 
admission for clinical observation appears to be based primarily on those who were older than 35 years 
living in geographic areas of least deprivation, which may reflect socio-economic factors. 
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Table 29: Predictors of TBI severity 
Independent variable B S.E. Wald Sig. Exp(B) 
Urban -0.525 0.256 4.216 0.040 0.591 
Traffic accident /MVA 0.654 0.26 6.333 0.012 1.923 
Exposure to mechanical force -1.645 0.602 7.459 0.006 0.193 
Constant -2.55 0.233 119.34 0.000 0.078 
            
Model ᵡ² 28.229 p.<0.000       
Pseudo-R² 0.061         
n 1369         
 
 Table 30: Predictors of hospitalisation among mild TBI 
Independent variable 
B S.E Wald Sig Exp(B) 
Young age  
-0.552 0.183 9.064 0.003 0.576 
NZDep 8-10 0.637 0.237 7.247 0.007 1.891 
Disability 0.521 0.238 4.807 0.028 1.684 
            
Model ᵡ² 26.694 p.<0.000       
Pseudo-R² 0.053         
n 691         
 
Characteristics of mild TBI, by those who were admitted to in-hospital care and those who were not 
The mild cohort included 691 participants (including both adults and children) who consented to follow 
up. Demographic and injury-related information for the BIONIC sample at baseline is provided in Table 
30. Roughly, 458 people (66%) were not admitted into hospital for observation; the average age at the 
time of mild TBI was 23 years (ranging from 0 to 91, with a median age of 19). In contrast for those who 
were admitted for observation, the sample were slightly older with an average age of 30.5 years 
(median age of 24; p<0.05).  The majority of mild TBI survivors were of European descent (60%), due in 
part to the absolute numbers which represent a larger population of NZ European compared with Maori 
or Pacific peoples in Hamilton/Waikato. Approximately 60% of each sample was male, while the 
majority of TBI survivors were earning less than NZ$20,000 per annum and were living in the city of 
Hamilton (76% vs 74%).  
Amongst the non-hospitalised sample, about 10% were rated as having a moderate/severe disability 
according to the Glasgow Outcome Score compared to 19.3% for those admitted. At the end of the 12-
month follow up, a 58% (19.3-8%) reduction in disability score between those receiving in-hospital 
observations compared to a 70% (10.3-3%) reduction in disability for those who did not. Among those 
who were hospitalised, brain injuries were caused by falls (41%), transport accident (28%), exposure to 
mechanical force (12%), assault (16%) or unknown/other (3%). The two samples (hospitalised versus 
non-hospitalised) differed significantly at baseline by age, area deprivation (10 indicating most 
deprived), disability and cause of injury.  
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Table 31: Characteristics of hospitalised versus non-hospitalised mild TBI at baseline 
  
Non Hospitalised 
mild TBI (n=458) 
Hospitalised mild 
TBI (n=233) 
Significance of 
difference 
  
n  (%) n  (%) 
Chi 
Square  
p-value 
Mean age in years (SD) 23.2 17.9 30.5 23.68 11.955 0.001 
Median age in years (IQR) 19 9-33 24 13-45     
Aged 34 years and younger 352 76.9% 147 63.1% 14.564 0.000 
Male 274 59.8% 138 59.2% 0.230 0.880 
Urban residency 347 75.8% 172 73.8% 0.312 0.577 
NZDep 8-10 45 9.8% 41 17.6% 8.547 0.003 
Low Income (less $20,000) 324 70.7% 153 65.7% 1.859 0.173 
Live alone 26 5.7% 21 9.0% 2.707 0.100 
Own home 83 18.1% 43 18.5% 0.110 0.915 
Moderate or Severe Disability 
(GOS 4 & 5) 
47 10.3% 45 19.3% 10.947 0.001 
More than one comorbidity 192 41.9% 115 49.4% 3.453 0.063 
Maori (vs Non-Maori) 152 33.2% 78 33.5% 0.006 0.939 
Cause of TBI         16.739 0.000 
Transport accident 61 13.3% 65 27.9%     
Fall 187 40.8% 95 40.8%     
Exposure to mechanical force 115 25.1% 29 12.4%     
Assault 83 18.1% 36 15.5%     
Other 1 0.2% 6 2.6%     
Unknown (not specified) 11 2.4% 2 0.9%     
 
Health service usage 
Resource consumption post injury at 12 months follow up is shown in Table 32. Of those mild TBI who 
were observed in hospital, there is clear evidence that they were more likely to receive health services 
post discharge. Irrespective of whether TBI sufferers were hospitalised or not, the most common health 
care received was general practice (39% vs 35%), followed by allied health care (24% vs 14%), then 
specialised medical care (19% vs 11%).  
 
Table 32: Resources used over 12 months post mild TBI 
  
mild TBI (GCS ≥13) 
Not hospitalised 
mild TBI (GCS ≥13) 
hospitalised 
  % % 
 Total (N) 458 233 
Healthcare     
Emergency department 34% 55% 
Initial hospitalisation 0% 100% 
Hospital readmission 2% 6% 
Allied health care 14% 24% 
Specialised medical care 11% 19% 
General practice 35% 39% 
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Outpatient care 3% 11% 
Nursing 2% 6% 
Radiology 1% 0% 
Community services 2% 7% 
Out-of-pocket expenses 2% 6% 
   
 
Predictors of receiving health care post TBI 
In order to understand the characteristics of people with mild TBI who are likely to receive on-going care 
after the acute stage, further multiple linear regression analyses were undertaken to examine possible 
predictors of needing on-going care. As can be seen in Table 33, young age, low income and males were 
significantly related to increased healthcare usage post-TBI. 
Table 33: Predictors of after care 
Independent variable B SE Sig 
Young age -0.477 0.179 0.008 
Low income 0.401 0.182 0.028 
Male -0.368 0.183 0.046 
Constant 18.09 0.192 0.000 
R 0.07     
n 725     
  Direct costs associated with mild TBI 
Translating health care resources into costs, a summary of first-year direct medical costs for mild TBI are 
shown in Table 34.  At baseline the average direct cost per mild TBI is NZ$4,528 (ranging from NZ$2,895 
per non-hospitalised to NZ$7,739 per hospitalised). When comparing two strategies, CT scanning for 
early management with in-hospital observation, the expected cost of resources for each alternative is 
also presented in the table below. It is estimated that administering CT scanning to diagnose all people 
with expected TBI is a cost saving of NZ$1,242 per person per year (NZ$4,528-NZ$3,286), translating to a 
potential cost saving for the country of up to NZ$46.5 million. Conversely, if all TBI patients are 
hospitalised that would amount to an additional NZ$3,211 per person (NZ$7,739-NZ$4,528), 
transforming to a total additional cost of NZ$34.5 million for the country.  
Table 34: Summary of direct medical costs associated with having a TBI 
  
Medical cost 
per person 
Total medical costs 
for NZ 
Expected cost of mild (if 100 % received CT scan) $3,286 $2,270,589 
Current cost of mild-baseline (12% received CT 
scan, 34% hospitalised) $4,528 $48,775,181 
Expected cost of mild (if 100% hospitalised) $7,739 $83,353,799 
 
A review of prevention strategies 
The summary of the estimated effectiveness of potential intervention is shown in Table 35. A total of 
eight reviews were found (Elder et al., 2002; Fagan & Catalano, 2013; Gillespie et al., 2012; Khouzam, Al-
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Mawed, Farah, & Mizeracki, 2014; Liu et al., 2008; Rivara et al., 1999; Thompson, Rivara, & Thompson, 
1999; Turner et al., 2005). Of these reviews two targeted children aged 14 years or younger (Fagan & 
Catalano, 2013; Turner et al., 2005) while one targeted older populations (Gillespie et al., 2012). 
Interventions for traffic injuries were most common with a reduction in injury ranging from 25% 
(Khouzam et al., 2014) to 69% (Liu et al., 2008). Interventions for assault and exposure to mechanical 
force were hard to find; however, a review of a school-based violence prevention programme among 
middle-school-aged children found a 32% reduction in self-reported assaults (Fagan & Catalano, 2013). 
Fall prevention programmes mostly centred around slip-proofing home environments, but a number of 
hospital and community-based exercise programmes to prevent falls were often restricted to the elderly 
(Gillespie et al., 2012); very little prevention programmes were found for all ages. 
Table 35: Summary of effectiveness of injury prevention 
Study Intervention Target group Effectiveness (based 
on literature) 
Intervention for traffic injuries 
Turner, McClure, Nixon, 
Spinks, 2005 
Promote car seat 
restraints 
Children aged 0-14 
years 
33% reduction in motor 
vehicle injury 
Elder, Shults, Sleet et al., 2002 Sobriety checkpoints 
(including mass 
media campaign and 
breath testing) 
General population 24% median decrease 
in non-fatal  injury 
crash 
Thompson DC, Rivara F, 
Thompson R, 1999 
Helmets for bicycles General population Injuries to the head and 
facial area are reduced 
to 65% 
Liu BC, Ivers R, Norton R, 
Boufous S, Blows S, Lo SK,  
2008 
Helmets for 
motorcycles 
General population 69% reduction in 
injuries 
Rivara, Thompson, Cummings, 
1999 
Mandatory seat belt 
use 
General population 45% reduction in motor 
vehicle-related death 
or injury 
Khouzam, Al-Mawed, Farah 
and Mizeracki, 2014 
Airbags in cars General population 25% reduction in 
mortality and injury 
Intervention for violence prevention 
Fagan and Catalano, 2013 School-based 
violence prevention 
programme 
Children aged 0-10 
years 
32% reduction of self-
reported assaults 
Intervention for fall prevention 
Gillespie LD, Robertson MC, 
Gillespie WJ, Sherrington C, 
Gates S, Clemson LM, Lamb 
SE, 2012 
Community-based 
prevention 
Older population 
(aged 65 years and 
older) 
31% reduction in falls 
 
Potential cost savings of prevention programmes 
The potential cost savings of introduced preventions are shown in Table 36. If a car seat restraint 
programme was implemented and yields 33% effectiveness in reducing injury (resulting in 136 injuries 
averted), the intervention would be a cost saving (at NZ$816,012). It is obviously demonstrated that as 
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the effectiveness of the intervention increases it will subsequently increase the number of injuries that 
can be averted (i.e. potential cost savings). Falls or unintentional injuries were the leading mechanism of 
TBI; however, most fall prevention programmes concentrated on the older population. Although, NZ$6 
million was the estimated likely return for fall prevention among the elderly, maximum cost savings are 
likely to accrue due to the higher incidence of fall-related injuries. The second most common cause of 
TBI was road traffic injuries. If a prevention programme for wearing bike helmets could reach an 
effectiveness of 69%, then the cost savings due to the campaign would be up to a maximum of NZ$15 
million. Taken together if all interventions were in place, the overall potential cost savings to the country 
could be up to NZ$16.3 million. However, this is only an approximation as the analysis does not 
acknowledge that the implementation of prevention strategies will have associated costs.  Further 
studies are needed to investigate potential cost savings together with implementation costs. 
1
0
0
 
 Ta
b
le
 3
6
: P
o
te
n
ti
a
l c
o
st
 s
a
vi
n
g
s 
if
 p
re
ve
n
ti
o
n
s 
a
re
 in
tr
o
d
u
ce
d
 (
co
st
s 
m
ea
su
re
d
 in
 N
Z 
2
0
1
0
 d
o
lla
rs
) 
In
te
rv
e
n
ti
o
n
 f
o
r 
TB
I 
A
ve
ra
ge
 d
ir
e
ct
 
co
st
 p
e
r 
p
e
rs
o
n
 b
y 
m
e
ch
an
is
m
 o
f 
in
ju
ry
 
To
ta
l d
ir
e
ct
 
co
st
s 
fo
r 
N
Z 
 
N
u
m
b
e
r 
o
f 
TB
I 
ca
se
s,
 b
y 
m
e
ch
an
is
m
 o
f 
in
ju
ry
 
(T
o
ta
l 1
1
,3
0
1
) 
P
e
rc
e
n
ta
ge
 o
f 
re
d
u
ct
io
n
 o
f 
in
ju
ry
 f
ro
m
 
b
as
e
lin
e
(f
ro
m
 
th
e
 li
te
ra
tu
re
) 
Ex
p
e
ct
e
d
 
n
u
m
b
e
r 
o
f 
TB
I c
as
e
s 
av
e
rt
e
d
 
P
o
te
n
ti
al
 c
o
st
 
sa
vi
n
g 
(b
as
e
d
 o
n
 
e
ff
e
ct
iv
e
n
e
ss
 
fr
o
m
 t
h
e
 
lit
e
ra
tu
re
) 
 
In
te
rv
e
n
ti
o
n
 f
o
r 
tr
af
fi
c 
in
ju
ri
e
s 
(n
=2
2
8
7
) 
P
ro
m
o
te
 c
ar
 s
ea
t 
re
st
ra
in
ts
 (
ag
ed
 0
-1
4
 y
ea
rs
) 
$
5
,9
9
1
*
 
$
2
,4
7
2
,7
6
4
 
4
1
3
 
3
3
%
 
1
3
6
 
$
8
1
6
,0
1
2
 
So
b
ri
et
y 
ch
ec
kp
o
in
ts
 (
in
cl
u
d
in
g 
m
as
s 
m
ed
ia
 c
am
p
ai
gn
 
an
d
 b
re
at
h
 t
es
ti
n
g)
 
$
9
,5
5
3
 
$
2
1
,8
4
4
,0
4
1
 
2
2
8
7
 
2
4
%
 
5
4
9
 
$
5
,2
4
2
,5
7
0
 
H
el
m
et
s 
fo
r 
b
ic
yc
le
s 
2
2
8
7
 
6
5
%
 
1
4
8
6
 
$
1
4
,1
9
8
,6
2
6
 
H
el
m
et
s 
fo
r 
m
o
to
rc
yc
le
s 
2
2
8
7
 
6
9
%
 
1
5
7
8
 
$
1
5
,0
7
2
,3
8
8
 
M
an
d
at
o
ry
 s
ea
t 
b
el
t 
u
se
 
2
2
8
7
 
4
5
%
 
1
0
2
9
 
$
9
,8
2
9
,8
1
8
 
A
ir
b
ag
s 
in
 c
ar
s 
2
2
8
7
 
2
5
%
 
5
7
2
 
$
5
,4
6
1
,0
1
0
 
In
te
rv
e
n
ti
o
n
 f
o
r 
vi
o
le
n
ce
 p
re
ve
n
ti
o
n
 (
n
=1
8
8
2
) 
  
  
  
  
  
  
Sc
h
o
o
l-
b
as
ed
 v
io
le
n
ce
 p
re
ve
n
ti
o
n
 p
ro
gr
am
m
e 
(a
ge
d
 
0
-1
0
 y
ea
rs
) 
$
2
,7
7
0
*
 
$
3
6
5
,8
5
9
 
1
3
2
 
3
2
%
 
4
2
 
$
1
1
7
,0
7
5
 
In
te
rv
e
n
ti
o
n
 f
o
r 
fa
lls
 (
n
=4
2
6
0
) 
  
  
  
  
  
  
C
o
m
m
u
n
it
y-
b
as
ed
 p
re
ve
n
ti
o
n
 (
ag
ed
 6
5
 y
ea
rs
 o
r 
o
ld
er
) 
$
2
7
,1
8
4
*
 
$
1
9
,9
7
1
,7
8
1
 
7
3
5
 
3
1
%
 
2
2
8
 
$
6
,1
9
1
,2
5
2
 
*A
ve
ra
ge
 c
o
st
s 
w
er
e 
ad
ju
st
ed
 f
o
r 
ag
e
 
 101 
 
Discussion 
Overall, the findings suggest that mild TBI is a common presenting condition in emergency departments and 
community settings. Identifying the characteristics of mild TBI are not well understood; a better understanding 
of these characteristics is important to inform public health efforts aimed at reducing the incidence of mild 
injuries. The findings suggest that the increased incidence of mild TBI indicates not only a need for public 
health action, but also that a targeted approach to prevention may be needed. 
A high proportion of children and young adults are at highest risk of mild TBI, especially those who are 
managed in the community. On the other hand those who are managed in-hospital tend to be older adults 
(mean age 30.5 years). Mild TBI is more common in men than in women with most common causes identified 
as falls followed by motor vehicle accidents. Previous authors have suggested that many people experience 
long-term consequences following a mild TBI (McMahon et al., 2014). Therefore it is important to include 
characteristics of people with mild TBI who seek medical attention as well as those that do not. 
Emergency medical staff face the difficult challenges of selecting patients for urgent CT, or in-hospital 
observation and those that can go home. The results suggest that screening for early diagnosis among mild TBI 
remains low. For instance, only 12% received CT compared to 71% for moderate/severe TBI.  The low CT 
screening among mild TBI may be due to their not meeting clinical criteria to undergo screening as 
recommended by current clinical guidelines.  The study also reported that overall there seems to be good 
awareness among those with mild TBI to seek immediate medical attention for their injuries (85% of mild TBI); 
however, of these cases 66% were not admitted into hospital. This could be reflective of a number of mild 
injuries being successfully managed in the community, thus minimising the burden on hospital services.  
This study identifies predictors of hospitalisation among mild TBI which can help public health officials identify 
high risk patients. Common predictors found tend to be older age (35 years+) and living in geographic areas of 
least deprivation. While urban residency, and TBI caused by either road traffic accident or exposure to 
mechanical force are significantly related to increased injury severity at baseline. This interpretation is 
consistent with previous studies (Delen, Sharda, & Bessonov, 2006; Kamel, Kamel, Foda, Khashab, & Aziz, 
1999) that risks of severe injury are dependent on the mechanism of injury. Improved early management 
(Ribbers, 2007; Sherer, Madison, & Hannay, 2000; Tate et al., 1998) can significantly reduce the predicted 
incidence on an ageing population. Additionally, more attention towards prevention and improving early 
management among mild TBI is warranted.  
It is unclear whether a strategy for increasing hospital observation is more beneficial or yields greater 
effectiveness when compared to an alternative of increasing CT to triage for mild TBI admission (or vice versa). 
Previous authors have stated that a large proportion of patients with mild TBI had no additional benefit from 
in-hospital care (Geijerstam, Britton, & Marke, 2004) and thus could be managed by CT scan and early 
discharge from the emergency department, assuming CT is easily available within the clinical context 
(Geijerstam, Oredsson, & Britton, 2006). There has been growing evidence suggesting screening and CT is 
more important than admission and both are absolutely necessary for the proper evaluation of TBI (Geijerstam 
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& Britton, 2005; Stein et al., 2006; Stein et al., 2008). No current international examples were found of where 
clinical practice or guidelines recommended either hospitalisation of all mild TBI or CT for all. At present in NZ 
there seems to be a mix of both strategies with a trend towards higher use of CT due to increased availability 
and lower costs. Even though potential cost savings could be made if NZ introduces a strategy to screen all 
mild TBI, an additional study is needed to examine the cost effectiveness (cost and health benefits) of 
implementing screening options within current trends. Further studies will need to consider both clinical 
benefit and patient safety.   
Patterns of resource usage, indicate that although small amounts of resources are consumed 12 months post 
TBI the variables of young age, low income and males are significantly related to increased health care usage 
post-TBI. This information is important for health services planning, including helping public health officials 
anticipate health care services needed to detect and treat TBI by identifying the characteristics of mild TBI.  
When interpreting the results a note of caution to consider involves the comparability of patients receiving 
care in hospitals. While there were some differences between those admitted to hospital and those who were 
not admitted, it is possible that those treated in-hospital were of poorer health than those who were treated 
in the community. As the current study is an observational comparison, the possibility exists that the 
differences in outcomes are dependent upon some unmeasured characteristic. The above caution needs to be 
considered when generalising these results to other settings.   
In summary, this chapter has described the characteristics of mild TBI in NZ and has major implications for 
current practice and future research. The results suggest greater improved prevention strategies particularly 
among mild TBI should be a priority. Furthermore there is a need to examine and increase current efforts 
towards CT scanning among mild TBI.  This study highlights the need for both targeted TBI prevention 
programmes to reduce the risk of TBI as well as universal strategies. 
 
 103 
 
CHAPTER SIX: Discussion and conclusions 
 
Introduction 
The purpose of this thesis was to explore the economic burden of TBI in NZ, using data collected from a 
prospective population-based study linked with self-reported health services usage and electronic medical 
records. This is an area that has received relatively little attention in health services research. This final chapter 
starts with a brief overview on the burden of TBI in NZ, investigating the first-ever incidence and prevalence of 
TBI for all ages as described in chapter three. This is followed by a discussion of the findings from the cost-of-
illness study reported in chapter four that examines the direct and indirect costs associated with TBI reported 
as per-person costs, then extrapolated to the whole prevalence sample (from chapter three) to project an 
estimated total cost for NZ. Lastly, a description to better understand the mild TBI cohort and those TBI 
survivors that do not seek immediate acute care for their injury was outlined in chapter five, with the goal of 
identifying areas where public health officials might intervene. A discussion of these findings in relation to 
previous research is considered together with a critical evaluation of the methods used in the current study. 
Finally, the implications for research, policy and prevention are explored. 
Summary of main findings 
The present research is based on the completed Brain Injury Outcomes New Zealand in the Community 
(BIONIC) study, the main results of which have been published (Feigin et al., 2013). Findings from the first 
traumatic brain injury (TBI) population-based incidence and one-year outcomes study found that the incidence 
of TBI in the population is far greater than previously estimated. The authors also provided evidence that there 
were significantly more mild injuries (95% of all cases) than previously reported. These findings help illustrate 
the size of the problem and contribute important information and characteristics to inform health planners 
and researchers on prevention programmes. This thesis extends that work by estimating the burden of TBI in 
NZ as well as the direct and indirect cost of treating TBI in a year. Viewing these findings alongside the 
reported incidence estimated from the BIONIC study not only informs decisions on resource allocation in 
health services but also provides information on the amount of money that might be saved from interventions 
aimed at reducing TBI. As such, this information is very important for researchers interested in understanding 
the impact of TBI on the health system and for evidence-based health care planning.  
As outlined in chapter three, in 2010, 11,301 first-ever TBI cases were estimated to have occurred in NZ, while 
prevalent cases were estimated to be 527,388 (Te Ao et al., 2015). The numbers of incident cases are expected 
to increase to 13,591 with a total period prevalence of 641,104 cases by the year 2020 if current trends 
continue. The estimated 20,300 DALYs attributable to TBI accounted for 27% of total injury related health loss 
and 2.4% of DALYs from all causes (Ministry of Health, 2012).  Although current research suggests that our 
communities are characterised by ageing populations (Cornwall & Davey, 2004) and people are generally living 
longer, these results suggest that for those who experience a TBI not all enjoy longer life and good health 
(Ministry of Health, 2012). Previous estimates for TBI were based on hospital admission data, which possibly 
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may have missed some cases. The burden of TBI estimated in this thesis draws upon the first population-based 
TBI incidence data, which includes those that were hospitalised for their injury and those that were not.  
Within that context, chapter four contained a number of ground breaking results relating to TBI. The COI 
results suggest that the cost of treating TBI varies greatly, with first-year and lifetime costs of mild TBI being 
significantly lower than that of moderate/severe TBI. In addition, the unexpectedly large number of mild TBI 
(defined by GCS) means that the total cost of treating these cases is three times that of moderate/severe TBI 
(Te Ao et al., 2014). With this in mind, any significant cost savings and improvements in outcomes may be 
achieved by targeting both high cost individuals as well as population-based programmes aimed at reducing 
the incidence of lower cost mild injuries. Given the considerable costs associated with TBI, there is an urgent 
need to develop effective interventions to prevent TBI and manage its consequences. 
Chapter five presented a general public health framework to identify possible areas for intervention by 
exploring the characteristics of TBI. This study has found that people with mild and moderate/severe TBI in NZ 
are doing quite well with 85% reporting seeking medical attention for their injury. There is evidence to suggest 
that good public health awareness exists for injury prevention including seeking acute medical care (Accident 
Compensation Coorporation, 2014). A number of areas were identified to guide prevention strategies for those 
at risk of TBI including the need to increase uptake of neuroimaging and screening. Currently 12% of all mild 
cases had CT scans which is relatively low; as a result there is a need to increase access to screening (Stein et 
al., 2006; Stein et al., 2008; Stein, Fabbri, Servadei, & Glick, 2009). However, most cases identified in BIONIC 
were classified as mild injuries, so may not have meet the selection criteria for screening.  
Interestingly, of mild TBI those who were hospitalised tended to be older than 35 years and living in 
geographic areas of least deprivation. Similar trends exist for those individuals with TBI needing long-term 
care. The results suggest an inequality in access to secondary and long-term care for children and young adults 
from low socio-economic backgrounds. The need for determining risk factors and the effectiveness of 
interventions is important to prevent injury. Public health officials need to design and implement interventions 
based on current evidence. Targeted interventions among mild TBI should account for these factors 
attributable to injury towards the individual (host), the mechanism of injury (agent) and the social and physical 
environment (Barnett et al., 2005; Runyan, 1998).  
How can the burden of TBI inform planning and monitoring? 
Public health surveillance of TBI is very important particularly for informing the rates of occurrence and for 
determining risk factors to guide the development of prevention strategies. It helps to quantify the magnitude 
of TBI on society by combining incidence and prevalence statistics with other measures of morbidity, mortality 
and financial burden.  TBIs are preventable; the burden of brain injury and its associated health loss (measured 
in DALYs (Murray et al., 2012; Salomon et al., 2012)) is largely avoidable. The results reported in this thesis 
highlight the scope of the potential health gains and cost savings through effective prevention, treatment and 
rehabilitation.  On-going surveillance is required to measure the frequency of the brain injury by socio-
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demographic group (e.g. age, sex, severity of injury). Its purpose will not only inform on the current burden of 
TBI on society but it can also be used to evaluate the effectiveness of prevention efforts to reduce injuries. 
There are a number of options that might be considered, including educational campaigns to raise awareness 
of TBI in the community (Emanuelson et al., 2003; Hatziandreu et al., 1995; Jacques, 1994; Mack et al., 2000; 
Palmer et al., 2001; Turner et al., 2005), increased neuroimaging during the pre-hospital assessment (Dharap, 
Khandkar, Pandey, & Sharma, 2005; Figg, Burry, & Vander Kolk, 2003; Weiss, Galanaud, Carpentier, Naccache, 
& Puybasset, 2007), or high intensity integrated rehabilitation services for moderate severe TBI (Carnevale, 
Anselmi, Busichio, & Millis, 2002; Smith et al., 2006; Turner-Stokes, Disler, Nair, & Wade, 2005). When deciding 
whether to adopt an intervention, decision makers must also consider the cost and resources that will be 
required and the outcomes (health benefit) that can be expected.  The current study did not investigate 
prevention measures or interventions of this kind. However, it is an important aspect to consider and 
opportunities exist for further studies to investigate the efficiency and cost effectiveness of TBI prevention.   
What is already known about the cost of TBI? 
The economic burden (including additional cost and lifetime costs) of TBI in NZ has not been previously 
quantified. The current study attempted to quantify these cost burdens to society by examining trends in TBI 
incidence, direct and indirect costs to the patients, families and society for the reference year 2010 and 
estimating the economic burden of TBI in NZ, projected to 2020. COI studies (as conducted in this study), are 
useful for measuring the potential cost savings of averting a case of illness. If the cost burdens of TBI are 
quantified and compared with other disease conditions this can provide another evidence-based argument to 
reallocate resources.   
The cost of health services for TBI is expected to increase considerably in the future as the number of people 
suffering a brain injury is expected to increase especially among young adults, and as the number of vehicle 
users increases (Murray, Butcher, & McHugh, 2007).  In addition, better early detection and treatment of brain 
injuries is expected to increase the survival rate from TBI. In the present study, we also estimated that one-
year prevalence costs in NZ are expected to increase by 21% to over NZ$182.7 million (US$122.6 million) by 
the year 2020 should the current trend in TBI incidence and outcomes continue. As a result, health systems 
can expect significantly higher expenditures on both acute care, immediately following TBI, and health services 
post TBI as more TBI sufferers and their families and informal caregivers learn to adjust to life after TBI.  
Assessing the economic burden of TBI on society provides information on the scope of the problem and 
potential savings from interventions aimed at reducing the incidence or severity, or improving treatment for 
TBI (Rice, 2000). The prevalence-based TBI cost estimates are essential to advocate for more preventive 
resources, as well as for policy makers to inform the changing allocation of scarce public resources (Hodgson & 
Meiners, 1982).    
Information on the cost and pattern of health service use has a number of advantages. First, it can be used for 
health services planning. Combined cost and health services information with projections of population trends 
and the number of TBI incidences in the future, provides funders with an understanding of the cost of care 
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likely to be incurred in the future.  Although the data only considers the cost of health services for the first 
year after TBI, the results here suggest that most TBI survivors receive little input from community and health 
care services after having a TBI.  
Second, the cost findings can be used to identify unmet needs and inequities in the accessing and delivery of 
health services after TBI. This requires identifying the appropriate level of care after TBI and requires 
consideration of a number of factors, including the severity of injury, availability of health services, 
developmental needs (in the case of children) and living situation upon returning to the home. The economic 
burden is disproportionately experienced by those in low socio-economic status and more marginalised 
communities. Of course these population groups also more often experience injuries (TBI included).  
Consequently, it is not uncommon to find that people who are injured and are also financially compromised 
fall even further into poverty (a well-recognised phenomenon described as the 'injury poverty trap'). However, 
the results do suggest that there are limited resources being made available to TBI survivors who return home 
in NZ. At the very least it suggests an unmet need that is not being recognised. The challenge here is that 
groups who have less access to health care and accident insurance beyond the acute injury phase will have 
spuriously lower reported costs of injury. So it is possible that Maori, Pacific and some other marginalised 
groups in NZ, will have disproportionately lower estimated costs of injury than might be expected had they 
experienced the same access to services.  
There are a number of challenges involved with accessing accurate information on the health services 
resources associated with care after having a TBI. Accurate information on some funded health services, such 
as primary care, home and vehicle modification, and vocational rehabilitation is difficult to obtain. Although 
there are electronic records containing this information, there is no central, accessible data with complete 
health services usage. Some information on cost of health services from the ACC schedule of treatment was 
obtained; however, selected services were routinely given on medical or rehabilitation wards and the costs of 
these medications were reflected in the bed day cost at hospitals. Therefore, this approach does not allow an 
accurate identification of the difference in costs between individuals. Accurate information on on-going health 
services is held by ACC’s claims database, but was not accessible for the current study. These limitations may 
have resulted in some underestimates of the costs; therefore, the results of the study should be interpreted 
with caution.  
Implications of the current estimates and projections of the study 
Previous authors have concluded that the incidence of mild TBI is far greater than was previously estimated 
(Feigin et al., 2013). It is accepted that mild TBI constitutes up to 95% of all cases and a large number of mild 
cases are not treated in hospitals (66% [458/691]). Almost 70% of all TBI cases were attributable to children 
and young adults; men are known to have a 77% greater risk of TBI than women in NZ. Current data in NZ, 
suggests that TBIs were mostly due to falls (41%), mechanical forces (21%) and transport accidents (18%). 
Understanding the external causes of injury may bring about primary prevention ideas. Interestingly, falls are 
the leading cause of TBI. Yet there is less evidence available for fall prevention especially among children and 
young adults, whereas previous fall prevention has focused heavily on the elderly population.  Fall prevention 
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awareness messages at home, school and the workplace should be a priority. Unlike other countries (Delen et 
al., 2006; Hoang et al., 2008) traffic accidents were the third leading cause of non-fatal TBI in NZ. The 
difference is likely to be due to a number of explanations. Firstly, road traffic accidents are renowned as being 
the leading cause of injury deaths, yet TBI-related mortality in NZ was relatively low. Secondly, there is good 
reason to accept that good prevention measures are in place for the evidence clearly states that traffic 
accident prevention is a cost-effective intervention. For instance, i) wearing helmets for both motorcycles and 
bicycles, ii) mandatory seat belts, iii) child restraint, and iv) airbag use in motor vehicles can prevent TBIs (Bunn 
et al., 2003; Elder et al., 2002; Soori, Nasermoadeli, Ainy, Hassani, & Mehmandar, 2011). However more 
prevention targeting pedestrian and bus passenger injury might be necessary, especially in the urban centres 
where walking and taking public transport is encouraged. Pedestrian injury prevention is often lacking in 
developing countries.   
The current research has demonstrated the importance of TBI as a public health problem and identified mild 
TBI as a priority. A conclusion drawn from the cost-of-illness study indicates that the economic burden of TBI is 
very significant and that improved prevention and treatment strategies are warranted. Substantial cost savings 
may be achieved by preventing TBI and targeting high cost individuals; in particular public health officials 
should identify measures to reduce the incidence of mild TBI. 
At present, current efforts in NZ to reduce brain injuries have been based on best available surveillance 
information. Common limitations on current literature are that it is primarily based on hospital and clinical 
databases. Although there are some discrepancies in case definition, most have relied on clinical diagnosis (i.e. 
ICD-10 codes). There is a possibility of missing mild cases that may have been treated in the emergency 
department but not admitted into hospital or misclassification into other injuries. This thesis highlights the 
importance of the need for on-going surveillance for TBI to provide useful information to inform decision 
makers on 1) resource allocation, 2) guiding development of prevention measures, and 3) the importance of 
the “value for money “of the health care provided. 
Strengths and weaknesses of the study 
The method for the current study was designed to be extremely thorough and is one of very few studies to 
meet criteria for “ideal” TBI incidence study (Barker-Collo & Feigin, 2009; Theadom et al., 2012). Similar hot-
pursuit data ascertainment methods used in this study have been used successful in Auckland for the 
incidence of stroke for three decades (Anderson et al., 2005; Bonita et al., 1993; Feigin et al., 2003; 
Krishnamurthi et al., 2014). Still no method is perfect; in addition given the access to nationwide 
hospitalisation data it is likely that any missed cases were mild rather than moderate to severe.  
A limitation of the current study is the absence of a control sample (i.e. a cohort without TBI) to quantify the 
additional burden by comparing the outcomes of those with TBI to those without. (Although a matched sample 
may be possible by means of statistical techniques such as propensity score matching (Dehejia & Wahba, 
2002), adjusting for age, gender, ethnicity and socio-economic status.) Unfortunately it was not feasible to 
obtain such a control sample given that the full BIONIC study included those who were aged under 16 years 
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and assessed on four follow-up occasions each (i.e. baseline, one, six and twelve months). A controlled sample 
could be achieved using national hospitalisation data; however, a large number of cases were mild (95% of all 
cases) and managed in the community (i.e. not hospitalised).  
Details on the mechanisms of injury were previously published (Feigin et al., 2013); similarly the detail of 
sports-injury mechanisms is also now available in the press (Theadom et al., 2014). Complications associated 
with having a TBI such as diffuse axonal injury, haemorrhage or intracranial pressure were obtained using 
medical codes extracted from hospital medical records and were reviewed weekly by a diagnostic adjudication 
team (which included neurologists, neuropsychologists and other allied health professionals). The costs 
associated with the different types of mechanisms were included in the results (e.g. injuries due to road traffic 
accidents, sports related etc. and were presented together on a population level. The relationship between 
impairment and functional consequences on productivity or performance in the workplace is very interesting. 
However, it is beyond the scope of this thesis. 
The overall mortality rate collected from the BIONIC study was very low (crude death rate 10 cases per 
100,000 person-years), and the costs associated with mortality were included in the study (e.g., 
hospitalisations and end-of-life care). Because the data collection period ended at 12 months, no data were 
available on the long-term costs. However TBI survivors were asked at 12 months to indicate the extent to 
which they had recovered from their TBI. We then applied this percentage to their costs for the first year to 
approximate the long-term costs. Lifetime costs reported in this thesis should be viewed as only an 
approximate and the study highlights the need for a longitudinal study to identify the long-term costs and 
outcomes. 
The COI results reported in the current study provide significant relevance to the cost of TBI in other high 
income countries. While it is accepted that there are international differences between health systems, NZ in 
particular is often a very good source of international benchmarking, because it has features that map on to 
many different systems in developed countries (Minister of Health, 2013). For instance, there are elements 
which align to the other publicly funded healthcare systems such as the National Health Service in the United 
Kingdom, the Dutch healthcare system in the Netherlands and also to a more North American and Australian 
paradigm. 
The reported medical care cost for moderate/severe cases was likely to be under-powered to detect 
statistically significant differences within this group. The BIONIC sample consisted of 1,369 newly registered 
TBI cases; of these 725 cases (53%) consented to follow up with 5% (n=34) identified as having a 
moderate/severe injury. Although the results are consistent with previous literature concluding that medical 
costs increase with higher injury severity, further investigation among moderate to severe cases may be 
needed.  While there were some limitations of the data on community and home support; the findings 
included some estimated costs based on responses in the baseline and subsequent surveys. While more 
extensive data collection would provide more accurate estimates; the estimates provided are likely to be 
indicative of the level of support people are actually receiving.   
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A more serious source of underestimation is the potential lack of access to community and home support. 
Previous work with other vulnerable populations in New Zealand (e.g. support for frail elderly or stroke 
sufferers) suggests that people in New Zealand frequently are not provided with adequate support services 
(Brown, 2009; Dyall, Feigin, Brown, & Roberts, 2008). Thus, the more significant source of underestimation of 
the 'true' cost of TBI may be the lack of access to services. Unfortunately, it was not possible to assess the level 
of unmet need in this study.  
Furthermore the indirect costs estimated in this study may look low, particularly when one considers the 
significant impact that TBIs can have on people with severe injuries. The relatively low estimates arise because 
they are average estimates that include those who had only minor or no impairment at 12 months post injury.  
Lifetime costs were determined based on the responses from both mild and moderate/severe TBI sufferers at 
12 months (i.e. whether there were persistent problems at 12 months). Most of those reporting on-going 
problems were people with moderate/severe TBI, but there were some mild sufferers with on-going problems. 
In addition, extrapolating costs from one region (Hamilton and Waikato district) to the entire country is subject 
to error, particularly if differences in lifestyles, clinical practices and treatment options impact rates and health 
service usage. The methodology did not provide accurate estimates of total caregiver time and effort in 
supporting injured persons. Lifetime costs were based on short-term data; therefore, it should be viewed as an 
estimate. But it highlights the need for a longitudinal study of the long-term effects. These issues will be 
addressed in the BIONIC four-year outcomes study.  
 
Suggestions for future research 
Based on current estimates, the cost of treating TBI varies greatly with the majority of sufferers having only 
minimal costs. However, high cost TBI sufferers can incur significant costs, and there are differences between 
treatments received as a function of severity of injury. The economic burden for TBI is high, but significant cost 
savings and improvements in outcomes may be achieved by targeting high cost individuals. Given the 
considerable costs associated with TBI, further investigation of the cost effectiveness of: i) prevention 
strategies, ii) early management and detection, and iii) a variety of rehabilitation services aimed at improving 
TBI, should be a priority. It is strongly recommended that it is important to describe the prevention strategies 
that are available, and this data is relevant in helping understand the cost savings that might result from a 
particular strategy.  Outlining the cost effectiveness of strategies to prevent TBIs and improve outcomes from 
TBI sufferers is the subject of the next phase of research. It also highlights the need for decision makers to 
form criteria around not only the effectiveness of proposed preventions but also to further explore the 
acceptability, equity and economic feasibility of the intervention.  
Substantial gaps in the literature remain with respect to investigating the long-term outcomes on quality of 
life, on-going healthcare service utilisation and informal carer costs associated with TBI. It is also interesting 
that internationally, fall prevention focuses on the elderly population, yet falls are identified as the leading 
cause of TBI in the current study. The same is true in NZ, with the majority of fall prevention initiatives 
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targeted to those aged 65 years or older. The New Zealand Fall Strategy (Minster of ACC, 2005) also 
acknowledges that a gap exists. Opportunity exists to further investigate the effectiveness of fall prevention 
interventions among children and including alcohol prevention activities is something worth considering for 
fall among young adults (Gentiello et al., 1999). This study has identified evidence-based messages that can be 
used to guide primary prevention strategies for TBI.  
Recommendations for further research 
The current research has raised important implications for future research, practice and policy in NZ.  
Key recommendations for further research are: 
1. At present, less is known about the long-term consequences associated with TBI. A longitudinal study 
observing risk factors, comorbidity, healthcare usage, return to work and health status is needed. 
a) Examine the impact of TBI on quality of life and social and economic costs. 
2. This thesis has demonstrated that a COI study can be carried out using population-based incidence 
and self-reported health usage data. Further COI studies should be carried out every ten years in 
conjunction with large population-based incidence studies. This will not only inform public health 
surveillance, but can also be used as an evaluation of improvement measures by comparing rates of 
injury, associated risk factors  and costs between decades. 
3. There is a need for standard health economic data, whether it is in the form of self-reported health 
care and service use or as a guideline to assist researchers conducting such analysis. This will ensure 
that future studies will be collecting similar information that is comparable.   
4. Further cost-effectiveness studies are needed to assess the efficiency of the following. 
a) Current interventions aiming to prevent injuries should be a priority, as they are important 
for informing decision making.  
b) A range of early management and neuroimaging for all TBIs and to the investigation of 
further options of whether all mild TBI or selected mild TBI receive CT scanning. 
c) Integrated rehabilitation services aimed at improving the quality of life and health outcomes 
for people with moderate/severe TBI.  
5. As the current COI study reported costs based on patterns of resources used, it is possible that some 
people with TBI that go untreated or have limited access to health care services or compensation 
beyond one year post TBI will have lower costs. Further COI studies need to identify the “additional” 
resources (i.e. community and home services) needed by TBI sufferers and their families/caregivers:  
a) For example, of those who went untreated or have limited access to resources post TBI, what 
proportion of these individuals needed additional resources in the first instance, but were 
unable to access them (i.e. identifying unmet need)?  
b) The current study did not account for informal caregiving costs borne by the families and 
friends of the individual. Further study is required to investigate the amount of informal care 
provided and to estimate the cost of that care.  
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6. Further evaluation of current interventions for TBI is needed to identify to what extent the 
intervention works in practice. This information will be used to guide the development of new 
prevention interventions including strategies to make sure people with TBI receive needed care.  
Key recommendations for practice are: 
7. There is a need for central accessible data with complete health service usage.  
8. Due to the high TBI incidence among Maori populations in NZ, more culturally appropriate prevention 
messages are merited: 
a) to extend current interventions to include ethnic-specific language translation of general 
public health messages and aired on Maori radio and television networks; or 
b) to develop an injury prevention programme based on a kaupapa Maori framework, 
incorporating appropriate Tikanga-based programmes similar to the PHARMAC’s ‘one heart 
healthy lives’ programme. 
Key recommendations for health policy are: 
9. Increase public health awareness and education efforts in the prevention of mild TBI particular from 
falls, at the home, school, workplace or through sport. 
This thesis has provided important information for quantifying not only the burden of TBI to NZ society, but 
also contributes towards the development of public health policies for reducing the incidence of TBI and policy 
decisions on health care delivery. Further studies are required to confirm the findings. Few high quality COI 
evidence exists for TBI. This thesis adds value and has demonstrated that information on the cost and patterns 
of health service usage can assist decision makers and public health officials anticipate and budget for health 
care resources needed to detect and treat TBI. It further provides evidence towards assessing whether new 
interventions for testing or treating are cost effective and to identify disparities and inequalities in accessing 
and delivery of health services post TBI. Lastly, the cost per case of TBI can also inform potential cost savings 
from preventing TBI particularly for high cost individuals. 
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Appendix one: Search methods 
 
Database: EBSCO Health database a collection of health databases 
Sources included: Biomedical Reference Collection: Basic, CINAHL Plus with Full Text, Health Business Elite, Health 
Source - Consumer Edition, Health Source: Nursing/Academic Edition, MEDLINE, Psychology and Behavioural Sciences 
Collection, SPORTDiscus with Full Text, Dentistry & Oral Sciences Source  
Search Strategy: 
-------------------------------------------------------------------------------- 
 
1. Economics/  
2. "costs and cost analysis"/  
3. Cost of illness/  
4. Health care costs/  
5. Direct service costs/ 
6. indirect costs/ 
7. Drug costs/  
8. Employer health costs/  
9. Hospital costs/  
10. Health expenditures/  
11. exp economics, hospital/  
12. exp economics, medical/  
13. Economics, nursing/  
14. Economics, pharmaceutical/  
15. exp "fees and charges"/  
16. (low adj cost).mp.  
17. (high adj cost).mp.  
18. (health?care adj cost$).mp.  
19. (fiscal or funding or financial or finance).tw.  
20. (cost adj estimate$).mp.  
21. (cost adj variable).mp.  
22. (unit adj cost$).mp.  
23. (economic$ or pharmacoeconomic$ or price$ or pricing).tw.  
24. Population based study/ 
25. Community based study/ 
26. Cohort study/ 
27. Prospective study 
28. Retrospective study 
29. Head injury/ 
30. Head trauma/ 
31. Brain injury/ 
32. Traumatic brain/ 
33. Traumatic brain injury/ 
34. Brain concussion/ 
35. OR/1-23 
36. OR/24-28 
37. OR/29-34 
38. 35 AND 36 AND 37  
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Appendix two: Quality checklist for health economic studies 
 
Checklist adapted from (Drummond et al., 2005). 
1. Was a clear definition of the illness given? 
*This need not be in one statement but may be a combination of statements throughout the article 
2. Were epidemiological sources carefully described? 
*This need not be in one statement but may be a combination of statements throughout the article  
- Score a “yes” if the epidemiological sources were stated  
3. Were costs sufficiently disaggregated? 
- Score “yes” if: 
a. results were projected, short-term results were presented 
4. Were activity data appropriately assessed? 
- Score a “yes” if: 
a. subgroup analyses were specified in a protocol, statistical analysis plan, or study concept document of 
the health economic analysis and referenced in the manuscript 
b. if estimate came from one source pre-specified at the beginning of the study or if no subgroup analysis 
was performed  
5. Were all sources of all cost values analytically described? 
- Score a “yes” if sources of costs were clearly described, and statistical analysis was used to address 
sampling variation AND sensitivity analysis covered more than one assumption 
6. Were unit costs appropriately valued? 
- Score “yes” if (a) - (c) are satisfied: 
a.   Important and relevant costs and consequences for each alternative were identified  
b.   Costs and consequences were measured accurately in appropriate physical units  
c.  Unit values for costs and consequences were credible and their source clearly described  
7. Were the methods adopted carefully explained? 
- Score “yes” if (a) - (d) are all satisfied: 
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a. Study methods for estimating both the numerator and denominator were displayed in a clear, 
transparent manner 
b. Numerator was displayed in a clear, transparent manner; presented group-specific costs and 
incremental difference in costs    
c. Denominator was displayed in a clear, transparent manner; presented group-specific effects and 
incremental difference in effects 
d. If a valid and reliable scale/measure was used OR if such scales/measures were not used, justification 
was given for the measures/scales used 
8. Were costs that went beyond one year discounted (3% to 5%) and justification given for the discount 
rate? 
- Score “yes” if :  
a. Justification for discount rate was provided for costs and benefits that occurred beyond a one-year 
period 
9. Were the major assumptions tested in a sensitivity analysis?  
- Score “yes” if:  
a. Main assumptions, and limitations were stated 
b. Main assumptions were justified 
10. Was the presentation of study results consistent with the methodology of the study?  
- Score “yes” if the conclusions/recommendations of the study were in agreement with the results reported; 
conclusions/recommendations should include aspects of (a-e). 
a.  Intelligently interpreted index/indices 
 Conclusions about cost analysis cannot be made based on inappropriate statistical testing (i.e. non-
parametric testing)  
b. Were comparisons made with others who answered the same question or answered a question of 
efficiency in TBI? 
c. Generalisability of results, other settings or patient/client groups  
d. Issues of implementation discussed  
e. Other important factors in choice/decision under consideration  
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Appendix three: Excluded studies 
 
Authors Title of article Reason for exclusion 
Kristman, Cote, Yang, Hogg-
Johnson, Vidmar and Rezai, 2014 
Health care utilisation of workers' compensation 
claimants associated with mild traumatic brain 
injury: a historical population-based cohort study 
of workers injured in 1997-1998. 
This was an epidemiological study. 
It did not include or report health 
service use costs 
Meerding, Mulder and Van Beeck, 
2006 
Incidence and cost of injuries in the Netherlands Included all injuries, TBI was not the 
main focus of the study 
Bener, Yassir, Rahman and Mitra, 
2008 
Incidence and severity of head and neck injuries 
in victims of road traffic crashes: in an 
economically developed country 
This study did not report health 
service use costs  
Yang, Yilan, Shih, Chang, Huang and 
Chien, 2011 
Long-term medical utilisation following 
ventilator-associated pneumonia in acute stroke 
and traumatic brain injury patients: a case-
control study 
TBI was not the main focus 
Hoang, Pham, Vo, Nguyen, Doran 
and Hill, 2008 
The costs of traumatic brain injury due to 
motorcycle accidents in Hanoi, Vietnam. 
Did not include TBI from all causes - 
only TBI due to motorcycle 
accidents 
Bradbury, Wodchis, Mikulis, Pano, 
Hitzig, McGillivary, Ahmad, Craven 
and Green, 2008 
Traumatic brain injury in patients with traumatic 
spinal cord injury: clinical and economic 
consequences. 
Only included TBI with spinal cord 
injury - therefore higher expected 
costs could be associated with this 
sample 
Singh, Vaishya, Gupta and Mehta, 
2006 
Economics of head injuries Did not report detailed health 
service costs aggregated by acute, 
rehabilitation, outpatient or 
community services 
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Appendix four: Included studies 
Ref: Mc Garry et al., (2002) Outcomes and Costs of Acute Treatment of Traumatic Brain Injury 
Was a clear definition of the illness given? 
YES 
Traumatic brain injury was briefly described. TBI was identified by reviewing discharge records from January 1 
1997 through to June 30 1999 with recorded ICD-9-CM diagnosis codes (ICD-9-CM 800.1–800.4, 800.6–800.9, 
801.1–801.4, 801.6–801.9, 803.1–803.4, 803.6–803.9, 804.1–804.4, and 804.6–804.9) as well as brain injury 
(851–854, inclusive of all fourth and fifth digit classifications). 
Were epidemiological sources carefully described? 
YES 
All hospital discharge records were reviewed. TBI was selected using the International Classification of 
Diseases, 9th Revision, Clinical Modification codes at admission. Dates of admission and discharge, source of 
admission (e.g. emergency department, transfer from another acute-care institution), billed charges, payer, 
and discharge disposition were also reported.  
Were costs sufficiently disaggregated? 
PARTIALLY 
Although hospitalisation costs were displayed by severity of injury, it would have been more helpful if the 
authors also gave cost estimates for all TBI and disaggregated by acute rehabilitation and outpatient services. 
Were activity data appropriately assessed? 
YES  
Patient flow, disposition after discharge were adequately traced using appropriate methods.  Subgroup 
analyses were performed on severity of injury and cause of injury.  
Were all sources of all cost values analytically described? 
YES 
Total costs of hospitalisation were estimated from billed charges using cost/charge ratios from the Health Care 
Financing Administration Prospective Payment System. 
Were unit costs appropriately valued? 
NO 
Unit costs or cost calculation were not described nor were the unit costs per item or weighted case value 
given. 
Were the methods adopted carefully explained? 
YES 
All parameters were adequately described in the methods section. Outcome measures of interest included 
average length of stay in hospital, in-hospital mortality (both overall and within two days of admission), and 
patients’ discharge disposition as well as hospitalisation costs. 
Were costs that went beyond one year discounted (3% to 5%) and justification given for the discount rate? 
NO 
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This study only assessed acute hospitalisation costs after having a TBI within the first month of care. This study 
did not address or attempt to estimate first-year costs or lifetime costs. 
Were the major assumptions tested in a sensitivity analysis?  
NO 
There was no mention of main assumptions within the analysis section.  
Was the presentation of study results consistent with the methodology of study?  
PARTIALLY 
Although the study presented results of the outcomes tested, the study did not present disaggregated costs by 
subgroup. Conclusions about cost analysis were adequately reflected.  
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Ref: Schootman et al., (2002) National Estimates of Hospitalisation Charges for the Acute Care of Traumatic 
Brain Injuries. 
Was a clear definition of the illness given? 
YES 
TBIs were identified using the Centres for Disease Control and Prevention case definition [11]. All hospital 
discharge records that contained, in one or more diagnostic fields, an International Classification of Diseases, 
9th Revision, Clinical Modification (ICD-9-CM) diagnostic code in the ranges 800–801, 803–804 or 850–854 
were considered to be TBIs. 
Were epidemiological sources carefully described? 
YES 
Rates of hospitalisation were calculated using 1996 population data available from the Bureau of the Census. 
The numerator consisted of the number of hospitalisations, rather than the numbers of individual patients 
since patient identifiers were not available. 
Were costs sufficiently disaggregated? 
YES 
Costs were reported by sex, age, race, severity and hospital region. As costs were derived using cost weights, 
the cost estimates were inclusive of acute and rehabilitation services.  
Were activity data appropriately assessed? 
YES 
Subgroup analyses were specified in the statistical analysis plan in the manuscript.  
Were all sources of all cost values analytically described? 
YES 
The billed charges were used to describe the burden of TBI in the US. The NIS contains billed charges, rather 
than the actual economic cost of hospitalisation for TBI. Billed charges differed from the amount paid because 
of discounts, deductibles, co-payments and co-insurances. 
Were unit costs appropriately valued? 
YES 
To obtain national estimates of the charges, sample weights available were used in the NIS in all analyses. 
Besides mean charges, the median charge to reduce the influence of large values on the mean was calculated. 
Were the methods adopted carefully explained? 
YES 
Study methods for estimating the rates were described in a clear manner. All valid and reliable 
scales/measures used were justified. 
Were costs that went beyond one year discounted (3% to 5%) and justification given for the discount rate? 
NO 
Costs were not analysed beyond one year. 
Were the major assumptions tested in a sensitivity analysis?  
NO 
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Was the presentation of study results consistent with the methodology of study?  
YES 
The conclusions of the study were in agreement with the results reported. 
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Ref: Ettaro et al., (2004) Abusive Head Trauma in Young Children: Characteristics and Medical Charges in a 
Hospitalised Population 
Was a clear definition of the illness given? 
YES 
All admissions with the following ICD-9-CM diagnostic codes were examined to identify head trauma events: 
intracranial haemorrhage following injury (852.00–852.59, 853.00–853.19); skull fracture, excluding fracture of 
face bones (800.00–800.99, 801.00–801.99, 803.00–803.99, and 804.00–804.99); intracranial injury of other 
and unspecified nature (854.00–854.19); unspecified head injury (959.01); and shaken baby syndrome 
(995.55). 
Were epidemiological sources carefully described? 
PARTIALLY 
There was no mention of epidemiological calculation. There was mention of case identification through a 
review of hospital records. 
Were costs sufficiently disaggregated? 
PARTIALLY 
Although the study reports hospitalisation costs only, due to cost source, the cost estimates were not able to 
be reported by service phase (i.e. emergency, acute and rehabilitation). 
Were activity data appropriately assessed? 
YES 
Details of case identification were clearly described, with special attention given to inclusion criteria for the 
subgroup analyses.  
Were all sources of all cost values analytically described? 
YES 
Medical and billing records were abstracted for all eligible subjects. Information gathered from the medical 
records included demographic information, injuries sustained, initial stated cause of injury, time/date of injury, 
discharge status (dead, rehabilitation institute, home, foster care), length of stay (LOS), insurance status 
(Medicaid, commercial insurance, or self-pay), and whether or not a child abuse report was filed with child 
protective services. 
Were unit costs appropriately valued? 
PARTIALLY 
Hospital charges were identified from associated UB-92 forms (National Uniform Billing Committee, 1996) for 
all identified events. The UB-92 form is a standard financial form accepted by the Health Care Financing 
Administration. Only charges associated with the acute event (initial hospitalisation) were included. If the 
patient was admitted from an emergency department (ED) visit at CHP, the charges associated with this visit 
were also included in the estimate of hospital charges; but when patients were transferred from outside 
hospitals, the ED visit was not included. 
Study based on internal estimates- unit costs were not provided. 
Were the methods adopted carefully explained? 
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YES 
The study clearly described the setting, study design, classification of subjects’ outcome measures in a 
transparent manner. 
Were costs that went beyond one year discounted (3% to 5%) and justification given for the discount rate? 
No 
Only hospitalisation costs were analysed. 
Were the major assumptions tested in a sensitivity analysis?  
NO 
There was no mention about any assumptions made in the analysis or any uncertainties addressed. 
Was the presentation of study results consistent with the methodology of study?  
YES 
The presentation of the current study results was consistent with the methodology of the study. The study 
found that the hospital charges (1999 dollars) were significantly higher for abused subjects (mean±SD: 
$40,082±$58,004) versus non-abused (mean±SD: $15,671±$41,777).  
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Ref: Vangel et al., (2005) Long-Term Medical Care Utilization and Costs among Traumatic Brain Injury 
Survivors 
Was a clear definition of the illness given? 
PARTIALLY 
However TBI complications were reflected by billings associated with TBI-related International Classification of 
Diseases, 9th revision, codes. 
Were epidemiological sources carefully described? 
PARTIALLY 
Calculation of rates was not clearly mentioned in the methods section of the study. However the authors did 
describe source of data (i.e. participants were enrolled in the Rehabilitation Institute of Michigan Primary Care 
Program and were at least one-year post injury at entry into the study protocol). 
Were costs sufficiently disaggregated? 
YES 
Short-term results were presented. 
Were activity data appropriately assessed? 
YES 
Costs were presented by healthcare category and by source of finance.  
Were all sources of all cost values analytically described? 
YES 
Healthcare utilisation and cost outcomes were codified in the following manner: billings were used as an index 
of utilisation, as they reflected an instance of a service, medication, or supply. Subcategories of billings 
included: home health care, primary care, outpatient services, medications, medical equipment and supplies, 
inpatient treatment, residential treatment, transportation, and case management by the State of Michigan. 
Costs were reflected in the charge (i.e. amounts billed for services, medication, or supplies). 
Were unit costs appropriately valued? 
PARTIALLY 
Although the costs were well described there were no references to or mention of unit costs used in the study. 
Were the methods adopted carefully explained? 
YES 
The authors described in detail the methods used in their study. As stated in their abstract, this was a 
retrospective cohort study of healthcare billings for 63 survivors of traumatic brain injury, over a 19-month 
period, using a state-sponsored Medicaid program. The relationship of indicators between injury severity and 
disability to billings and payments was investigated. Mean age at time of injury was 33 years. Mean highest 
Glasgow Coma Scale rating immediately after brain injury was eight. 
Were costs that went beyond one year discounted (3% to 5%) and justification given for the discount rate? 
NO 
Costs were estimated within one year. 
Were the major assumptions tested in a sensitivity analysis?  
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YES 
Before analysis, the variables were screened for assumptions of univariate and multivariate parametric tests. 
Each of the billing outcome variables showed significant skew. Some of these variables were amenable to 
transformation, which improved normality and linearity to within acceptable levels for parametric analyses. 
Was the presentation of study results consistent with the methodology of study?  
YES 
The conclusions of the study were in agreement with the results reported.  
 The study reported appropriate statistical testing (i.e. non parametric testing).  
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Ref: Faul et al., (2007) Using a Cost-Benefit Analysis to Estimate Outcomes of a Clinical Treatment Guideline: 
Testing the Brain Trauma Foundation Guidelines for the Treatment of Severe Traumatic Brain Injury. 
Was a clear definition of the illness given? 
YES 
The authors applied the International Classification of Diseases Clinical Modification diagnosis codes found in 
the CDC Traumatic Brain Injury Case Definition to the 2002 National Hospital Discharge Survey (NHDS) public 
use dataset. 
Were epidemiological sources carefully described? 
YES 
The study population and inclusion criteria used were clearly described.  
Were costs sufficiently disaggregated? 
YES 
Faul et al. described in great detail the source of medical and social costs and presented the results in a 
consistent manner. The results were projected to estimate lifetime costs per person. 
Were activity data appropriately assessed? 
YES 
BTF Adoption is used to describe the state of medical care as it relates to hospital implementation of the BTF 
guidelines. 
Were all sources of all cost values analytically described? 
YES 
Direct medical and societal costs for TBI mortality and morbidity were calculated from The Incidence and 
Economic Burden of Injuries in the United States. Societal costs for TBI mortality were calculated by summing 
long-term wage and production loss costs. The average cost for rehabilitation per day was $1,423.15 in 1996, 
which was adjusted to be $1,631.77 in 2002 using an inflation calculator. 
Were unit costs appropriately valued? 
PARTIALLY 
Average cost of direct medical, societal and rehabilitation costs were sourced from various sources but were 
clearly stated. 
Were the methods adopted carefully explained? 
YES 
The study design used decision-modelling techniques to estimate expected outcomes for people with TBI and 
associated costs. Using data from various sources the authors projected the results of Brain Trauma 
Foundation guideline adoption to estimate the impact of widespread adoption across the United States.  
Were costs that went beyond one year discounted (3% to 5%) and justification given for the discount rate? 
NO 
No mention of discounting costs to reflect present net value of costs for costs projected over their lifetime of 
the cohort. 
Were the major assumptions tested in a sensitivity analysis?  
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YES 
As stated in the methods section, the biggest difference in outcomes was the number of expected deaths. 
Because these differences come from uncertain sources, a sensitivity analysis was performed on these 
variables. 
Was the presentation of study results consistent with the methodology of study?  
YES 
The conclusions/recommendations of the study were in agreement with the results reported. The cost analysis 
did not use appropriate methods and statistical testing. The authors concluded that adoption of the BTF 
guidelines for the treatment of severe TBI would result in substantial savings in costs and lives. 
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Ref: Rockhill et al., (2010) Healthcare Costs Associated with Mild Traumatic Brain Injury and Psychological 
Distress in Children and Adolescents 
 
Was a clear definition of the illness given? 
YES 
The authors clearly describe the TBI classification definition of mild TBI according to CDC criteria: International 
Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) [31] codes indicated brief (<1 hour) or 
no loss of consciousness and no traumatic intracranial lesions. 
Were epidemiological sources carefully described? 
PARTIALLY 
No mention was made about the hospitalisation rates found. But the authors clearly described the sources 
used to collect information on mild TBI patients. As stated within the methods section, the study utilised 
computerised records of enrolees in a large staff model HMO, Group Health Cooperative of Puget Sound (GHC) 
that serves _500,000 members throughout Washington State. 
Were costs sufficiently disaggregated? 
YES 
The author presented cost results by health care category. 
Were activity data appropriately assessed? 
YES 
Subgroup analyses were specified in the statistical analysis plan, or study concept document of the health 
economic analysis and referenced in the manuscript.  
Were all sources of all cost values analytically described? 
YES 
Costs were determined using the HMO’s automated cost accounting system. These included outpatient 
services for general medical or mental healthcare, inpatient medical and mental health services, emergency 
visits, pharmacy costs, laboratory and radiology costs. 
Were unit costs appropriately valued? 
PARTIALLY 
The cost sources were clearly described but the authors fell short on detailed descriptions of unit values for 
costs and their source. 
Were the methods adopted carefully explained? 
YES 
The author described in great detail the study population and valid measure used. 
Were costs that went beyond one year discounted (3% to 5%) and justification given for the discount rate? 
PARTIALLY 
A discount rate of 3% was stated for costs beyond the first year; however, no justification was given for the 
discount rate. 
Were the major assumptions tested in a sensitivity analysis?  
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NO 
No mention of uncertainty of the estimates.  
Was the presentation of study results consistent with the methodology of study?  
YES 
The conclusions/recommendations of the study were in agreement with the results reported. 
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Ref: Chen et al., (2012) Direct Cost Associated with Acquired Brain Injury in Ontario 
Was a clear definition of the illness given? 
YES 
Patients with the following diagnoses were classified into TBI category: fracture of skull, intracranial injury, late 
effects of injuries, poisonings and toxic effects, and other external causes. Patients with a stroke in any 
diagnosis position and patients with hospital-acquired ABI diagnosis were excluded. 
Were epidemiological sources carefully described? 
YES 
The epidemiological sources were stated.  
Were costs sufficiently disaggregated? 
YES 
Costs were presented by healthcare category within the first year and again in year two and three. 
Were activity data appropriately assessed? 
YES 
Subgroup analyses were specified in a study concept document of the health economic analysis and 
referenced in the manuscript.  
Were all sources of all cost values analytically described? 
YES 
According to the authors, patient-specific health care utilisation data were abstracted from provincial 
administrative databases and then linked across databases using patients’ scrambled health card identifier. 
Given the source of cost described, the authors also provided appropriate statistical analysis that was used. 
Were unit costs appropriately valued? 
YES 
Unit costs of inpatient acute care, ED visits, home care and complex continuing care were obtained from the 
Ministry of Health and Long-Term Care (MOHLTC) Health Data Branch website. The authors stated that each 
case cost was estimated by multiplying the weight by provincial cost per weighted case for acute care valued 
at $5,212 in 2007. This unit cost was cited in the reference.  
Were the methods adopted carefully explained? 
YES 
This is a population-based cohort of patients discharged from acute hospital with an ABI code in any diagnosis 
position in 2004 through to 2007 in Ontario. Participants were identified from administrative data. Publicly 
funded health care utilisation was obtained from several Ontario administrative health care databases. 
Patients were stratified according to traumatic and non-traumatic causes of brain injury and whether or not 
they were discharged to an inpatient rehabilitation centre. Health system costs were calculated across a 
continuum of institutional and community settings for up to three years after initial discharge. 
Were costs that went beyond one year discounted (3% to 5%) and justification given for the discount rate? 
NO 
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This study reported costs over a one-year period but does not state whether the projected results were 
adjusted using a justified discount rate. 
Were the major assumptions tested in a sensitivity analysis?  
YES 
The main assumptions around cost estimates used within emergency department and acute visits were clearly 
described and justified. 
Was the presentation of study results consistent with the methodology of study?  
YES 
The authors present a well-written paper on the direct costs associated with acquired brain injury in Ontario. 
Their findings were consistent with previous literature that the direct costs are substantial and vary 
considerably by cause of injury. 
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Ref: Leibson et al., (2002) Medical Care Costs Associated with Traumatic Brain Injury over the Full Spectrum 
of Disease: A Controlled Population-Based Study 
Was a clear definition of the illness given? 
YES 
Similar to other studies using hospital administration data. The current study used the extensive list of the 
International Classification of Diseases, 9th Revision-Clinical Modification (ICD-9-CM) and Mayo adaptation of 
H-ICDA codes used to identify cases. 
Were epidemiological sources carefully described? 
YES 
The epidemiological sources were stated. The authors used the Rochester Epidemiology Project (REP) 
resources to estimate long-term medical costs for clinically-confirmed incident TBI across the full range of 
severity after controlling for pre-existing conditions and co-occurring injuries. 
Were costs sufficiently disaggregated? 
YES 
Short-term costs were presented (1-6 months), medium term (6-12 months) and long term (1-6 years). Costs 
were aggregated together; they were not disaggregated by health care service category. 
Were activity data appropriately assessed? 
YES 
The authors clearly described and referenced sources of data collection and linking/matching across data sets 
by patient identification code. The data source follows the cohort over six years. 
Were all sources of all cost values analytically described? 
YES 
Costs were clearly described. Through an electronic data-sharing agreement signed by administration at Mayo 
Clinic and OMC, patient-level administrative data on health care utilisation and associated billed charges 
incurred at these institutions are shared and archived within the Olmsted County Healthcare Expenditure and 
Utilization Database (OCHEUD) for use in approved research studies 
Were unit costs appropriately valued? 
PARTIALLY 
The authors referred the reader to another study to review costing methods.  
Were the methods adopted carefully explained? 
YES 
The authors clearly described the study in a clear and transparent manner and presented costs by subgroup 
analysis. 
Were costs that went beyond one year discounted (3% to 5%) and justification given for the discount rate? 
NO 
No justification for discounted rate was provided for costs that occurred beyond a one-year period. 
Were the major assumptions tested in a sensitivity analysis?  
NO 
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No mention of uncertainty or main assumption is made in the study. 
Was the presentation of study results consistent with the methodology of study?  
YES  
The study conclusions were in agreement with the results reported. 
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Ref: Yuan et al., (2012) Characteristics of Acute Treatment Costs of Traumatic Brain Injury in Eastern China—
A Multi-Centre Prospective Observational Study 
Was a clear definition of the illness given? 
PARTIALLY 
The authors stated that the diagnosis of TBI was made by admitting neurosurgeons or emergency room 
physicians and confirmed by computed tomography (CT) within six hours of admission. 
Were epidemiological sources carefully described? 
PARTIALLY 
Epidemiological sources were briefly stated.  
Were costs sufficiently disaggregated? 
YES 
Acute costs were presented by subgroups (sex, age, cause of TBI). 
Were activity data appropriately assessed? 
PARTIALLY 
It was unclear as to the pathway followed. But this study only assessed the acute phase of hospitalisation, 
probably due to the lack of data for the post-acute phase.  
Were all sources of all cost values analytically described? 
PARTIALLY 
Unlike previous studies the authors did not elaborate extensively on the sources of cost. However the authors 
stated that any patient who had incomplete financial data was excluded. Total acute hospitalisation treatment 
costs derived from unsubsidised total hospital billings were used as the main outcome measure, as these were 
the most robust means of obtaining the total care costs per inpatient. 
Were unit costs appropriately valued? 
NO 
No evidence of important and relevant costs and consequences for each alternative is identified. Unit values 
for costs were not source clearly. 
Were the methods adopted carefully explained? 
PARTIALLY 
The authors could have described in more detail patient selection and data source. But they did mention that 
clinical variables included demographic variables, such as age, sex, date of injury, live state, place of 
occurrence, payment type, hospital type, ward type, and date of admission and discharge. The latter two 
variables were used to compute the acute LOS (days). Ward types were reclassified into the neurosurgical 
intensive care unit (NICU), intensive care unit (ICU), and general ward.  
Were costs that went beyond one year discounted (3% to 5%) and justification given for the discount rate? 
NO 
No justification for discount rate was provided for costs that occurred beyond a one-year period.  
Were the major assumptions tested in a sensitivity analysis?  
NO 
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No mention of main assumptions, and limitations were stated. 
Was the presentation of study results consistent with the methodology of study?  
YES 
The conclusions of the study were in agreement with the results reported. 
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Ref: Rockhil et al., (2012) Health Care Costs Associated with Traumatic Brain Injury and Psychiatric Illness in 
Adults 
Was a clear definition of the illness given? 
YES 
Subjects were persons 15 years or older who were diagnosed with mild or moderate to severe TBI in the 
emergency department (ED), hospital, or outpatient clinic in 1993, and who were enrolled in GHC but had not 
had an International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) diagnosis of TBI in 
the year prior to the study. 
Were epidemiological sources carefully described? 
YES 
The epidemiological sources were stated. This prospective cohort study used computerised records of enrolees 
in a large staff model health maintenance organisation (HMO), Group Health Cooperative of Puget Sound 
(GHC). 
Were costs sufficiently disaggregated? 
YES 
Short-term and one-year results were presented by the following healthcare categories: primary care, 
specialty care, emergency care, medication, radiology outpatient care, ambulatory care and inpatient care. 
Were activity data appropriately assessed? 
YES 
Subgroup analyses were specified in the methods document of the health economic analysis and referenced in 
the manuscript.  
Were all sources of all cost values analytically described? 
YES 
Costs were determined using the HMO’s automated cost accounting system. This system tracks all health care 
services provided for or paid for by GHC during the study period. These included outpatient services for 
general medical or mental health care, inpatient medical and mental health services, emergency visits, 
pharmacy costs, laboratory and radiology costs, and other health care services paid for by GHC.  
Were unit costs appropriately valued? 
PARTIALLY 
Although the authors clearly described important sources and relevant costs were identified, unit values for 
costs were not sourced clearly.  
Were the methods adopted carefully explained? 
YES 
The authors clearly described the use of data sources in the study outlining valid measures used. 
Were costs that went beyond one year discounted (3% to 5%) and justification given for the discount rate? 
YES 
Costs of health services in the Seattle/Puget Sound region were discounted 3% per year for years two and 
three. 
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Were the major assumptions tested in a sensitivity analysis?  
PARTIALLY 
There was no clear description of the main assumption used in the study, but the authors did conduct a 
sensitivity analysis using a Poisson model and log link in their proposed regression analysis to test for 
differences in costs between subgroups. 
Was the presentation of study results consistent with the methodology of study?  
YES 
The conclusions of the study were in agreement with the results reported. The authors main findings were a 
significant interaction between moderate-to-severe TBI and psychiatric illness indicated a 3.39 times greater 
cost among patients with both exposures compared with those exposed to moderate-to-severe TBI without 
psychiatric illness. 
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Ref: Farhad et al., (2013) Trends in Outcomes and Hospitalisation Costs for Traumatic Brain Injury in Adult 
Patients in the United States 
Was a clear definition of the illness given? 
YES 
As stated in the study the authors identified adult patients, ‡18 years of age, with a primary diagnosis of TBI 
using the International Classification of Disease, 9th Revision (ICD-9-CM) codes in the ranges 800.0–801.9, 
803.0– 804.9, or 850.0–854. We used ICD codes 96.7, 96.70, 96.71, and 96.72 to identify patients with TBI who 
were mechanically ventilated. 
Were epidemiological sources carefully described? 
YES 
The study used data from the Nationwide Inpatient Sample (NIS) sponsored by the Agency for Healthcare 
Research and Quality to determine the demographic and clinical characteristics of TBI patients for the two 
study periods (1993–1994 and 2006–2007). 
Were costs sufficiently disaggregated? 
NO  
Costs were reported as an aggregated total for the year.  
Were activity data appropriately assessed? 
YES 
Subgroup analyses were specified in a protocol, statistical analysis plan, or study concept document of the 
health economic analysis and referenced in the manuscript, if estimates came from one source pre-specified at 
the beginning of the study or if no subgroup analysis was performed.  
Were all sources of all cost values analytically described? 
PARTIALLY 
National cost estimates, the Nationwide Inpatient Sample (NIS) provided both hospitalisation and discharge 
weights. Not all sources of costs were clearly described. 
Were unit costs appropriately valued? 
NO 
The cost weight unit was not provided. 
Were the methods adopted carefully explained? 
PARTIALLY 
The authors gave a brief description of the data source used. More details around costing would have been 
more useful. 
Were costs that went beyond one year discounted (3% to 5%) and justification given for the discount rate? 
NO 
Results for costs did not occur beyond a one-year period. 
Were the major assumptions tested in a sensitivity analysis?  
NO 
No mention of any assumptions was stated in the analysis. 
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Was the presentation of study results consistent with the methodology of study?  
YES 
The authors concluded that although the number of TBI admissions was reduced, a significant increase in 
average hospitalisation charges and in-hospital mortality rates was observed in 2006–2007 compared with 
1993–1994. 
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Ref: Stroup et al., (2013) Healthcare Utilisation and Costs of Veterans Screened and Assessed for Traumatic 
Brain Injury 
Was a clear definition of the illness given? 
PARTIALLY 
The study included a national retrospective sample of OIF/OEF veterans who received care at VA facilities in 
the United States between April 2007 (initiation of the mandatory TBI screen) and September 2008. The study 
examined the association between results of the TBI screen (positive, negative, or no screen) and patient 
characteristics, facility characteristics and healthcare utilisation. However the study fell short of defining TBI or 
explaining how they coded for the diagnosis. 
Were epidemiological sources carefully described? 
YES 
The authors extracted data from various databases (namely VA National OEF/OIF Roster, VA National TBI 
health factors database, and comprehensive TBI evaluation databases).  
Were costs sufficiently disaggregated? 
YES 
Costs were presented by outcome of TBI screen and healthcare category. 
Were activity data appropriately assessed? 
YES 
Were all sources of all cost values analytically described? 
YES 
The authors examined the direct costs of health care from the VAs’ (i.e. the payer/provider) perspective, 
where cost estimates reflect the VAs’ expenditure for each veteran. Costs for outpatient care, outpatient 
pharmacy, and inpatient care provided by a VA facility were obtained from VA DSS NDEs. In summary, total 
costs per patient, which consisted of total outpatient (primary care, rehabilitation care, polytrauma care, 
mental health care, other specialty care, other VA outpatient, and non-VA outpatient costs), total outpatient 
pharmacy (chronic and acute medication costs), and total inpatient (short-term medical or surgical, SCI, 
psychiatric, rehabilitation, long-term care, and non-VA fee basis care) costs during the 12 months following the 
index date. Total outpatient costs also included costs on the day of the index visit and costs on the day of the 
TBI evaluation. All costs were adjusted to 2008 dollars using the Consumer Price Index. 
Were unit costs appropriately valued? 
PARTIALLY 
All important and relevant costs for each health service were identified and in some cases cited in the 
references. However the authors did not clearly state the unit values for costs used.  
Were the methods adopted carefully explained? 
YES 
The present study examined veterans who screened positive for a comprehensive TBI evaluation. A national 
retrospective study of OIF/OEF veterans receiving care at VA facilities between 2007 and 2008 was conducted. 
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The authors examined the association of the TBI screen with healthcare costs over a 12-month period 
following the initial evaluation. 
Were costs that went beyond one year discounted (3% to 5%) and justification given for the discount rate? 
NO 
No justification for discount rate was provided for costs as the result did not extend beyond a one-year period. 
Were the major assumptions tested in a sensitivity analysis?  
NO 
No mention of assumptions was stated. 
Was the presentation of study results consistent with the methodology of study?  
YES 
The authors concluded that total healthcare costs of veterans who screened positive, screened negative, or 
had no TBI screening were $9,610, $5,184, and $3,399, respectively. 
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Appendix five: Burden of traumatic brain injury in New Zealand article 
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 Zealanders estimated to have ever experienced a TBI (preva-
lent cases). The estimated 20,300 DALYs attributable to TBI 
accounted for 27% of total injury-related health loss and 
2.4% of DALYs from all causes. Of the total DALYs attribut-
able to TBI, 71% resulted from fatal injuries. However, non-
fatal outcomes accounted for a substantial share of the bur-
den (29%) with mild TBI making the greater contribution of 
non-fatal outcomes (56%).  Conclusions: The burden of TBI 
in NZ is substantial, and mild TBI contributes to a major part 
of non-fatal outcomes.  © 2015 S. Karger AG, Basel 
 Introduction 
 Traumatic brain injury (TBI) is a major cause of dis-
ability and death in New Zealand (NZ)  [1] . In addition to 
these long-term impacts on personal and whanau/family 
wellbeing, TBI has major economic consequences in the 
society  [2] . Robust information on the population-based 
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 Abstract 
 Objective: The study aimed to estimate the incidence, prev-
alence and disability-adjusted life years (DALY) for traumatic 
brain injury (TBI) in New Zealand (NZ) in 2010.  Methods: A 
multi-state life table model was constructed using inputs 
from the Brain Injury Outcomes New Zealand in the Commu-
nity study for the first-ever incidence of TBI in a lifetime and 
its severity distribution, from the NZ Ministry of Health’s Mor-
tality Collection for the data on TBI mortality and from Sta-
tistics of NZ for the population data. The modeled estimate 
of prevalence was combined with the disability weights for 
TBI (by stage and severity level) from the Global Burden 
of  Disease 2010 study to obtain estimates of health loss 
(DALYs) for TBI.  Results: Approximately, 11,300 first-ever in-
cident TBIs occurred in NZ during 2010, with 527,000 New 
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epidemiology and health impact of TBI should guide 
health policy, including the allocation of resources to pre-
vention, treatment and rehabilitation.
 However, previous attempts to measure the impact of 
TBI suffer from major methodological limitations. For 
instance, many studies have focused solely on injuries 
that had been admitted to hospitals  [3] . Case ascertain-
ment often relies on clinical diagnosis alone  [4, 5] . Yet, 
TBI is often overshadowed by other comorbid injuries 
 [6] . Estimates based on routinely collected data may fail 
to identify a substantial proportion of TBI, especially mild 
cases  [4, 7] . Approximately, 70–95% of injuries are clas-
sified as mild severity  [1, 8] , which have been managed in 
the community by primary care providers, and the pa-
tients are not hospitalized  [7, 9] .
 The recently completed Brain Injury Outcomes New 
Zealand in the Community (BIONIC) study  [1] was the 
first to assess the incidence of TBI for all severities across 
all age groups and in both rural and urban populations. 
The authors found that when community cases were in-
cluded, the incidence of TBI, especially that of mild TBI, 
was far greater in NZ than had been previously estimated.
 The current study combines incidence rates of region-
al brain injury from the BIONIC study with current mor-
tality statistics and NZ population data to construct a 
multi-state life table model to estimate national inci-
dence, prevalence and disability-adjusted life years 
(DALY) for TBI in NZ during 2010. The DALY is an in-
tegrated measure of health loss that combines both fatal 
and non-fatal health outcomes into a single metric  [10] .
 Materials and Methods 
 Brain Injury Outcomes: NZ in the Community Study 
 TBI was defined according to the World Health Organization 
(WHO) recommendations as an acute brain injury caused by me-
chanical energy to the head from external physical forces which 
resulted in the presence of one or more of the following: (1) confu-
sion or disorientation, (2) loss of consciousness, (3) post-traumat-
ic amnesia, and (4) other neurological abnormalities (e.g. focal 
signs, seizure)  [11] .
 Incidence estimates were obtained from the BIONIC study. 
This is a large prospective population-based TBI register covering 
the total population of the Hamilton and Waikato districts of NZ 
(approximately 170,000 rural and urban residents). The popula-
tion from Hamilton and Waikato districts has demographic and 
social characteristics that are reflective of the NZ population ac-
cording to the 2006 NZ census data. Details on the methodology 
of the BIONIC study are described elsewhere  [12, 13] . All cases 
(n  = 1,369) of TBI were ascertained over a 12-month period be-
tween March 1, 2010 to February 28, 2011, using prospective and 
retrospective surveillance. Complete case ascertainment was as-
sured by using multiple overlapping sources of information for all 
the newly hospitalized and non-hospitalized TBI cases (fatal and 
non-fatal). Hot pursuit methods were used to identify additional 
cases of TBI through cross-checks of general practitioner databas-
es and hospital admissions.
 Regional TBI incidence estimates and the definition of TBI se-
verity utilized are reported elsewhere  [1] . Our focus is on the esti-
mation of first-ever incidence of TBI in a lifetime (n = 521); as a 
measure of true incidence, this is different from the injury rates 
(incidence and recurrent TBI) that had previously been reported 
 [1] . TBI mortality was defined as deaths resulting from TBIs as 
registered in the NZ Ministry of Health’s Mortality Collection 
(ICD10 S06.0–S06.9). Deaths from causes other than TBI are de-
scribed as ‘other cause’ mortality. All-cause deaths and population 
denominator data were obtained from Statistics NZ.
 Current TBI Incidence, Prevalence and Mortality Estimates 
 Age and sex structures of population census data during 2006 
for Hamilton city (urban residents) and Waikato district (rural 
residents) were used as denominators to calculate age- and sex-
specific TBI regional incidence. These data were then extrapolated 
over the NZ national population. Due to the low number of deaths 
recorded in the BIONIC study, TBI mortality rates for 2010 ob-
tained from the national mortality collection were used.
 Multi-state life tables were constructed using DISMOD II soft-
ware  [14, 15] as used in the Global Burden of Disease (GBD) stud-
ies for estimating the epidemiology of a disease. This software 
package is based on a series of algorithms reflecting the mathemat-
ical relationships between incidence, prevalence, remission, cause-
specific mortality and ‘other cause’ mortality. The theoretical 
background and the application of multi-state life tables to epide-
miology are discussed elsewhere  [14, 16] .
 The model was built by first smoothing the input data using a 
‘moving average’ interpolation, whereby smoothening out shape 
continuities between adjacent 5-year age groups prevents difficul-
ties in modeling prevalence. The incidence estimates were consid-
ered more reliable than the cause-specific mortality estimates, 
which were derived from routine cause-of-death coding. Accord-
ingly, the DISMOD modeling was carried out by anchoring on 
incidence, thereby giving less ‘weight’ to the excess mortality esti-
mates. Remission was zero by definition (since at this stage we are 
modeling the prevalence of survivors of first ever in lifetime TBI, 
irrespective of disability level). Direct standardization was em-
ployed to age standardize the rate to the world population, using 
the WHO world standard population  [17] for comparison of sub-
groups. Computing of 95% uncertainty intervals were performed 
using the 2.5th and 97.5th percentile of the distribution.
 Quantifying DALYs 
 Population burden of TBI was measured in DALYs  [10, 18] . 
DALYs can be expressed as the sum of the ‘years of life lost’ (YLL) 
and ‘years lived with disability’ (YLD). YLL was calculated by mul-
tiplying the number of deaths due to TBI by the remaining life ex-
pectancy at the age of occurrence in 5-year age bands. Remaining 
life expectancy at each age was taken from the GBD 2010 standard 
life table  [19] . YLDs were calculated by multiplying the prevalence 
of the condition by severity level in each 5-year age band by the 
relevant disability weight, taken from the GBD 2010.
 At 12 months post TBI, the proportion of participants identi-
fied as having no, mild or moderate/severe disability (defined by 
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the Glasgow Outcome Score  [20] ) was sourced from the BIONIC 
data set and used to determine the probability of residual disabil-
ity (i.e. after 12 months). If an individual had residual disability 
(including mild or moderate/severe TBI) at 12 months, this was 
assumed to persist for a lifetime  [2] .
 Disability weights are based on health state valuations on a scale 
from 0 (no health loss) to 1 (complete health loss, equivalent to be-
ing dead), estimated from a set of global health surveys  [8, 18] . 
Disability weights were specific for stage (i.e. year post occurrence) 
and level of severity  [10, 21] . A short-term (year 1) disability weight 
of 0.235 was assigned to all cases  [10] . A long-term (year 2+) dis-
ability weight for mild and moderate/severe residual disability of 
0.106 and 0.425, respectively, was also applied  [10, 21] . A disabil-
ity weight of 0 was attributed to those with no neurological deficit 
after the first year post TBI.
 Results 
 Incidence 
 Table 1 summarizes the estimated national incidence 
of first-ever in lifetime TBI in NZ during 2010. Higher 
incidence rates of first-ever TBI are observed among 
younger age groups and among males. Translating rates 
into counts, the model estimates that almost 11,300 first-
ever TBIs occurred in NZ in 2010, 57% of them in males. 
Almost 43% of first-ever TBIs occurred in people aged 
0–14 years. The crude incidence rate of first-ever TBI was 
281 cases per 100,000 person-years (males 330 cases per 
100,000, females 233 cases per 100,000). The estimated 
mean age at diagnosis of first TBI was 23.0 years (males 
22.9 years and females 23.9 years).
 Prevalence 
 Modeled prevalence estimates of TBI are summarized 
in  table 2 . The results indicate that in 2010 approximate-
ly 527,400 New Zealanders (13% of the NZ population) 
had experienced at least one TBI event at some time in 
their lives. Crude prevalence estimates were 14.8% for 
males and 11.4% for females. The prevalence of TBI was 
23% higher in males than it was in females, adjusting for 
differences in age distributions. The highest prevalence 
occurred in the age group of 40–49 years age group in 
both male and female. The age distribution of TBI survi-
vors is skewed to the right with two-thirds (68%) of prev-
alent cases aged 35 years and older.
 Duration of Survival 
 Table 3 presents the estimated duration of survival af-
ter first-ever TBI (i.e. the time from occurrence of first 
TBI to death from any cause). Males were slightly young-
er at onset than females and also had a higher mortality. 
On an average, females survived nearly 5 years longer af-
ter the first TBI than males (58.9 vs. 54.3 years).
Table 1.  Modeled age- and sex-specific incidence of first TBI, 2010
Age group, 
years
Rates per 100,000  Number of new cases
male female persons ma le female persons
0–4 685 (534–744) 602 (557–651) 644 (546–698) 962 (750–1,044) 811 (750–877) 1,773 (1,500–1,921)
5–9 591 (314–673) 494 (458–529) 543 (386–601) 866 (460–986) 691 (641–740) 1,557 (1,101–1,726)
10–14 563 (387–633) 436 (404–468) 501 (396–551) 885 (608–994) 649 (601–697) 1,534 (1,209–1,691)
15–19 556 (470–636) 380 (357–406) 469 (414–521) 847 (716–970) 562 (528–600) 1,409 (1,244–1,570)
20–24 466 (415–526) 264 (249–283) 365 (332–405) 630 (561–711) 359 (338–385) 989 (899–1,096)
25–29 342 (313–372) 187 (180–196) 262 (247–284) 401 (367–436) 235 (226–245) 636 (593–681)
30–34 232 (221–243) 149 (143–155) 189 (182–199) 304 (290–318) 218 (209–225) 522 (499–543)
35–39 173 (167–178) 122 (119–126) 146 (143–152) 247 (239–255) 194 (188–199) 441 (427–454)
40–44 164 (159–170) 102 (99–104) 132 (129–137) 248 (240–256) 166 (162–169) 414 (402–425)
45–49 192 (186–199) 97 (94–99) 143 (140–149) 275 (266–284) 146 (142–149) 421 (408–433)
50–54 202 (193–210) 104 (101–106) 152 (147–158) 250 (239–262) 133 (130–136) 383 (369–398)
55–59 164 (159–169) 132 (128–136) 148 (144–153) 189 (184–195) 156 (151–161) 345 (335–356)
60–64 164 (158–169) 199 (189–207) 182 (174–188) 145 (140–149) 181 (173–189) 326 (313–338)
65–69 112 (108–116) 165 (159–171) 139 (134–144) 81 (78–83) 126 (121–131) 207 (199–214)
70–74 68 (66–69) 93 (90–97) 81 (78–83) 38 (37–39) 57 (55–59) 95 (92–98)
75–79 83 (81–85) 63 (62–64) 73 (72–75) 38 (37–39) 35 (34–35) 73 (71–74)
80–84 134 (128–139) 88 (85–89) 111 (107–114) 39 (37–40) 38 (37–39) 77 (74–79)
85+ 244 (232–256) 145 (140–149) 195 (186–203) 43 (41–45) 56 (55–58) 99 (96–103)
 Results are indicated as point estimates with 95% uncertainty intervals in parentheses.
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 TBI-Related Mortality 
 TBI-related deaths among males were 1.98 times high-
er than in females, with an annual death rate of 15 deaths 
per 100,000 in the males compared with 8 deaths per 
100,000 in the females. Translating rates into counts, 448 
deaths in 2010 were estimated to be attributable to TBI, 
of which 293 (66%) were male. Modeled TBI-related 
deaths numbered 16% fewer than those registered as be-
ing caused by TBI in routine mortality statistics (448 
modeled deaths vs. 519 registered).
 DALYs Due to TBI in NZ 
 As presented in  table 4 , TBI accounted for approxi-
mately 20,300 DALYs. This is 27% of all injury-related 
health loss and 2.4% of DALYs from all causes in 2010 
 [21] . The TBI DALYs were made up of 14,386 YLLs 
(71%) and only 5,891 YLDs (29%). Thus, the majority of 
health loss due to TBI reflects fatal outcomes. Of the non-
fatal health loss from TBI, 56% (approximately 3,300 
YLDs) resulted from mild cases and 44% (approximately 
2,600 YLDs) from moderate to severe cases. DALY rates 
Table 2.  Modeled age- and sex-specific prevalence of people who have had one or more TBI in 2010
Age 
group, 
years
Rates per 100,000 Number of cases 
male female persons ma le female persons
0–4 1,739 
(1,580–1,836)
1,533 
(1,419–1,661)
1,638 
(1,500–1,749)
2,441 
(2,217–2,578)
2,064 
(1,911–2,237)
4,505 
(4,128–4,815)
5–9 4,933 
(4,671–5,199)
4,286 
(3,954–4,572)
4,617 
(4,313–4,886)
7,229 
(6,845–7,618)
5,998 
(5,534–6,399)
13,227 
(12,379–14,017)
10–14 7,765 
(7,348–8,190)
6,564 
(6,133–6,976)
7,181 
(6,741–7,583)
12,199 
(11,545–12,868)
9,774 
(9,132–10,387)
21,973 
(20,677–23,255)
15–19 10,570 
(9,972–11,185)
8,626 
(8,221–9,100)
9,614 
(9,097–10,143)
16,114 
(15,201–17,050)
12,746 
(12,148–13,446)
28,860 
(27,349–30,496)
20–24 13,085 
(12,311–13,924)
10,204 
(9,755–10,670)
11,640 
(11,033–12,297)
17,675 
(16,630–18,809)
13,867 
(13,256–14,500)
31,542 
(29,886–33,309)
25–29 15,022 
(14,068–15,942)
11,286 
(10,819–11,799)
13,092 
(12,444–13,871)
17,608 
(16,490–18,686)
14,133 
(13,549–14,775)
31,741 
(30,039–33,461)
30–34 16,371 
(14,390–17,297)
12,103 
(11,635–12,645)
14,123 
(13,013–14,971)
21,427 
(18,834–22,639)
17,631 
(16,949–18,421)
39,058 
(35,783–41,060)
35–39 17,302 
(12,224–18,209)
12,771 
(12,310–13,315)
14,920 
(12,267–15,762)
24,742 
(17,480–26,040)
20,249 
(19,518–21,110)
44,991 
(36,998–47,150)
40–44 18,068 
(13,020–18,951)
13,310 
(12,856–13,854)
15,599 
(12,938–16,403)
27,265 
(19,648–28,598)
21,669 
(20,929–22,554)
48,934 
(40,577–51,152)
45–49 18,900 
(13,870–19,776)
13,774 
(13,321–14,318)
16,273 
(13,596–17,047)
27,036 
(19,841–28,290)
20,712 
(20,030–21,529)
47,748 
(39,871–49,819)
50–54 19,863 
(14,851–20,749)
14,250 
(13,792–14,792)
17,011 
(14,322–17,771)
24,691 
(18,461–25,793)
18,300 
(17,712–18,996)
42,991 
(36,173–44,789)
55–59 20,714 
(15,717–21,605)
14,799 
(14,341–15,344)
17,717 
(15,029–18,475)
23,868 
(18,109–24,894)
17,514 
(16,972–18,159)
41,382 
(35,081–43,053)
60–64 21,465 
(16,477–22,365)
15,615 
(15,167–16,170)
18,492 
(15,822–19,268)
18,961 
(14,555–19,756)
14,253 
(13,844–14,759)
33,214 
(28,399–34,515)
65–69 22,102 
(17,121–23,022)
16,533 
(16,102–17,027)
19,237 
(16,612–20,025)
15,938 
(12,346–16,601)
12,637 
(12,307–13,014)
28,575 
(24,653–29,615)
70–74 22,429 
(17,448–23,360)
17,099 
(16,656–17,552)
19,647 
(17,052–20,456)
12,533 
(9,750–13,053)
10,441 
(10,170–10,717)
22,974 
(19,920–23,770)
75–79 22,670 
(17,630–23,609)
17,398 
(16,953–17,923)
19,813 
(17,292–20,766)
10,510 
(8,173–10,945)
9,544 
(9,300–9,832)
20,054 
(17,473–20,777)
80–84 23,024 
(18,058–23,956)
17,649 
(17,209–18,147)
19,815 
(17,634–21,052)
6,705 
(5,259–6,977)
7,609 
(7,419–7,824)
14,314 
(12,678–14,801)
85+ 23,792 
(19,132–24,694)
18,208 
(17,766–18,691)
19,949 
(18,449–21,693)
4,204 
(3,381–4,363)
7,101 
(6,929–7,289)
11,305 
(10,310–11,652)
 Results are indicated as point estimates with 95% uncertainty intervals in parentheses.
D
ow
nl
oa
de
d 
by
:  
. S
. K
AR
G
ER
, B
AS
EL
   
   
   
   
   
   
   
   
   
   
   
   
   
 - 
27
78
1
14
9.
12
6.
78
.9
7 
- 6
/1
6/
20
15
 1
:4
6:
27
 P
M
 Burden of Traumatic Brain Injury in 
New Zealand 
Neuroepidemiology 2015;44:255–261
DOI: 10.1159/000431043
259
were approximately twice as high in males than in females 
(adjusting for differences in their age distributions). 
DALY rates were higher in the younger than in the older 
age groups, peaking in the 20–24 years age group ( fig. 1 ).
 Discussion 
 The aim of this study was to estimate the first-ever in-
cidence of TBI in a lifetime, prevalence of TBI survivors 
in the population, deaths attributable to TBI and loss of 
health attributable to TBI (denominated in DALYs) in 
NZ during the year 2010. Combining information from 
the BIONIC study with the NZ national health data, the 
modeled results suggest that there were approximately 
11,300 first-ever TBI events in 2010 with a total preva-
lence of approximately 527,000. Males experienced high-
er rates of TBI than those of females. A high proportion 
of TBIs occurred among children (aged <16 years) and 
young adults (aged <34 years), accounting for about 75% 
of all the first-ever TBI cases.
 Health loss attributable to TBI in NZ was estimated to 
be approximately 20,300 DALYs in 2010. This is over 
one-quarter (27%) of all losses of health attributable to 
intentional and unintentional injuries in that year, and 
almost 2.4% of all losses of health from all causes (i.e. all 
diseases and injuries)  [22] . Importantly, we found that 
most of the loss of health attributable to TBI (71%) re-
Table 3.  Modeled survival times (years) of TBI survivors, 2010
Age at first TBI, years  Duration of survival after first TBI, years
ma le female
0–4 73.8 (73.6–74) 79.7 (79.6–79.8)
5–9 69.2 (27.7–69.3) 75 (75–75.1)
10–14 64.2 (48.2–64.4) 70.1 (70–70.2)
15–19 59.5 (55.9–59.7) 65.4 (65.4–65.5)
20–24 55.2 (53.5–55.3) 60.8 (60.7–60.8)
25–29 50.8 (49.7–50.9) 56 (56–56)
30–34 46.3 (45.5–46.4) 51.2 (51.1–51.2)
35–39 41.6 (41–41.7) 46.3 (46.3–46.4)
40–44 36.9 (36.4–37) 41.6 (41.6–41.6)
45–49 32.3 (32–32.4) 36.9 (36.9–36.9)
50–54 28 (27.7–28.1) 32.3 (32.3–32.4)
55–59 23.7 (23.5–23.8) 27.7 (27.7–27.8)
60–64 19.7 (19.5–19.7) 23.6 (23.6–23.6)
65–69 16.1 (16–16.2) 19.8 (19.8–19.9)
70–74 12.6 (12.4–12.6) 16.2 (16.2–16.3)
75–79 9.3 (9.2–9.3) 12.7 (12.7–12.8)
80–84 6.9 (6.8–6.9) 9.8 (9.8–9.9)
85+ 4.3 (4.2–4.3) 7 (7–7)
 Results are indicated as point estimates with 95% uncertainty intervals in parentheses.
Table 4.  DALYs due to TBI, 2010
  YLL YLD (mild) YLD 
(moderate 
severe)
% YLD due to 
short-term 
consequence
% YLD due to 
long-term 
consequence
DALYs DALYs per 
100,000 
population
Current 2010
Boys and men 9,823 1,745 2,153 39 61 13,721 698
Girls and women 4,564 1,532 461 57 43 6,556 318
Total 14,386 3,277 2,614 45 55 20,277 503
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sulted from fatal injuries. However, non-fatal outcomes 
(i.e. disability) still accounted for a substantial share of the 
total TBI burden. While both moderate/severe and mild 
TBI contributed to this non-fatal burden, mild TBI made 
the greater contribution (56% of total TBI YLDs).
 Our findings are consistent with previously reported 
studies. Tagliaferri et al.  [23] reviewed 23 studies con-
ducted in Europe and reported an aggregate incidence 
rate of those hospitalized due to TBI as 235 per 100,000 
person-years. However, these estimates reflect episode 
rates of TBI (incident and recurrent) sourced from hos-
pitalization data. In the BIONIC study, approximately 
30% of incident TBI cases were never seen in hospital. 
Similarly, Corrigan et al.  [3] reviewed the incidence and 
prevalence studies regarding TBI that were conducted in 
the United States and abroad. The authors concluded that 
approximately 235,000 Americans were hospitalized for 
non-fatal TBI each year, but were unable to estimate the 
incidence of non-hospitalized events. In contrast, a pro-
spective birth cohort study by McKinlay et al.  [24] found 
the incidence of TBI to be much higher. The authors re-
ported an incidence rate of 1,750 per 100,000 per year. 
The result was based on a population capture methodol-
ogy that included people with non-hospitalized TBI. 
However, their findings were limited to an age group of 
0–25 year age group. It is of note that high quality epide-
miological design and case ascertainment are lacking in 
most previous studies. TBI DALYs have previously been 
reported for NZ in the New Zealand Burden of Disease 
Study  [21] . These estimates are consistent with those re-
ported here, despite differences in time period, method-
ology and data sources.
 Strengths of this study include the use of data from a 
population-based TBI incidence study  [1, 12, 13] . Unlike 
previous studies  [4, 8, 9] , the estimates reported here are 
based on the investigations conducted on TBI in both 
hospital and community settings across all ages and se-
verities of injury.
 The main limitation of our study is the use of routine-
ly collected mortality data to estimate TBI mortality. 
However, the multi-state life table model corrects for in-
accuracy in routine cause of death coding. Thus, we esti-
mated 448 deaths from TBI in NZ in 2010, whereas 519 
deaths were coded to this cause in the official mortality 
statistics. This correction is itself a useful output of our 
study and helps to inform policy makers regarding the 
true impact of TBI on our society. The reasons for TBI 
appearing to be over-reported as the underlying cause of 
death require further investigation so as to help us under-
stand the coding of underlying causes of death, especially 
where multiple trauma is involved. Secondly, the data 
used on levels of disability (from the BIONIC Study) is 
subject to self-report bias; however, it is the best available 
data.
 Finally, the model as currently constructed does not 
disaggregate by ethnicity or by socioeconomic status due 
to insufficient data. This clearly reduces the policy rele-
vance and value of our findings. Despite these limitations, 
the model still provides an internally consistent descrip-
tion of TBI epidemiology (including incidence, preva-
lence and survival) and current burden (including both 
YLL and YLD).
 In conclusion, the current study quantifies the sub-
stantial population health impact of TBI in NZ. Further 
studies are needed to extend the findings to ethnic and 
socioeconomic subpopulations and study trends in TBI 
 Fig. 1.  TBI DALYs by sex and total population. 
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epidemiology and impacts over time, including recurrent 
TBI. Such data is essential for planning and evaluating 
public health interventions and clinical TBI services.
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Appendix six: DISMOD II input variables 
 
Table 37: Input variables in DISMOD II modelling for traumatic brain injury in New Zealand, 2010 
Age 
group 
(years) 
Input Variables 
Incidence  
*(100 000)† 
Mortality  
* (100 000)ⱡ 
Total Population§ 
Male Female Male Female Male Female 
0-4 772.38 664.81 5.7 3.71 140,379 134,697 
5-9 500.45 461.2 0.68 0.71 146,535 139,956 
10-14 442.73 307.5 2.55 2.69 157,116 148,896 
15-19 687.43 510.55 17.71 7.44 152,439 147,762 
20-24 422.78 234.47 24.43 9.57 135,084 135,891 
25-29 351.41 180.09 19.62 3.99 117,216 125,226 
30-34 213.33 156.94 10.7 1.37 130,884 145,677 
35-39 155.36 106.5 18.18 2.52 143,001 158,550 
40-44 170.07 107.08 13.92 6.76 150,900 162,798 
45-49 196.5 81.66 9.09 7.98 143,052 150,369 
50-54 225.64 151.69 17.7 4.67 124,308 128,421 
55-59 137.55 108.51 15.62 3.38 115,224 118,347 
60-64 182.82 261.32 16.98 5.48 88,335 91,278 
65-69 203.5 187.27 22.19 17.01 72,111 76,434 
70-74 50.58 90.7 32.21 21.29 55,878 61,059 
75-79 125.55 50.05 28.04 14.58 46,359 54,858 
80-84 109.4 512.82 103.01 51.03 29,124 43,113 
85+ 303.03 143.99 192.42 112.82 17,670 39,000 
Notes 
† First-ever TBI incidence rates derived from the Brain Injury Outcomes New Zealand in the Community 
(BIONIC) study (Feigin et al., 2013). 
ⱡ TBI-related mortality obtained from the New Zealand Mortality Collection Database, Ministry of Health, 2010 
(Ministry of Health, 2010a) 
§ New Zealand general population based on 2006 census information, obtained from Statistics New Zealand. 
(Population projection assumes medium fertility, mortality and net migration) (Statistics New Zealand, 2010b) 
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Cost of traumatic brain injury in
New Zealand
Evidence from a population-based study
ABSTRACT
Objective: We aimed to estimate from a societal perspective the 1-year and lifetime direct and
indirect costs of traumatic brain injury (TBI) for New Zealand (NZ) in 2010 projected to 2020.
Methods: An incidence-based cost of illness model was developed using data from the Brain Injury
Outcomes New Zealand in the Community Study. Details of TBI-related resource use during the
first 12 months after injury were obtained for 725 cases using resource utilization information
from participant surveys and medical records. Total costs are presented in US dollars year
2010 value.
Results: In 2010, 11,301 first-ever TBI cases were estimated to have occurred in NZ; total first-
year cost of all new TBI cases was estimated to be US $47.9 million with total prevalence costs of
US $101.4 million. The average cost per new TBI case during the first 12 months and over a life-
time was US $5,922 (95% confidence interval [CI] $4,777–$7,858), varying from US $4,636
(95% CI $3,756–$5,561) for mild cases to US $36,648 (95% CI $16,348–$65,350) for mode-
rate/severe cases. Because of the unexpectedly large number of mild TBI cases (95% of all TBI
cases), the total cost of treating these cases is nearly 3 times that of moderate/severe. The total
lifetime cost of all TBI survivors in 2010was US $146.5 million and is expected to increase to US
$177.1 million in 2020.
Conclusion: The results suggest that there is an urgent need to develop effective interventions to
prevent both mild and moderate/severe TBI. Neurology® 2014;83:1645–1652
GLOSSARY
BIONIC 5 Brain Injury Outcomes New Zealand in the Community; CI 5 confidence interval; GCS 5 Glasgow Coma Scale;
ICD-10 5 International Classification of Diseases, tenth revision; MOH 5 Ministry of Health; NMDS 5 National Minimum
Dataset; NZ 5 New Zealand; TBI 5 traumatic brain injury; WIES 5 Weighted Inlier Equivalent Separations.
Traumatic brain injury (TBI) is the leading cause of long-term disability in children1 and young
adults,2 having a significant impact on the person, their family, caregivers, and society.3 A recent
TBI population-based incidence and 1-year outcomes study (Brain Injury Outcomes New
Zealand in the Community [BIONIC])2 found that the incidence of TBI in the population
is far greater than previously estimated.
Previous authors have concluded that the financial burden of TBI is substantial,4–6 with
hospitalization costs accounting for 60% to 70% of overall direct medical costs.7–11 Previous
studies are limited because they focused primarily on hospitalized individuals.12 These patients
tend to have the most severe injuries. Cases of mild TBI (defined by Glasgow Coma Scale [GCS]
score $13) constitute 95% of all cases2 and frequently are not hospitalized. By focusing on
hospitalized cases, previous studies might overstate the average cost per individual but understate
the total cost of TBI to society. A further limitation of previous studies is the lack of inclusion of
nonhospitalization costs of TBI.
From the National Institute for Stroke and Applied Neurosciences (B.T.A., A.T., K.J., V.L.F.), and Health and Rehabilitation Research Institute
(K.M.), Faculty of Health and Environmental Studies, AUT University, Auckland, New Zealand; School of Social Sciences, Humanities and Arts
(P.B.), University of California, Merced; Public Health Intelligence (M.T.), Ministry of Health, Wellington; School of Population Health, Faculty
of Medical and Health Sciences (S.A.), and Department of Psychology (S.B.-C.), The University of Auckland; Department of Psychology (N.S.),
Faculty of Arts and Social Sciences, The University of Waikato, Hamilton; and Primary Health Care and General Practice (A.D.), University of
Otago, Wellington, New Zealand.
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Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
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This study utilized data from the
population-based BIONIC Study in combina-
tion with electronic hospital records, official
death records, and self-reported health services
usage. The objective was to estimate the soci-
etal cost of TBI in the first year, and lifetime
direct and indirect costs of TBI by severity lev-
els for New Zealand (NZ) in 2010 projected
to 2020.
METHODS Estimating NZ TBI incidence and
prevalence. The BIONIC Study used multiple overlapping
sources of information to capture all new TBI cases (fatal/nonfa-
tal, hospitalized/nonhospitalized) across all ages and all TBI se-
verities (mild, moderate, severe) in urban and rural residents of
Hamilton and Waikato Districts (population approximately
173,000) from March 1, 2010 to February 28, 2011. All TBI
cases consenting to participate in the study (n5 725; 53%) were
followed up over 12 months post-TBI. Further details of the
methodology, diagnostic criteria, and main incidence results of
the study are reported elsewhere.2,13
Where possible, all surviving participants were interviewed at
baseline and 1, 6, and 12 months postinjury. TBI severity was
defined using standard definitions14–16 (see e-Methods on the
Neurology® Web site at Neurology.org). Baseline information
included demographics, medical history, and place of residence
before TBI. One-month assessment documented initial acute
treatment. At 6 and 12 months, participant’s use of outpatient,
rehabilitation and home care services, and health status were
recorded. Information on emergency department presentations
and hospital admissions was obtained from the National Mini-
mum Dataset (NMDS), NZ Ministry of Health (MOH). The
NMDS includes all presentations and admissions to public or
private hospitals in NZ and these are linked to individuals via
National Health Index numbers.17 Only services funded in whole
or part by District Health Boards and the Accident Compensa-
tion Corporation, a no-fault personal accident insurance cover
(health funders in NZ), were available.
Prevalence was modeled18 from data on incidence, remission,
and mortality using multistate life table methods.19,20 Compared
with the total NZ population census (base 2006) information, the
Hamilton and Waikato populations have demographic and social
characteristics that are reflective of NZ. TBI incidence and prev-
alence were estimated for NZ in the reference year and then
projected to 2020, assuming similar trends in TBI prevalence
to that estimated for 2010.
Cost of illness model. An incidence-based cost of illness model
(bottom up approach) was developed to estimate the economic
cost of TBI in NZ. All costs are expressed in US dollars using
purchasing power parity conversion rate of 1.49 (NZ$).21
Costs. The types and unit costs of each health service are shown
in table e-1. The cost analysis included direct health care costs
(e.g., hospitalizations, outpatient rehabilitation services), indirect
costs (e.g., productivity loss for person with TBI), and out-of-
pocket expenses (e.g., aids, home modification).
Hospital inpatient and outpatient costs. TBI hospitaliza-
tions were confirmed by ICD-10 codes S06.0 to S06.9. NZ has
a national health service with government-run hospital care
available free of charge. There is one major hospital in the Wai-
kato Region that provides care for the region22 (see e-Methods for
background of NZ health system). The cost of hospital care is
assessed from hospital reimbursements from the MOH. Hospi-
talization costs were determined using weighted discharge value
(i.e., Weighted Inlier Equivalent Separations [WIES]) for all
NMDS events by the MOH.17 The national price for financial
year 2010/2011 per WIES was US $2,959.98.23 Because the
hospital services are provided by the publicly owned District
Health Boards (not patient charges), the costs are internal
weighted estimates (based on Disease Related Groups and length
of stay) of the cost of each type of care. WIES cost weight includes
medical costs, ward stay, medication, laboratory tests, diagnostic
imaging, and nursing and other ward staff.
Community and home support. Although most formal care
for home support services is funded by the state, providers con-
tracted with the government provide the bulk of services. As such,
no accurate information exists on individual charges for TBI-
related community and home support. To estimate the cost of
these services, a resource-based costing approach was used where a
common price was applied to each resource (e.g., cost per hour
per therapist).
Number of visits to therapists (i.e., visiting nurses, physiothera-
pists, medical specialists, occupational therapist, speech therapist,
general practitioners, counselors, psychologists, and social workers)
over the month before each BIONIC assessment (i.e., 1, 6, and 12
months post-TBI) was assessed via patient and significant other
questionnaires. The cost of therapy visits was estimated by multi-
plying visit number by resource unit cost. Similarly, hours of home
support (home help and personal care) were estimated using
BIONIC follow-up questionnaire data by multiplying the number
of hours provided by the current cost of care for the service (in US$,
2010). Finally, the cost of basic maintenance and home modifica-
tion support resulting from TBI was estimated by combining infor-
mation obtained from the patient, family, or caregiver survey
responses with current market prices.
Direct costs included hospitalization and emergency depart-
ment visits, regardless of whether they resulted in an admission,
and the number of therapy visits provided to individuals living
at home included home help and personal care services. All cate-
gories were summed together to estimate average cost per case.
Lifetime direct costs associated with TBI. At each follow-up,
BIONIC participants were questioned about direct medical
resources used relating to their TBI. At 12 months post-TBI,
the proportion of participants identified as having a moderate to
severe disability (defined by the Glasgow Outcome Scale) was
sourced from the BIONIC dataset and used to determine the
probability of needing ongoing health resources (i.e., after 12
months). If an individual had residual disability (including mild
or moderate/severe TBI) at 12 months, this was assumed to
persist for a lifetime. A weighted average cost for adults and
children identified as having a moderate to severe TBI was then
calculated (i.e., average direct cost per case 3 probability of
having a moderate/severe disability). The discounted lifetime
health care costs (see statistical analysis section) occurring in
each year were then summed together with the first-year costs.
Productivity loss. First, production losses within 12 months of
injury were estimated only for a friction period after the loss of
paid work.24,25 Short-term productivity loss was valued using a
friction cost approach, which assumes that individuals absent
from paid employment because of disablement or early
mortality will be replaced after a specific time period.25 In line
with previous cost of illness studies, a friction period of 3 months
was used.26 Second, at 12-month follow-up, the proportion of
participants reporting a decrease in income was identified. The
value of time lost from employment or productive activity up to
age 65 years was estimated for adults in paid workforce and adults
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in unpaid productive activity before injury. Costs of productivity
were estimated using reported loss of income from BIONIC case
record forms combined with Statistics NZ data on average weekly
earnings linked to occupation for those who were in the paid
workforce.27 Because of lack of accurate information, cost of
informal care (including care for childhood TBI) or
compensation was not included in our analysis.
Statistical analysis. SPSS statistics version 20 (IBM Corp.,
Armonk, NY) was used to analyze data. Costs per person and total
cost for NZ are presented as means with 95% confidence intervals
(CIs) for a given year and over a lifetime. Significance of differences
between the costs of mild and moderate/severe TBI was tested using
t tests andWilcoxon rank sum tests. Significance level was set at p,
0.05 (2-sided). Multivariate probabilistic uncertainty analyses
including a 5,000 replications Monte Carlo simulation were
undertaken using @Risk software version 6 (2013; Palisade
Corporation, Ithaca, NY) to test the uncertainty of the estimates
and strength of the results. Calculation of sensitivity analysis used
gamma distributions for cost estimates. A discount rate of 3.5% was
used for lifetime cost projections as recommended by the NZ
Treasury28,29 and PHARMAC (NZ Pharmaceutical organization).30
RESULTS Incidence and prevalence of TBI in NZ. In
2010, 11,301 first-ever TBI cases were estimated to
have occurred in NZ, 57% of whom were male. The
majority (75%) were younger than 35 years. Taken
together, the total number of patients with TBI in
NZ (including prevalent cases) was estimated to be
527,388. In 2020, the number of first-ever cases was
estimated to increase to 13,591 and the number of
prevalent cases (period prevalence) was expected to
increase to 641,104 cases.
Average first-year per-person cost of TBI in NZ. A detailed
breakdown of 12-month follow-up resources used and
average per-person costs is presented in table 1. Of the
725 cases, approximately 64% were not initially
hospitalized for their TBI. Of those who were
hospitalized, survivors spent on average 2.6 days
(95% CI 1.8–3.3) in hospital. After discharge, most
patients used general practitioner (36% [263]), allied
health (18% [133]), and specialized medical (14%
[105]) services at follow-up. Total direct health care
costs over 12 months per patient amounted to US
$3,783 (minimum US $26, maximum US
$112,115). On average, 17% (124) reported having
lost income due to their injury; costs attributable to
production losses were estimated at US $2,000
(minimum US $163, maximum US $13,252), with
an average total first-year cost of US $4,123 per person
(95% CI $3,442–$4,997). This amount reflects the
high proportion of mild TBI (95%) identified in the
Table 1 Proportion and cost per case for the categories of resource use during the first year and cost of all
traumatic brain injury in New Zealand
Users, %
(n 5 725)
Resources per
patient (mean no. of
days or no. of visits)
Cost per category, US$
Mean 95% CIa
Health care
Emergency department 42 $181
Initial hospitalization 36 2.6 $2,936 $2,119–$3,893
Hospital readmission 4 6.5 $4,704 $2,410–$7,692
Outpatient care 6 6.1 $1,791 $967–$3,975
Specialized medical care 14 9.6 $2,333 $1,731–$2,968
Allied health care 18 21.4 $4,221 $3,410–$5,161
General practice 36 9 $954 $835–$1,081
Nursing 4 19.1 $2,259 $1,091–$3,964
Radiology 1 3.8 $2,379 $534–$4,918
Community services 3 $21,299 $10,706–$34,809
Out-of-pocket expenses 4 $693 $236–$1,288
Other expense 100 $144 $142–$146
Total direct medical costs per person 100 $3,783 $3,091–$4,670
Non–health care (indirect) loss in productivity 17 $2,000 $1,658–$2,385
Total 1-y costs per person 100 $4,123 $3,442–$4,997
Ongoing direct medical costsb 5 $17,402 $6,276–$33,403
Long-term productivityb 3 $30,960 $16,923–$47,775
Total lifetime cost per personb 100 $5,922 $4,777–$7,858
Abbreviation: CI 5 confidence interval.
a Bootstrap results are based on 1,000 bootstrap samples.
b3.5% discount rate used.
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study and the high proportion of cases not needing
acute hospitalization.
Average first-year cost by TBI severity. Table 2 summa-
rizes resources used and average per-person cost in
survivors who had a mild or a moderate/severe TBI.
Most cases (n 5 691 of 725; 95%) were mild (GCS
score $13) and 34 cases were moderate/severe
(GCS score #12). A consistent pattern of resource
usage was found in the mild cohort, with cost
composition varying over the 12-month follow-up
period; general practice (n 5 253; 37%) and allied
health services (n 5 119; 17%) were the most
frequently used. In contrast, a higher percentage of
those with moderate/severe TBI (n 5 30; 88%)
required initial hospitalization (minimum US $583,
maximum US $73,367) with an average length of
stay of 13.4 days (95% CI 7.3–19.6). Of those who
were hospitalized, 12% (4 of 34) were readmitted. Cost
of hospital readmission was significantly greater than for
those with mild injuries (Wilcoxon rank sum z 5
22.191, p 5 0.028). Of the 34 admitted, after
discharge allied health services (41%), general
practitioner (32%) and specialized medical care (29%)
were the most frequently utilized services, with 12%
having some community home care support. One-
year cost per case for mild (95% of all cases) and
moderate/severe TBI was US $3,395 (95% CI
$2,803–$4,021) and US $21,379 (95% CI $11,957–
$31,505), respectively. Because of the higher cost of
hospitalization, 1-year cost of moderate/severe TBI
was significantly greater than for mild TBI (Wilcoxon
rank sum z525.914, p# 0.0001). However, because
of the large number of mild cases, total costs of mild
TBI (10,771 3 $3,395) was 3 times that of moderate/
severe TBI (530 3 $21,379).
Total first-year incidence and prevalence costs.Details of
primary cost drivers during the first year for all TBIs
are in the figure. When applied to all TBI survivors in
NZ (table 3), the total first-year costs of all new cases
of TBI that occurred in NZ during 2010 were
estimated to be US $47.9 million (95% CI $35.7–
$59.3 million). Using a prevalence-based approach,
Table 2 Cost (in US$) of TBI in New Zealand by severity
Mild TBI (GCS ‡13) Moderate/severe TBI (GCS £12)
% of all mild
(n 5 691) Mean 95% CIa
% of all
moderate/
severe (n 5 34) Mean 95% CIa
Health care
Emergency department 41 $181 44 $181
Initial hospitalization 34 $1,888 $1,450–$2,394 88 $11,074 $4,979–$18,143
Hospital readmission 3 $3,774 $1,475–$7,155 12 $9,587 $5,385–$12,140
Outpatient care 6 $1,067 $528–$1,584 15 $7,584 $467–$21,256
Specialized medical care 14 $2,254 $1,599–$3,236 29 $3,090 $1,134–$6,111
Allied health care 17 $3,939 $3,189–$4,938 41 $6,613 $2,811–$11,182
General practice 37 $960 $842–$1,126 32 $815 $467–$1,283
Nursing 4 $1,548 $829–$2,495 12 $6,703 $705–$17,592
Radiology 1 $1,252 $362–$2,160 3 $6,883 —b
Community services 3 $19,894 $9,133–$35,711 12 $28,320 $1,869–$71,156
Out-of-pocket expenses 4 $763 $232–$1,439 15 $328 $208–$453
Other expense 100 $144 $141–$146 100 $152 $151–$153
Total direct medical costs per person 100 $3,079 $2,519–$3,668 100 $20,591 $11,405–$32,002
Non–health care (indirect) loss in productivity 16 $1,973 $1,591–$2,399 35 $2,250 $1,186–$3,617
Total 1-y costs per person 100 $3,395 $2,803–$4,021 100 $21,379 $11,957–$31,505
Ongoing direct medical costsc 4 $6,466 $3,778–$10,448 27 $53,856 $9,964–$127,981
Long-term productivity lossc 3 $32,753 $18,544–$50,393 6 $12,134 2$98,042–$122,310d
Total lifetime cost per personc 100 $4,636 $3,756–$5,561 100 $36,648 $16,348–$65,350
Abbreviations: CI 5 confidence interval; GCS 5 Glasgow Coma Scale; TBI 5 traumatic brain injury.
a Bootstrap results are based on 1,000 bootstrap samples.
bSample size in this group was too small to estimate 95% CI.
c 3.5% discount rate used.
dSome or all bootstrap sample results are missing, so no bootstrap estimation has been performed for this item.
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total cost for all TBIs equates to US $101.4 million
(95% CI $75.8–$125 million). Assuming similar
trends in TBI incidence to the reference year, the
prevalence cost of TBI is expected to increase by
21% to more than US $122.6 million (95% CI
$91.7–$151.3 million) in 2020.
Estimated lifetime costs per person. Total average life-
time cost per person was estimated at US $5,922
(95% CI $4,777–$7,858). Estimated lifetime costs
for mild and moderate/severe TBI were US $4,636
(95% CI $3,756–$5,561) and US $36,648 (95% CI
$16,348–$65,350), respectively (see tables 1 and 2).
The results suggest that the average lifetime cost of a
mild TBI is significantly lower (i.e., ,15%) than the
cost of moderate/severe cases. The total lifetime cost
of all incident and prevalent TBI cases in NZ was US
$146.5 million (95% CI $97.4–$194.7 million) in
2010 (see table 3).
Sensitivity and uncertainty analysis. Sensitivity analysis
indicated that total lifetime cost of TBI in NZ (TBI
occurring in 2010) ranges between US $57.7 mil-
lion and US $80.5 million (table 4). The average
lifetime cost per person was US $5,381 (95%
uncertainty interval $5,311, $5,485), ranging from
US $4,907 (95% uncertainty interval $4,829,
$5,027) for mild cases to US $39,783 (95% uncer-
tainty interval $38,985, $40,827) for moderate/
severe cases. Overall, the probabilistic sensitivity
analysis revealed that the results were robust to
changes in the parameter values.
DISCUSSION Our study utilized data from a
population-based TBI incidence study to report first-
year and lifetime costs of TBIs by severity levels for
NZ. The results suggest that the cost per TBI was
US $5,922, varying from US $4,636 for mild cases
to US $36,648 for moderate/severe cases. Although
the cost per case of mild TBI was significantly
lower than that of moderate/severe injuries, the
unexpectedly large number of mild TBI cases (95%
of cases) resulted in the total cost of treating mild
TBI being 3 times that of moderate/severe TBI. The
total lifetime cost of all TBI survivors in 2010 was
estimated at US $146.5 million.
The per-person (first-year) cost estimates reported
here are much lower than those reported in previous
studies.5,6,10,11,31,32 This may be because previous
studies focused primarily on patients who were hos-
pitalized for their TBI. These patients tend to have
more severe injuries and, as a result, the highest direct
Figure Accumulated first-year costs according to cost category for traumatic brain injury
Table 3 Current and future burden of TBI (US$ 2010)
Cost estimates for New Zealand Current burden 2010 Projected burden 2020
Incidence (first-ever TBI)
1-y direct health care cost $44,077,939 $52,476,407
1-y indirect cost $3,817,768 $4,576,946
1-y total cost $47,895,707 $57,053,354
Lifetime cost $69,357,619 $82,437,411
Prevalence (recurrent TBI)
1-y direct health care cost $93,254,189 $112,782,385
1-y indirect cost $8,132,954 $9,836,062
1-y total cost $101,387,143 $122,618,448
Lifetime cost $146,499,490 $177,177,693
Abbreviation: TBI 5 traumatic brain injury.
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and indirect health care costs. By contrast, the present
results are based on the first large prospective
population-based study investigating TBI incidence
and outcomes in hospitalized and nonhospitalized
patients with TBI.2,13
Information on the total cost and pattern of health
services usage post-TBI can be used for health services
planning, including helping hospitals and the MOH
(1) anticipate and budget for the health care services
needed to detect and treat TBI, (2) assess whether
new methods of testing or treating are cost effective,
and (3) identify disparities and inequities in accessing
and delivery of health services post-TBI. The cost per
case of TBI can also inform decisions regarding cost-
effective interventions to reduce TBI by providing
information on the costs that can be averted through
prevention activities.
There are a number of caveats regarding the inter-
pretation of the results. First, cost estimates only
report the services that people use. People with TBI
that is untreated or who have access to only limited
health care services and compensation beyond the
Table 4 Results of uncertainty analyses on cost estimates (US$ 2010)
Modeled point estimatesa 95% Uncertainty intervala
Mean Median Lower bound Higher bound
All TBI cases
No. of TBI cases 11,301 11,300 9,442 13,158
First-year direct costs $43,606,150 $43,604,992 $36,433,317 $50,772,988
First-year indirect costsb $4,610,589 $4,509,371 $3,625,360 $5,919,230
Total first-year costs $48,216,740 $47,470,385 $39,662,957 $55,273,743
Lifetime direct costsc $43,606,801 $43,606,072 $36,427,019 $50,776,760
Lifetime indirect costsc $17,203,864 $16,971,121 $13,724,878 $21,394,564
Total lifetime costsc $60,810,665 $69,148,050 $57,764,168 $80,519,858
Total first-year/incident TBI (cost per case) $4,273 $4,258 $4,242 $4,309
Total lifetime costs/incident TBI (cost per case) $5,381 $5,361 $5,311 $5,485
Mild TBI
No. of TBI cases 10,796 10,794 9,020 12,570
First-year direct costs $32,810,818 $32,810,119 $27,412,028 $38,204,803
First-year indirect costsb $4,090,254 $4,019,579 $3,196,114 $5,231,018
Total first-year costs $36,901,072 $36,262,542 $30,296,566 $42,225,050
Lifetime direct costsc $36,162,340 $36,142,348 $30,140,568 $42,192,448
Lifetime indirect costsc $16,820,254 $16,636,592 $13,412,929 $20,994,200
Total lifetime costsc $52,982,594 $50,038,236 $41,804,389 $58,263,595
Total first-year/incident TBI (cost per case) $3,418 $3,412 $3,393 $3,456
Total lifetime costs/incident TBI (cost per case) $4,907 $4,890 $4,829 $5,027
Moderate/severe TBI
No. of TBI cases 505 504 422 588
First-year direct costs $10,358,521 $10,358,364 $8,654,401 $12,061,414
First-year indirect costsb $477,091 $468,089 $372,874 $611,809
Total first-year costs $10,835,612 $10,759,274 $8,989,353 $12,528,277
Lifetime direct costsc $19,171,829 $19,069,217 $15,714,579 $22,878,453
Lifetime indirect costsc $918,298 $909,792 $736,903 $1,127,599
Total lifetime costsc $20,090,127 $18,318,790 $15,304,693 $21,330,493
Total first-year/incident TBI (cost per case) $21,456 $21,481 $21,392 $21,553
Total lifetime costs/incident TBI (cost per case) $39,783 $39,641 $38,985 $40,827
Abbreviation: TBI 5 traumatic brain injury.
a 5,000 simulations.
b Friction cost approach.
c 3.5% discount rate used.
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acute injury phase will have spuriously lower reported
costs. This is true in NZ where marginalized groups
have disproportionately lower access to health care
services. Further study is needed to identify the addi-
tional community and home services that are needed
by those who experience TBI. Second, accurate infor-
mation on some funded health services (e.g., primary
care, home/vehicle modification, vocational rehabili-
tation) is difficult to obtain. Although there are elec-
tronic records containing this information, there are
no central, accessible data with complete health serv-
ices usage. Given the access to nationwide hospitaliza-
tion data, it is likely that any missed cases were mild
rather than moderate or severe. Third, extrapolating
costs from one region to the entire county is subject
to error, particularly if differences in lifestyles, clinical
practices, and treatment options affect rates and
health services usage. Fourth, our methodology did
not provide accurate estimates of total caregiver time
and effort dedicated to supporting injured persons.
Caregiver time and expenses are clearly significant
costs to those living at home, but estimating them
requires a different methodology than used in the cur-
rent study. Fifth, the lifetime cost estimates, based on
short-term data, should be viewed as only approxi-
mate and highlight the need for a longitudinal study
of the long-term effects of TBI including cognitive
decline and dementia. Taken together, the uncer-
tainty caused by these factors may underestimate
the costs of TBI in NZ and care should be taken
when extrapolating the results to other counties.
In conclusion, the findings suggest that the eco-
nomic burden of TBI is significant and that improved
prevention and treatment strategies are warranted.
Significant cost savings may be achieved by prevent-
ing TBI, particularly for high-cost individuals. Fur-
thermore, given the high number of mild TBI
cases, public health officials should identify strategies
to reduce incidence of mild injuries. The results also
suggest that interventions to improve detection and
treatment outcomes will be associated with significant
cost savings. Further studies are required to identify
cost-effective strategies for prevention, detection,
and treatment, and to explore the impact of TBI on
families and caregivers.
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Appendix nine: Long-term productivity loss 
Long-term productivity loss was estimated using the following data sources and calculation:  
 From Statistics NZ 
o Average individual income was obtained and linked to occupation responses in the 
BIONIC questionnaire. 
o National median income in 2010 was used as a proxy measure for those participants in 
our sample that did not have individual income data. Using the median weekly wage 
(in 2010) of $769 yields an annual estimate of $39,988 ($769 * 52 weeks).  
 From the BIONIC dataset 
o Information on income decrease (at 12 months). Two possible options (i) 50% 
decrease (or 0.5) and (ii) 15% decrease (or 0.85). 
 Average income reduction was used as proxy for missing data. 
o Estimate for working age remaining (i.e. 65 years (age of retirement) subtracting their 
age). 
 This would yield: projected loss of productivity= % income decrease * individual annual income 
* working age remaining. 
Productivity loss was estimated for four categories based on survey response to having a reduction in 
their income at 12 months post TBI. 
1. Those who did respond to the question, and data was available for their occupation 
2. Those who did not respond to the question and data was available for their occupation. 
3. Those who responded to the question but no data on their occupation was available. 
4. Those who did not respond to the question and no data on their occupation was available (this 
included those who were of working age and not working). 
 Survey 
response 
Occupation data 
(linked to income) 
Formula used 
1 Yes Yes loss of productivity= % income decrease(from BIONIC 
questionnaire) * individual annual income * working age 
remaining 
2 No Yes loss of productivity= % income decrease (an estimate of 
reduction in productivity) * individual annual income * working 
age remaining 
3 Yes No loss of productivity= % income decrease (from BIONIC 
questionnaire) * average annual income (using median weekly 
wage) * working age remaining 
4 No No loss of productivity= % income decrease(an estimate of 
reduction in productivity) * average annual income (using 
median weekly wage) * working age remaining 
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